How many Osimertinib clinical trials are there?

246 Osimertinib clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 64 are actively recruiting participants. 51 are marked completed.

Are Osimertinib clinical trials recruiting in 2026?

Yes — 64 Osimertinib trials are actively recruiting in 2026, with 1678 U.S. sites across 51 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Osimertinib being studied for?

Osimertinib is being studied for Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer, NSCLC, Lung Cancer and 269 more. The trials are grouped by indication on this page.

What phase is Osimertinib in?

Osimertinib clinical trials span 5 Phase 4, 32 Phase 3, 107 Phase 2, 45 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Osimertinib clinical trials?

The lead sponsor across the most Osimertinib trials is AstraZeneca, with 139 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Osimertinib Clinical Trials (2026): 246 Studies for Non-small Cell Lung Cancer & Non-Small Cell Lung Cancer

Creator: Hipa.ai Research
Published: 2026-05-08T19:22:43.312Z

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: June 18, 2026.

246 Osimertinib clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 93 indications (including Non-small Cell Lung Cancer & Non-Small Cell Lung Cancer) and 65,247 total planned enrollment. 32 Phase 3 Osimertinib trials and 107 Phase 2, 5 Phase 4 are listed. 89 Osimertinib clinical trials are actively recruiting at 1,678 U.S. sites across 51 states. Most recent activity: NCT07005102 (Nov 2036).

Where to Participate: All Osimertinib Trial Sites in the U.S. (1,678 sites across 51 states)

Every actively recruiting Osimertinibtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

State	Facility	City	Trial	Map
AL	The Kirklin Clinic at Acton Road	Birmingham35243	NCT05624996	Map
AL	University of Alabama at Birmingham	Birmingham35294	NCT06538038	Map
AL	University of Alabama at Birmingham	Birmingham35294	NCT06618287	Map
AL	University of Alabama at Birmingham Cancer Center	Birmingham35233	NCT05624996	Map
AL	Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis	Daphne36526	NCT05624996	Map
AL	Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis	Daphne36526	NCT05642572	Map
AL	Thomas Hospital	Fairhope36532	NCT05624996	Map
AL	Thomas Hospital	Fairhope36532	NCT05642572	Map
AL	Mobile Infirmary Medical Center	Mobile36607	NCT05624996	Map
AL	Mobile Infirmary Medical Center	Mobile36607	NCT05642572	Map
AL	Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland	Saraland36571	NCT05624996	Map
AL	Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland	Saraland36571	NCT05642572	Map
AK	Alaska Oncology and Hematology LLC	Anchorage99508	NCT04181060	Map
AK	Katmai Oncology Group	Anchorage99508	NCT04181060	Map
AK	Katmai Oncology Group	Anchorage99508	NCT05642572	Map
AK	Fairbanks Memorial Hospital	Fairbanks99701	NCT03191149	Map
AK	Fairbanks Memorial Hospital	Fairbanks99701	NCT04181060	Map
AZ	Ironwood Cancer and Research Centers - Chandler II /ID# 275443	Chandler85224	NCT07005102	Map
AZ	Kingman Regional Medical Center	Kingman86401	NCT05624996	Map
AZ	Kingman Regional Medical Center	Kingman86401	NCT05642572	Map
AZ	Cancer Center at Saint Joseph's	Phoenix85004	NCT04181060	Map
AZ	Cancer Center at Saint Joseph's	Phoenix85004	NCT05624996	Map
AR	Research Site	Fayetteville72703	NCT06417814	Map
AR	Mercy Clinic Fort Smith Communities	Fort Smith72903	NCT06538038	Map
AR	Mercy Hospital Fort Smith	Fort Smith72903	NCT03191149	Map
AR	Mercy Research	Fort Smith72903	NCT06538038	Map
AR	Fowler Family Cancer Center - Jonesboro	Jonesboro72401	NCT06538038	Map
AR	NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro	Jonesboro72401	NCT04181060	Map
AR	NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro	Jonesboro72401	NCT05624996	Map
AR	NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro	Jonesboro72401	NCT05642572	Map
AR	CARTI Cancer Center	Little Rock72205	NCT03191149	Map
AR	University of Arkansas for Medical Sciences	Little Rock72205	NCT05624996	Map
AR	University of Arkansas for Medical Sciences	Little Rock72205	NCT05642572	Map
CA	Kaiser Permanente-Deer Valley Medical Center	Antioch94531	NCT04181060	Map
CA	PCR Oncology	Arroyo Grande93420	NCT05642572	Map
CA	Sutter Auburn Faith Hospital	Auburn95602	NCT05642572	Map
CA	AIS Cancer Center at San Joaquin Community Hospital	Bakersfield93301	NCT05624996	Map
CA	Alta Bates Summit Medical Center-Herrick Campus	Berkeley94704	NCT05642572	Map
CA	Cedars-Sinai Cancer at Beverly Hills (THO)	Beverly Hills90211	NCT05401110	Map
CA	Tower Cancer Research Foundation	Beverly Hills90211	NCT05642572	Map
CA	Mills-Peninsula Medical Center	Burlingame94010	NCT05624996	Map
CA	City of Hope Medical Center	Duarte91010	NCT06014827	Map
CA	Kaiser Permanente Dublin	Dublin94568	NCT04181060	Map
CA	Stanford Cancer Center Emeryville	Emeryville94608	NCT06538038	Map
CA	Research Site	Fountain Valley92708	NCT06417814	Map
CA	Kaiser Permanente-Fremont	Fremont94538	NCT04181060	Map
CA	Palo Alto Medical Foundation-Fremont	Fremont94538	NCT05624996	Map
CA	Palo Alto Medical Foundation-Fremont	Fremont94538	NCT05642572	Map
CA	Washington Hospital	Fremont94538	NCT04181060	Map
CA	Kaiser Permanente Fresno Orchard Plaza	Fresno93720	NCT04181060	Map
CA	Kaiser Permanente-Fresno	Fresno93720	NCT04181060	Map
CA	Kaiser Permanente-Fresno	Fresno93720	NCT05642572	Map
CA	Research Site	La Jolla92093	NCT06417814	Map
CA	UC San Diego Moores Cancer Center	La Jolla92093	NCT05642572	Map
CA	Loma Linda University Medical Center	Loma Linda92354	NCT05642572	Map
CA	Research Site	Los Alamitos90720	NCT06350097	Map
CA	Cedars-Sinai Cancer at SOCC	Los Angeles90048	NCT05401110	Map
CA	Cedars-Sinai Cancer at The Angeles Clinic and Research Institute	Los Angeles90025	NCT05401110	Map
CA	Cedars-Sinai Medical Center	Los Angeles90048	NCT05401110	Map
CA	Cedars-Sinai Medical Center	Los Angeles90048	NCT05642572	Map
CA	Los Angeles General Medical Center	Los Angeles90033	NCT05624996	Map
CA	Research Site	Los Angeles90017	NCT06350097	Map
CA	Research Site	Los Angeles90033	NCT06350097	Map
CA	UCLA / Jonsson Comprehensive Cancer Center	Los Angeles90095	NCT07323641	Map
CA	USC / Norris Comprehensive Cancer Center	Los Angeles90033	NCT05624996	Map
CA	USC Norris Comprehensive Cancer Center /ID# 275343	Los Angeles90033	NCT07005102	Map
CA	Valkyrie Clinical Trials	Los Angeles90067	NCT04486833	Map
CA	Fremont - Rideout Cancer Center	Marysville95901	NCT05624996	Map
CA	Kaiser Permanente- Modesto MOB II	Modesto95356	NCT04181060	Map
CA	Kaiser Permanente-Modesto	Modesto95356	NCT04181060	Map
CA	Memorial Medical Center	Modesto95355	NCT05624996	Map
CA	Memorial Medical Center	Modesto95355	NCT05642572	Map
CA	Palo Alto Medical Foundation-Camino Division	Mountain View94040	NCT05624996	Map
CA	Usc Norris Oncology/Hematology Treatment Center /ID# 278673	Newport Beach92663	NCT07005102	Map
CA	Kaiser Permanente-Oakland	Oakland94611	NCT04181060	Map
CA	Kaiser Permanente-Oakland	Oakland94611	NCT05642572	Map
CA	Palo Alto Medical Foundation Health Care	Palo Alto94301	NCT05624996	Map
CA	Stanford Cancer Institute Palo Alto	Palo Alto94304	NCT04181060	Map
CA	Stanford Cancer Institute Palo Alto	Palo Alto94304	NCT06538038	Map
CA	Kaiser Permanente-Richmond	Richmond94801	NCT04181060	Map
CA	Kaiser Permanente-Roseville	Roseville95661	NCT04181060	Map
CA	Kaiser Permanente-Roseville	Roseville95661	NCT05642572	Map
CA	Sutter Cancer Centers Radiation Oncology Services-Roseville	Roseville95661	NCT05624996	Map
CA	Sutter Roseville Medical Center	Roseville95661	NCT05624996	Map
CA	Sutter Roseville Medical Center	Roseville95661	NCT05642572	Map
CA	Kaiser Permanente Downtown Commons	Sacramento95814	NCT04181060	Map
CA	Kaiser Permanente Downtown Commons	Sacramento95814	NCT05642572	Map
CA	Kaiser Permanente-South Sacramento	Sacramento95823	NCT04181060	Map
CA	Sutter Medical Center Sacramento	Sacramento95816	NCT05624996	Map
CA	Sutter Medical Center Sacramento	Sacramento95816	NCT05642572	Map
CA	UC Davis Cancer Center (Data Collection Only)	Sacramento95817	NCT04410796	Map
CA	University of California Davis Comprehensive Cancer Center	Sacramento95817	NCT04181060	Map
CA	University of California Davis Comprehensive Cancer Center	Sacramento95817	NCT05642572	Map
CA	University of California, Davis Comprehensive Cancer Center	Sacramento95817	NCT05785741	Map
CA	Research Site	San Diego92123	NCT06350097	Map
CA	Research Site	San Diego92123	NCT06417814	Map
CA	California Pacific Medical Center-Pacific Campus	San Francisco94115	NCT05624996	Map
CA	California Pacific Medical Center-Pacific Campus	San Francisco94115	NCT05642572	Map
CA	Kaiser Permanente-San Francisco	San Francisco94115	NCT04181060	Map
CA	Kaiser Permanente-San Francisco	San Francisco94115	NCT05642572	Map
CA	UCSF Helen Diller Family Comprehensive Cancer Center	San Francisco94158	NCT04665206	Map
CA	University of California, San Francisco	San Francisco94143	NCT04085315	Map
CA	Veterans Affairs Medical Center - San Francisco	San Francisco94121	NCT05642572	Map
CA	Kaiser Permanente-Santa Teresa-San Jose	San Jose95119	NCT04181060	Map
CA	Kaiser Permanente-Santa Teresa-San Jose	San Jose95119	NCT05642572	Map
CA	Stanford Cancer Center South Bay	San Jose95124	NCT06538038	Map
CA	Kaiser Permanente San Leandro	San Leandro94577	NCT04181060	Map
CA	Kaiser Permanente San Leandro	San Leandro94577	NCT05642572	Map
CA	Mills Health Center	San Mateo94401	NCT05624996	Map
CA	Mills Health Center	San Mateo94401	NCT05642572	Map
CA	Kaiser San Rafael-Gallinas	San Rafael94903	NCT04181060	Map
CA	Kaiser San Rafael-Gallinas	San Rafael94903	NCT05642572	Map
CA	Kaiser Permanente Medical Center - Santa Clara	Santa Clara95051	NCT04181060	Map
CA	Kaiser Permanente Medical Center - Santa Clara	Santa Clara95051	NCT05642572	Map
CA	Palo Alto Medical Foundation-Santa Cruz	Santa Cruz95065	NCT05642572	Map
CA	Research Site	Santa Monica90404	NCT06350097	Map
CA	UCLA Hematology/Oncology - Santa Monica	Santa Monica90404	NCT05785741	Map
CA	Kaiser Permanente-Santa Rosa	Santa Rosa95403	NCT04181060	Map
CA	Sutter Pacific Medical Foundation	Santa Rosa95403	NCT05624996	Map
CA	Sutter Pacific Medical Foundation	Santa Rosa95403	NCT05642572	Map
CA	Kaiser Permanente-South San Francisco	South San Francisco94080	NCT04181060	Map
CA	Kaiser Permanente-South San Francisco	South San Francisco94080	NCT05642572	Map
CA	Kaiser Permanente-Stockton	Stockton95210	NCT04181060	Map
CA	Palo Alto Medical Foundation-Sunnyvale	Sunnyvale94086	NCT05624996	Map
CA	Palo Alto Medical Foundation-Sunnyvale	Sunnyvale94086	NCT05642572	Map
CA	Cedars-Sinai Cancer at Hunt Cancer Center - TMPNCC	Torrance90505	NCT05401110	Map
CA	Torrance Memorial Physician Network - Cancer Care	Torrance90505	NCT05642572	Map
CA	Kaiser Permanente Medical Center-Vacaville	Vacaville95688	NCT04181060	Map
CA	Kaiser Permanente-Vallejo	Vallejo94589	NCT04181060	Map
CA	Kaiser Permanente-Vallejo	Vallejo94589	NCT05642572	Map
CA	Sutter Solano Medical Center/Cancer Center	Vallejo94589	NCT05624996	Map
CA	Sutter Solano Medical Center/Cancer Center	Vallejo94589	NCT05642572	Map
CA	John Muir Health	Walnut Creek94598	NCT06538038	Map
CA	Kaiser Permanente-Walnut Creek	Walnut Creek94596	NCT04181060	Map
CA	Kaiser Permanente-Walnut Creek	Walnut Creek94596	NCT05642572	Map
CA	Research Site	Walnut Creek94598	NCT06350097	Map
CO	Rocky Mountain Cancer Centers-Aurora	Aurora80012	NCT04181060	Map
CO	UCHealth University of Colorado Hospital	Aurora80045	NCT05624996	Map
CO	UCHealth University of Colorado Hospital	Aurora80045	NCT05642572	Map
CO	University Colorado Cancer Center /ID# 275382	Aurora80045-2517	NCT07005102	Map
CO	Rocky Mountain Cancer Centers-Boulder	Boulder80304	NCT04181060	Map
CO	Memorial Hospital North	Colorado Springs80920	NCT05624996	Map
CO	Memorial Hospital North	Colorado Springs80920	NCT05642572	Map
CO	Research Site	Colorado Springs80909	NCT06417814	Map
CO	Rocky Mountain Cancer Centers-Penrose	Colorado Springs80907	NCT05624996	Map
CO	UCHealth Memorial Hospital Central	Colorado Springs80909	NCT05624996	Map
CO	UCHealth Memorial Hospital Central	Colorado Springs80909	NCT05642572	Map
CO	Kaiser Permanente-Franklin	Denver80205	NCT04181060	Map
CO	Sarah Cannon Research Institute at HealthONE	Denver80218	NCT06507306	Map
CO	UCHealth - Cherry Creek	Denver80206	NCT05624996	Map
CO	Rocky Mountain Cancer Centers - Swedish	Englewood80113	NCT04181060	Map
CO	Cancer Care and Hematology-Fort Collins	Fort Collins80528	NCT05624996	Map
CO	Cancer Care and Hematology-Fort Collins	Fort Collins80528	NCT05642572	Map
CO	Poudre Valley Hospital	Fort Collins80524	NCT05624996	Map
CO	Poudre Valley Hospital	Fort Collins80524	NCT05642572	Map
CO	Research Site	Fort Collins80528	NCT06417814	Map
CO	UCHealth Greeley Hospital	Greeley80631	NCT05624996	Map
CO	UCHealth Greeley Hospital	Greeley80631	NCT05642572	Map
CO	UCHealth Highlands Ranch Hospital	Highlands Ranch80129	NCT05624996	Map
CO	Kaiser Permanente-Rock Creek	Lafayette80026	NCT04181060	Map
CO	Kaiser Permanente-Lone Tree	Lone Tree80124	NCT04181060	Map
CO	Rocky Mountain Cancer Centers	Lone Tree80124	NCT04486833	Map
CO	UCHealth Lone Tree Health Center	Lone Tree80124	NCT05624996	Map
CO	UCHealth Lone Tree Health Center	Lone Tree80124	NCT05642572	Map
CO	Medical Center of the Rockies	Loveland80538	NCT05624996	Map
CO	Medical Center of the Rockies	Loveland80538	NCT05642572	Map
CT	Smilow Cancer Hospital-Derby Care Center	Derby06418	NCT04181060	Map
CT	Smilow Cancer Hospital-Derby Care Center	Derby06418	NCT05642572	Map
CT	Smilow Cancer Hospital Care Center-Fairfield	Fairfield06824	NCT04181060	Map
CT	Smilow Cancer Hospital Care Center-Fairfield	Fairfield06824	NCT05642572	Map
CT	Smilow Cancer Hospital Care Center at Glastonbury	Glastonbury06033	NCT04181060	Map
CT	Smilow Cancer Hospital Care Center at Glastonbury	Glastonbury06033	NCT05642572	Map
CT	Smilow Cancer Hospital Care Center at Greenwich	Greenwich06830	NCT04181060	Map
CT	Smilow Cancer Hospital Care Center at Greenwich	Greenwich06830	NCT05642572	Map
CT	Smilow Cancer Hospital Care Center - Guilford	Guilford06437	NCT04181060	Map
CT	Smilow Cancer Hospital Care Center - Guilford	Guilford06437	NCT05642572	Map
CT	Hartford Hospital	Hartford06102	NCT04181060	Map
CT	Smilow Cancer Hospital Care Center at Saint Francis	Hartford06105	NCT04181060	Map
CT	Smilow Cancer Hospital Care Center at Saint Francis	Hartford06105	NCT05642572	Map
CT	Midstate Medical Center	Meriden06451	NCT04181060	Map
CT	The Hospital of Central Connecticut	New Britain06050	NCT04181060	Map
CT	Research Site	New Haven06510	NCT06350097	Map
CT	Yale University	New Haven06520	NCT04181060	Map
CT	Yale University	New Haven06520	NCT05642572	Map
CT	Yale-New Haven Hospital North Haven Medical Center	North Haven06473	NCT04181060	Map
CT	Yale-New Haven Hospital North Haven Medical Center	North Haven06473	NCT05642572	Map
CT	Smilow Cancer Hospital-Orange Care Center	Orange06477	NCT05642572	Map
CT	Smilow Cancer Hospital Care Center at Long Ridge	Stamford06902	NCT04181060	Map
CT	Smilow Cancer Hospital Care Center at Long Ridge	Stamford06902	NCT05642572	Map
CT	Stamford Hospital/Bennett Cancer Center	Stamford06904	NCT04181060	Map
CT	Smilow Cancer Hospital-Torrington Care Center	Torrington06790	NCT04181060	Map
CT	Smilow Cancer Hospital-Torrington Care Center	Torrington06790	NCT05642572	Map
CT	Smilow Cancer Hospital Care Center-Trumbull	Trumbull06611	NCT04181060	Map
CT	Smilow Cancer Hospital Care Center-Trumbull	Trumbull06611	NCT05642572	Map
CT	Smilow Cancer Hospital-Waterbury Care Center	Waterbury06708	NCT04181060	Map
CT	Smilow Cancer Hospital-Waterbury Care Center	Waterbury06708	NCT05642572	Map
CT	Smilow Cancer Hospital Care Center - Waterford	Waterford06385	NCT04181060	Map
CT	Smilow Cancer Hospital Care Center - Waterford	Waterford06385	NCT05642572	Map
DE	Bayhealth	Dover19901	NCT06538038	Map
DE	Bayhealth Hospital Kent Campus	Dover19901	NCT05642572	Map
DE	Beebe Medical Center	Lewes19958	NCT05624996	Map
DE	Bayhealth Hospital Sussex Campus	Milford19963	NCT05642572	Map
DE	Satellite of Bayhealth Sussex	Milford19901	NCT06538038	Map
DE	Beebe South Coastal Health Campus	Millville19967	NCT05624996	Map
DE	Christiana Care Health System-Christiana Hospital	Newark19718	NCT05624996	Map
DE	Helen F Graham Cancer Center	Newark19713	NCT05624996	Map
DE	Medical Oncology Hematology Consultants PA	Newark19713	NCT05624996	Map
DE	Beebe Health Campus	Rehoboth Beach19971	NCT05624996	Map
DE	Christiana Care Health System-Wilmington Hospital	Wilmington19801	NCT05624996	Map
DC	George Washington University Medical Center	Washington D.C.20037	NCT04181060	Map
DC	Kaiser Permanente-Capitol Hill Medical Center	Washington D.C.20002	NCT05642572	Map
DC	MedStar Georgetown University Hospital	Washington D.C.20007	NCT03191149	Map
DC	Sibley Johns Hopkins University	Washington D.C.20016	NCT06538038	Map
FL	Bay Pines VA Healthcare System	Bay Pines33744	NCT05624996	Map
FL	Morton Plant Hospital	Clearwater33756	NCT05624996	Map
FL	Halifax Health Medical Center-Centers for Oncology	Daytona Beach32114	NCT05624996	Map
FL	Holy Cross Hospital	Fort Lauderdale33308	NCT03191149	Map
FL	Holy Cross Hospital	Fort Lauderdale33308	NCT04181060	Map
FL	Memorial Regional Hospital/Joe DiMaggio Children's Hospital	Hollywood33021	NCT05624996	Map
FL	Memorial Regional Hospital/Joe DiMaggio Children's Hospital	Hollywood33021	NCT05642572	Map
FL	Mayo Clinic in Florida	Jacksonville32224-9980	NCT05624996	Map
FL	Research Site	Jacksonville32256	NCT06350097	Map
FL	Research Site	Jacksonville32256	NCT06417814	Map
FL	Jupiter Medical Center	Jupiter33458	NCT05624996	Map
FL	BAPTIST ALLIANCE - MCI (Data Collection Only)	Miami33143	NCT06741085	Map
FL	University of Miami Hospital and Clinics, Sylvester Cancer Center	Miami33136	NCT06618287	Map
FL	Research Site	Ocala34474	NCT06350097	Map
FL	Mid Florida Hematology And Oncology Center /ID# 275278	Orange City32763	NCT07005102	Map
FL	Research Site	Orange City32763	NCT06350097	Map
FL	Orlando Health Cancer Institute	Orlando32806	NCT05624996	Map
FL	Sarah Cannon Research Institute at Florida Cancer Specialists	Orlando32827	NCT05785741	Map
FL	Sarah Cannon Research Institute at Florida Cancer Specialists - Lake Nona -	Orlando32827	NCT06507306	Map
FL	Memorial Hospital West	Pembroke Pines33028	NCT05624996	Map
FL	Memorial Hospital West	Pembroke Pines33028	NCT05642572	Map
FL	BRCR global	Plantation33322	NCT05785741	Map
FL	Florida Cancer Specialists	Sarasota34232	NCT05785741	Map
FL	Florida Cancer Specialists - Sarasota	Sarasota34232	NCT06507306	Map
FL	BRCR Medical Center Inc.	Tamarac33321	NCT05785741	Map
FL	Moffitt Cancer Center	Tampa33612	NCT04410796	Map
FL	Moffitt Cancer Center	Tampa33612	NCT05642572	Map
FL	Saint Joseph's Hospital/Children's Hospital-Tampa	Tampa33607	NCT05624996	Map
FL	Winter Haven Hospital	Winter Haven33881	NCT05624996	Map
GA	Research Site	Athens30607	NCT06417814	Map
GA	University Cancer and Blood Center LLC	Athens30607	NCT05642572	Map
GA	Emory Proton Therapy Center	Atlanta30308	NCT05624996	Map
GA	Emory Saint Joseph's Hospital	Atlanta30342	NCT03191149	Map
GA	Emory Saint Joseph's Hospital	Atlanta30342	NCT05624996	Map
GA	Emory University Hospital Midtown	Atlanta30308	NCT03191149	Map
GA	Emory University Hospital Midtown	Atlanta30308	NCT04181060	Map
GA	Emory University Hospital Midtown	Atlanta30308	NCT05624996	Map
GA	Emory University Hospital/Winship Cancer Institute	Atlanta30322	NCT04762199	Map
GA	Emory University Hospital/Winship Cancer Institute	Atlanta30322	NCT03191149	Map
GA	Emory University Hospital/Winship Cancer Institute	Atlanta30322	NCT04181060	Map
GA	Emory University Hospital/Winship Cancer Institute	Atlanta30322	NCT05624996	Map
GA	Grady Health System	Atlanta30303	NCT05624996	Map
GA	Northside Hospital	Atlanta30342	NCT05642572	Map
GA	Research Site 111	Atlanta30322	NCT05785741	Map
GA	Augusta University Medical Center	Augusta30912	NCT05624996	Map
GA	WellStar Cobb Hospital	Austell30106	NCT05624996	Map
GA	Hamilton Medical Center - Peeples Cancer Institute	Dalton30720	NCT05624996	Map
GA	Northside Hospital - Duluth	Duluth30096	NCT05642572	Map
GA	Northeast Georgia Medical Center-Gainesville	Gainesville30501	NCT05642572	Map
GA	Lewis Cancer and Research Pavilion at Saint Joseph's/Candler: Liberty County Cancer Care	Hinesville31313	NCT06538038	Map
GA	Lewis Cancer and Research Pavilion at Saint Joseph's/Candler: Regional Cancer Care	Jesup31545	NCT06538038	Map
GA	Northside Hospital - Gwinnett	Lawrenceville30046	NCT05642572	Map
GA	Wellstar Kennestone Hospital	Marietta30060	NCT05624996	Map
GA	CTCA at Southeastern Regional Medical Center	Newnan30265	NCT05624996	Map
GA	Lewis Cancer and Research Pavilion at Saint Joseph's/Candler	Savannah31405	NCT04181060	Map
GA	Lewis Cancer and Research Pavilion at Saint Joseph's/Candler	Savannah31405	NCT05624996	Map
GA	Lewis Cancer and Research Pavilion at Saint Joseph's/Candler	Savannah31405	NCT05642572	Map
GA	Lewis Cancer and Research Pavilion at Saint Joseph's/Candler	Savannah31405	NCT06538038	Map
HI	Hawaii Cancer Care - Westridge	‘Aiea96701	NCT05624996	Map
HI	Hawaii Cancer Care - Westridge	‘Aiea96701	NCT05642572	Map
HI	Pali Momi Medical Center	‘Aiea96701	NCT05624996	Map
HI	Hawaii Cancer Care Inc - Waterfront Plaza	Honolulu96813	NCT05624996	Map
HI	Hawaii Cancer Care Inc - Waterfront Plaza	Honolulu96813	NCT05642572	Map
HI	Kaiser Permanente Moanalua Medical Center	Honolulu96819	NCT04181060	Map
HI	Kaiser Permanente Moanalua Medical Center /ID# 275942	Honolulu96819	NCT07005102	Map
HI	Kuakini Medical Center	Honolulu96817	NCT05624996	Map
HI	Queen's Cancer Cenrer - POB I	Honolulu96813	NCT05624996	Map
HI	Queen's Cancer Cenrer - POB I	Honolulu96813	NCT05642572	Map
HI	Queen's Cancer Center - Kuakini	Honolulu96817	NCT05624996	Map
HI	Queen's Cancer Center - Kuakini	Honolulu96817	NCT05642572	Map
HI	Queen's Medical Center	Honolulu96813	NCT05624996	Map
HI	Queen's Medical Center	Honolulu96813	NCT05642572	Map
HI	Straub Clinic and Hospital	Honolulu96813	NCT05624996	Map
HI	The Cancer Center of Hawaii-Liliha	Honolulu96817	NCT05624996	Map
HI	University of Hawaii Cancer Center	Honolulu96813	NCT05624996	Map
ID	Saint Alphonsus Cancer Care Center-Boise	Boise83706	NCT03191149	Map
ID	Saint Alphonsus Cancer Care Center-Boise	Boise83706	NCT04181060	Map
ID	Saint Alphonsus Cancer Care Center-Boise	Boise83706	NCT05642572	Map
ID	Saint Luke's Cancer Institute - Boise	Boise83712	NCT04181060	Map
ID	Saint Alphonsus Cancer Care Center-Caldwell	Caldwell83605	NCT03191149	Map
ID	Saint Alphonsus Cancer Care Center-Caldwell	Caldwell83605	NCT04181060	Map
ID	Saint Alphonsus Cancer Care Center-Caldwell	Caldwell83605	NCT05642572	Map
ID	Kootenai Health - Coeur d'Alene	Coeur d'Alene83814	NCT03191149	Map
ID	Kootenai Health - Coeur d'Alene	Coeur d'Alene83814	NCT04181060	Map
ID	Kootenai Health - Coeur d'Alene	Coeur d'Alene83814	NCT05642572	Map
ID	Saint Luke's Cancer Institute - Fruitland	Fruitland83619	NCT04181060	Map
ID	Idaho Urologic Institute-Meridian	Meridian83642	NCT03191149	Map
ID	Saint Luke's Cancer Institute - Meridian	Meridian83642	NCT04181060	Map
ID	Saint Alphonsus Cancer Care Center-Nampa	Nampa83687	NCT03191149	Map
ID	Saint Alphonsus Cancer Care Center-Nampa	Nampa83687	NCT04181060	Map
ID	Saint Alphonsus Cancer Care Center-Nampa	Nampa83687	NCT05642572	Map
ID	Saint Luke's Cancer Institute - Nampa	Nampa83687	NCT04181060	Map
ID	Kootenai Clinic Cancer Services - Post Falls	Post Falls83854	NCT03191149	Map
ID	Kootenai Clinic Cancer Services - Post Falls	Post Falls83854	NCT04181060	Map
ID	Kootenai Clinic Cancer Services - Post Falls	Post Falls83854	NCT05642572	Map
ID	Kootenai Clinic Cancer Services - Sandpoint	Sandpoint83864	NCT03191149	Map
ID	Kootenai Clinic Cancer Services - Sandpoint	Sandpoint83864	NCT04181060	Map
ID	Kootenai Clinic Cancer Services - Sandpoint	Sandpoint83864	NCT05642572	Map
ID	Saint Luke's Cancer Institute - Twin Falls	Twin Falls83301	NCT04181060	Map
IL	OSF Saint Anthony's Health Center	Alton62002	NCT03191149	Map
IL	Advocate Outpatient Center - Aurora	Aurora60506	NCT05624996	Map
IL	Rush-Copley Medical Center	Aurora60504	NCT03191149	Map
IL	Rush-Copley Medical Center	Aurora60504	NCT04181060	Map
IL	Rush-Copley Medical Center	Aurora60504	NCT05624996	Map
IL	Advocate Good Shepherd Hospital	Barrington60010	NCT05624996	Map
IL	Advocate Good Shepherd Hospital	Barrington60010	NCT05642572	Map
IL	Advocate Good Shepherd Hospital	Barrington60010	NCT06538038	Map
IL	Illinois CancerCare-Bloomington	Bloomington61704	NCT03191149	Map
IL	Illinois CancerCare-Bloomington	Bloomington61704	NCT04181060	Map
IL	Illinois CancerCare-Bloomington	Bloomington61704	NCT05624996	Map
IL	Illinois CancerCare-Bloomington	Bloomington61704	NCT05642572	Map
IL	OSF Saint Joseph Medical Center	Bloomington61701	NCT05624996	Map
IL	Illinois CancerCare-Canton	Canton61520	NCT03191149	Map
IL	Illinois CancerCare-Canton	Canton61520	NCT04181060	Map
IL	Illinois CancerCare-Canton	Canton61520	NCT05624996	Map
IL	Illinois CancerCare-Canton	Canton61520	NCT05642572	Map
IL	Memorial Hospital of Carbondale	Carbondale62902	NCT03191149	Map
IL	SIH Cancer Institute	Carterville62918	NCT03191149	Map
IL	Illinois CancerCare-Carthage	Carthage62321	NCT03191149	Map
IL	Illinois CancerCare-Carthage	Carthage62321	NCT04181060	Map
IL	Illinois CancerCare-Carthage	Carthage62321	NCT05624996	Map
IL	Illinois CancerCare-Carthage	Carthage62321	NCT05642572	Map
IL	Centralia Oncology Clinic	Centralia62801	NCT03191149	Map
IL	Centralia Oncology Clinic	Centralia62801	NCT04181060	Map
IL	Centralia Oncology Clinic	Centralia62801	NCT05624996	Map
IL	Centralia Oncology Clinic	Centralia62801	NCT05642572	Map
IL	Advocate Illinois Masonic Medical Center	Chicago60657	NCT05624996	Map
IL	Advocate Illinois Masonic Medical Center	Chicago60657	NCT05642572	Map
IL	Advocate Illinois Masonic Medical Center	Chicago60657	NCT06538038	Map
IL	John H Stroger Jr Hospital of Cook County	Chicago60612	NCT06538038	Map
IL	Northwestern University	Chicago60611	NCT04181060	Map
IL	Northwestern University	Chicago60611	NCT05624996	Map
IL	Northwestern University	Chicago60611	NCT05642572	Map
IL	Northwestern University	Chicago60611	NCT06538038	Map
IL	Research Site	Chicago60611	NCT06417814	Map
IL	Rush MD Anderson Cancer Center	Chicago60612	NCT05642572	Map
IL	University of Chicago Medical Center	Chicago60637	NCT04665206	Map
IL	University of Illinois	Chicago60612	NCT04181060	Map
IL	AMG Crystal Lake - Oncology	Crystal Lake60014	NCT05624996	Map
IL	AMG Crystal Lake - Oncology	Crystal Lake60014	NCT05642572	Map
IL	Carle at The Riverfront	Danville61832	NCT03191149	Map
IL	Carle at The Riverfront	Danville61832	NCT05624996	Map
IL	Carle at The Riverfront	Danville61832	NCT05642572	Map
IL	Cancer Care Specialists of Illinois - Decatur	Decatur62526	NCT03191149	Map
IL	Cancer Care Specialists of Illinois - Decatur	Decatur62526	NCT04181060	Map
IL	Cancer Care Specialists of Illinois - Decatur	Decatur62526	NCT05624996	Map
IL	Cancer Care Specialists of Illinois - Decatur	Decatur62526	NCT05642572	Map
IL	Decatur Memorial Hospital	Decatur62526	NCT03191149	Map
IL	Decatur Memorial Hospital	Decatur62526	NCT05624996	Map
IL	Decatur Memorial Hospital	Decatur62526	NCT05642572	Map
IL	Northwestern Medicine Cancer Center Kishwaukee	DeKalb60115	NCT04181060	Map
IL	Northwestern Medicine Cancer Center Kishwaukee	DeKalb60115	NCT05624996	Map
IL	Northwestern Medicine Cancer Center Kishwaukee	DeKalb60115	NCT05642572	Map
IL	Northwestern Medicine Cancer Center Kishwaukee	DeKalb60115	NCT06538038	Map
IL	Illinois CancerCare-Dixon	Dixon61021	NCT03191149	Map
IL	Illinois CancerCare-Dixon	Dixon61021	NCT04181060	Map
IL	Illinois CancerCare-Dixon	Dixon61021	NCT05642572	Map
IL	Advocate Good Samaritan Hospital	Downers Grove60515	NCT05624996	Map
IL	Advocate Good Samaritan Hospital	Downers Grove60515	NCT05642572	Map
IL	Carle Physician Group-Effingham	Effingham62401	NCT03191149	Map
IL	Carle Physician Group-Effingham	Effingham62401	NCT05624996	Map
IL	Carle Physician Group-Effingham	Effingham62401	NCT05642572	Map
IL	Crossroads Cancer Center	Effingham62401	NCT03191149	Map
IL	Crossroads Cancer Center	Effingham62401	NCT04181060	Map
IL	Crossroads Cancer Center	Effingham62401	NCT05624996	Map
IL	Crossroads Cancer Center	Effingham62401	NCT05642572	Map
IL	Advocate Sherman Hospital	Elgin60123	NCT05624996	Map
IL	Advocate Sherman Hospital	Elgin60123	NCT05642572	Map
IL	Illinois CancerCare-Eureka	Eureka61530	NCT03191149	Map
IL	Illinois CancerCare-Eureka	Eureka61530	NCT04181060	Map
IL	Illinois CancerCare-Eureka	Eureka61530	NCT05624996	Map
IL	Illinois CancerCare-Eureka	Eureka61530	NCT05642572	Map
IL	Research Site	Evanston60201	NCT06417814	Map
IL	Illinois CancerCare-Galesburg	Galesburg61401	NCT03191149	Map
IL	Illinois CancerCare-Galesburg	Galesburg61401	NCT04181060	Map
IL	Illinois CancerCare-Galesburg	Galesburg61401	NCT05624996	Map
IL	Illinois CancerCare-Galesburg	Galesburg61401	NCT05642572	Map
IL	Northwestern Medicine Cancer Center Delnor	Geneva60134	NCT04181060	Map
IL	Northwestern Medicine Cancer Center Delnor	Geneva60134	NCT05624996	Map
IL	Northwestern Medicine Cancer Center Delnor	Geneva60134	NCT05642572	Map
IL	Northwestern Medicine Cancer Center Delnor	Geneva60134	NCT06538038	Map
IL	Northwestern Medicine Glenview Outpatient Center	Glenview60026	NCT04181060	Map
IL	Northwestern Medicine Glenview Outpatient Center	Glenview60026	NCT05642572	Map
IL	Northwestern Medicine Glenview Outpatient Center	Glenview60026	NCT06538038	Map
IL	Northwestern Medicine Grayslake Outpatient Center	Grayslake60030	NCT04181060	Map
IL	Northwestern Medicine Grayslake Outpatient Center	Grayslake60030	NCT05642572	Map
IL	Northwestern Medicine Grayslake Outpatient Center	Grayslake60030	NCT06538038	Map
IL	Ingalls Memorial Hospital	Harvey60426	NCT04181060	Map
IL	Advocate South Suburban Hospital	Hazel Crest60429	NCT05624996	Map
IL	Advocate South Suburban Hospital	Hazel Crest60429	NCT05642572	Map
IL	Advocate South Suburban Hospital	Hazel Crest60429	NCT06538038	Map
IL	Edward Hines Jr VA Hospital	Hines60141	NCT05642572	Map
IL	Research Site	Hinsdale60521	NCT06350097	Map
IL	Illinois CancerCare-Kewanee Clinic	Kewanee61443	NCT03191149	Map
IL	Illinois CancerCare-Kewanee Clinic	Kewanee61443	NCT04181060	Map
IL	Illinois CancerCare-Kewanee Clinic	Kewanee61443	NCT05624996	Map
IL	Illinois CancerCare-Kewanee Clinic	Kewanee61443	NCT05642572	Map
IL	Northwestern Medicine Lake Forest Hospital	Lake Forest60045	NCT04181060	Map
IL	Northwestern Medicine Lake Forest Hospital	Lake Forest60045	NCT05642572	Map
IL	Northwestern Medicine Lake Forest Hospital	Lake Forest60045	NCT06538038	Map
IL	AMG Libertyville - Oncology	Libertyville60048	NCT05624996	Map
IL	AMG Libertyville - Oncology	Libertyville60048	NCT05642572	Map
IL	Condell Memorial Hospital	Libertyville60048	NCT05624996	Map
IL	Condell Memorial Hospital	Libertyville60048	NCT05642572	Map
IL	Illinois CancerCare-Macomb	Macomb61455	NCT03191149	Map
IL	Illinois CancerCare-Macomb	Macomb61455	NCT04181060	Map
IL	Illinois CancerCare-Macomb	Macomb61455	NCT05624996	Map
IL	Illinois CancerCare-Macomb	Macomb61455	NCT05642572	Map
IL	Carle Physician Group-Mattoon/Charleston	Mattoon61938	NCT03191149	Map
IL	Carle Physician Group-Mattoon/Charleston	Mattoon61938	NCT05624996	Map
IL	Carle Physician Group-Mattoon/Charleston	Mattoon61938	NCT05642572	Map
IL	Loyola University Medical Center	Maywood60153	NCT05642572	Map
IL	SSM Health Good Samaritan	Mount Vernon62864	NCT03191149	Map
IL	SSM Health Good Samaritan	Mount Vernon62864	NCT04181060	Map
IL	Carle Cancer Institute Normal	Normal61761	NCT06538038	Map
IL	Research Site	North Chicago60064	NCT06350097	Map
IL	Cancer Care Center of O'Fallon	O'Fallon62269	NCT03191149	Map
IL	Cancer Care Center of O'Fallon	O'Fallon62269	NCT04181060	Map
IL	Cancer Care Center of O'Fallon	O'Fallon62269	NCT05624996	Map
IL	Cancer Care Center of O'Fallon	O'Fallon62269	NCT05642572	Map
IL	HSHS Saint Elizabeth's Hospital	O'Fallon62269	NCT03191149	Map
IL	HSHS Saint Elizabeth's Hospital	O'Fallon62269	NCT05624996	Map
IL	Northwestern Medicine Oak Brook	Oak Brook60523	NCT04181060	Map
IL	Northwestern Medicine Oak Brook	Oak Brook60523	NCT05642572	Map
IL	Advocate Christ Medical Center	Oak Lawn60453-2699	NCT05624996	Map
IL	Advocate Christ Medical Center	Oak Lawn60453-2699	NCT05642572	Map
IL	Advocate Christ Medical Center	Oak Lawn60453	NCT06538038	Map
IL	Rush MD Anderson Cancer Center at Rush Oak Park	Oak Park60304	NCT05642572	Map
IL	Northwestern Medicine Orland Park	Orland Park60462	NCT04181060	Map
IL	Northwestern Medicine Orland Park	Orland Park60462	NCT05642572	Map
IL	Northwestern Medicine Orland Park	Orland Park60462	NCT06538038	Map
IL	Illinois CancerCare-Ottawa Clinic	Ottawa61350	NCT03191149	Map
IL	Illinois CancerCare-Ottawa Clinic	Ottawa61350	NCT04181060	Map
IL	Illinois CancerCare-Ottawa Clinic	Ottawa61350	NCT05624996	Map
IL	Illinois CancerCare-Ottawa Clinic	Ottawa61350	NCT05642572	Map
IL	Advocate High Tech Medical Park	Palos Heights60463	NCT05624996	Map
IL	Advocate Lutheran General Hospital	Park Ridge60068	NCT05624996	Map
IL	Advocate Lutheran General Hospital	Park Ridge60068	NCT05642572	Map
IL	Advocate Lutheran General Hospital	Park Ridge60068	NCT06538038	Map
IL	Illinois CancerCare-Pekin	Pekin61554	NCT03191149	Map
IL	Illinois CancerCare-Pekin	Pekin61554	NCT04181060	Map
IL	Illinois CancerCare-Pekin	Pekin61554	NCT05624996	Map
IL	Illinois CancerCare-Pekin	Pekin61554	NCT05642572	Map
IL	Illinois CancerCare-Peoria	Peoria61615	NCT03191149	Map
IL	Illinois CancerCare-Peoria	Peoria61615	NCT04181060	Map
IL	Illinois CancerCare-Peoria	Peoria61615	NCT05624996	Map
IL	Illinois CancerCare-Peoria	Peoria61615	NCT05642572	Map
IL	Methodist Medical Center of Illinois	Peoria61636	NCT03191149	Map
IL	Methodist Medical Center of Illinois	Peoria61636	NCT05624996	Map
IL	OSF Saint Francis Medical Center	Peoria61637	NCT05624996	Map
IL	OSF Saint Francis Radiation Oncology at Peoria Cancer Center	Peoria61615	NCT05624996	Map
IL	Illinois CancerCare-Peru	Peru61354	NCT03191149	Map
IL	Illinois CancerCare-Peru	Peru61354	NCT04181060	Map
IL	Illinois CancerCare-Peru	Peru61354	NCT05624996	Map
IL	Illinois CancerCare-Peru	Peru61354	NCT05642572	Map
IL	Valley Radiation Oncology	Peru61354	NCT03191149	Map
IL	Illinois CancerCare-Princeton	Princeton61356	NCT03191149	Map
IL	Illinois CancerCare-Princeton	Princeton61356	NCT04181060	Map
IL	Illinois CancerCare-Princeton	Princeton61356	NCT05624996	Map
IL	Illinois CancerCare-Princeton	Princeton61356	NCT05642572	Map
IL	OSF Saint Anthony Medical Center	Rockford61108	NCT05642572	Map
IL	UW Health Carbone Cancer Center Rockford	Rockford61114	NCT05624996	Map
IL	Southern Illinois University School of Medicine	Springfield62702	NCT03191149	Map
IL	Southern Illinois University School of Medicine	Springfield62702	NCT04181060	Map
IL	Southern Illinois University School of Medicine	Springfield62702	NCT05624996	Map
IL	Southern Illinois University School of Medicine	Springfield62702	NCT05642572	Map
IL	Springfield Clinic	Springfield62702	NCT03191149	Map
IL	Springfield Clinic	Springfield62702	NCT04181060	Map
IL	Springfield Clinic	Springfield62702	NCT05624996	Map
IL	Springfield Clinic	Springfield62702	NCT05642572	Map
IL	Springfield Memorial Hospital	Springfield62781	NCT03191149	Map
IL	Springfield Memorial Hospital	Springfield62781	NCT04181060	Map
IL	Springfield Memorial Hospital	Springfield62781	NCT05624996	Map
IL	Springfield Memorial Hospital	Springfield62781	NCT05642572	Map
IL	Carle Cancer Center	Urbana61801	NCT03191149	Map
IL	Carle Cancer Center	Urbana61801	NCT05624996	Map
IL	Carle Cancer Center	Urbana61801	NCT05642572	Map
IL	Carle Cancer Institute	Urbana61801	NCT04486833	Map
IL	Carle Founation Hospital	Urbana61801	NCT06538038	Map
IL	The Carle Foundation Hospital	Urbana61801	NCT03191149	Map
IL	Northwestern Medicine Cancer Center Warrenville	Warrenville60555	NCT04181060	Map
IL	Northwestern Medicine Cancer Center Warrenville	Warrenville60555	NCT05624996	Map
IL	Northwestern Medicine Cancer Center Warrenville	Warrenville60555	NCT05642572	Map
IL	Northwestern Medicine Cancer Center Warrenville	Warrenville60555	NCT06538038	Map
IL	Illinois CancerCare - Washington	Washington61571	NCT03191149	Map
IL	Illinois CancerCare - Washington	Washington61571	NCT04181060	Map
IL	Illinois CancerCare - Washington	Washington61571	NCT05624996	Map
IL	Illinois CancerCare - Washington	Washington61571	NCT05642572	Map
IL	Rush-Copley Healthcare Center	Yorkville60560	NCT03191149	Map
IL	Midwestern Regional Medical Center	Zion60099	NCT05624996	Map
IN	Northwest Cancer Center - Crown Point	Crown Point46307	NCT04181060	Map
IN	Northwest Cancer Center - Main Campus	Crown Point46307	NCT05624996	Map
IN	Northwest Oncology LLC	Dyer46311	NCT04181060	Map
IN	Northwest Oncology LLC	Dyer46311	NCT05624996	Map
IN	Research Site	Fort Wayne46845	NCT06350097	Map
IN	Northwest Cancer Center - Hobart	Hobart46342	NCT04181060	Map
IN	Northwest Cancer Center - Hobart	Hobart46342	NCT05624996	Map
IN	Saint Mary Medical Center	Hobart46342	NCT04181060	Map
IN	Saint Mary Medical Center	Hobart46342	NCT05624996	Map
IN	Saint Catherine Hospital	Indianapolis46312	NCT04181060	Map
IN	The Community Hospital	Munster46321	NCT04181060	Map
IN	The Community Hospital	Munster46321	NCT05624996	Map
IN	Women's Diagnostic Center - Munster	Munster46321	NCT04181060	Map
IN	Women's Diagnostic Center - Munster	Munster46321	NCT05624996	Map
IN	Northwest Cancer Center - Valparaiso	Valparaiso46383	NCT04181060	Map
IN	Northwest Cancer Center - Valparaiso	Valparaiso46383	NCT05624996	Map
IA	Mary Greeley Medical Center	Ames50010	NCT04181060	Map
IA	Mary Greeley Medical Center	Ames50010	NCT05624996	Map
IA	McFarland Clinic - Ames	Ames50010	NCT04181060	Map
IA	McFarland Clinic - Ames	Ames50010	NCT05624996	Map
IA	UI Health Care Mission Cancer and Blood - Ankeny Clinic	Ankeny50023	NCT04181060	Map
IA	UI Health Care Mission Cancer and Blood - Ankeny Clinic	Ankeny50023	NCT05624996	Map
IA	UI Health Care Mission Cancer and Blood - Ankeny Clinic	Ankeny50023	NCT05642572	Map
IA	Saint Anthony Regional Hospital	Carroll51401	NCT04181060	Map
IA	Saint Luke's Hospital	Cedar Rapids52402	NCT05624996	Map
IA	Mercy Cancer Center-West Lakes	Clive50325	NCT05624996	Map
IA	UI Health Care Mission Cancer and Blood - West Des Moines Clinic	Clive50325	NCT04181060	Map
IA	UI Health Care Mission Cancer and Blood - West Des Moines Clinic	Clive50325	NCT05624996	Map
IA	UI Health Care Mission Cancer and Blood - West Des Moines Clinic	Clive50325	NCT05642572	Map
IA	Heartland Oncology and Hematology LLP	Council Bluffs51503	NCT03191149	Map
IA	Methodist Jennie Edmundson Hospital	Council Bluffs51503	NCT03191149	Map
IA	Methodist Jennie Edmundson Hospital	Council Bluffs51503	NCT05624996	Map
IA	Nebraska Cancer Specialists/Oncology Hematology West PC - MEJ	Council Bluffs51503	NCT03191149	Map
IA	Greater Regional Medical Center	Creston50801	NCT05624996	Map
IA	Broadlawns Medical Center	Des Moines50314	NCT04181060	Map
IA	Iowa Methodist Medical Center	Des Moines50309	NCT04181060	Map
IA	Iowa Methodist Medical Center	Des Moines50309	NCT05624996	Map
IA	Iowa Methodist Medical Center	Des Moines50309	NCT05642572	Map
IA	Mercy Medical Center - Des Moines	Des Moines50314	NCT05624996	Map
IA	Mercy Medical Center - Des Moines	Des Moines50314	NCT05642572	Map
IA	UI Health Care Mission Cancer and Blood - Des Moines Clinic	Des Moines50309	NCT04181060	Map
IA	UI Health Care Mission Cancer and Blood - Des Moines Clinic	Des Moines50309	NCT05624996	Map
IA	UI Health Care Mission Cancer and Blood - Des Moines Clinic	Des Moines50309	NCT05642572	Map
IA	UI Health Care Mission Cancer and Blood - Laurel Clinic	Des Moines50314	NCT04181060	Map
IA	UI Health Care Mission Cancer and Blood - Laurel Clinic	Des Moines50314	NCT05624996	Map
IA	UI Health Care Mission Cancer and Blood - Laurel Clinic	Des Moines50314	NCT05642572	Map
IA	McFarland Clinic - Trinity Cancer Center	Fort Dodge50501	NCT04181060	Map
IA	UI Healthcare Mission Cancer and Blood - Fort Dodge	Fort Dodge50501	NCT04181060	Map
IA	McFarland Clinic - Marshalltown	Marshalltown50158	NCT04181060	Map
IA	UI Health Care Mission Cancer and Blood - Waukee Clinic	Waukee50263	NCT04181060	Map
IA	UI Health Care Mission Cancer and Blood - Waukee Clinic	Waukee50263	NCT05624996	Map
IA	UI Health Care Mission Cancer and Blood - Waukee Clinic	Waukee50263	NCT05642572	Map
IA	Mercy Medical Center-West Lakes	West Des Moines50266	NCT05624996	Map
KS	University of Kansas Clinical Research Center	Fairway66205	NCT05642572	Map
KS	Central Care Cancer Center - Garden City	Garden City67846	NCT03191149	Map
KS	Central Care Cancer Center - Great Bend	Great Bend67530	NCT03191149	Map
KS	HaysMed	Hays67601	NCT05642572	Map
KS	University of Kansas Cancer Center	Kansas City66160	NCT05624996	Map
KS	University of Kansas Cancer Center	Kansas City66160	NCT05642572	Map
KS	Lawrence Memorial Hospital	Lawrence66044	NCT05624996	Map
KS	Lawrence Memorial Hospital	Lawrence66044	NCT05642572	Map
KS	The University of Kansas Cancer Center - Olathe	Olathe66061	NCT05624996	Map
KS	The University of Kansas Cancer Center - Olathe	Olathe66061	NCT05642572	Map
KS	University of Kansas Cancer Center-Overland Park	Overland Park66210	NCT05624996	Map
KS	University of Kansas Cancer Center-Overland Park	Overland Park66210	NCT05642572	Map
KS	University of Kansas Hospital-Indian Creek Campus	Overland Park66211	NCT05642572	Map
KS	Mercy Hospital Pittsburg	Pittsburg66762	NCT03191149	Map
KS	Salina Regional Health Center	Salina67401	NCT05624996	Map
KS	Salina Regional Health Center	Salina67401	NCT05642572	Map
KS	University of Kansas Health System Saint Francis Campus	Topeka66606	NCT05624996	Map
KS	University of Kansas Health System Saint Francis Campus	Topeka66606	NCT05642572	Map
KS	University of Kansas Hospital-Westwood Cancer Center	Westwood66205	NCT05624996	Map
KS	University of Kansas Hospital-Westwood Cancer Center	Westwood66205	NCT05642572	Map
KS	Ascension Via Christi Hospitals Wichita	Wichita67214	NCT04181060	Map
KS	Ascension Via Christi Hospitals Wichita	Wichita67214	NCT05624996	Map
KS	Cancer Center of Kansas - Wichita	Wichita67214	NCT04181060	Map
KS	Cancer Center of Kansas-Wichita Medical Arts Tower	Wichita67208	NCT04181060	Map
KY	Markey Cancer Center	Lexington40536	NCT04486833	Map
KY	University of Kentucky Chandler Medical Center	Lexington40536	NCT05142189	Map
KY	University of Kentucky/Markey Cancer Center	Lexington40536	NCT05624996	Map
KY	University of Kentucky/Markey Cancer Center	Lexington40536	NCT05642572	Map
KY	Norton Cancer Institute	Louisville40202	NCT05142189	Map
KY	Research Site	Louisville40207	NCT06417814	Map
LA	Louisiana State University Health Science Center	New Orleans70112	NCT05624996	Map
LA	Touro Infirmary	New Orleans70115	NCT05624996	Map
LA	University Medical Center New Orleans	New Orleans70112	NCT05624996	Map
ME	Lafayette Family Cancer Center-EMMC	Brewer04412	NCT05642572	Map
ME	MaineHealth Maine Medical Center - Portland	Portland04102	NCT05624996	Map
ME	MaineHealth Cancer Care Center of York County	Sanford04073	NCT05624996	Map
ME	MaineHealth Maine Medical Center- Scarborough	Scarborough04074	NCT05624996	Map
ME	MaineHealth Cancer Care and IV Therapy - South Portland	South Portland04106	NCT05624996	Map
MD	Greater Baltimore Medical Center	Baltimore21204	NCT05624996	Map
MD	Greater Baltimore Medical Center	Baltimore21204	NCT06538038	Map
MD	John Hopkins Medical Center	Baltimore21287	NCT04410796	Map
MD	Johns Hopkins Sidney Kimmel Comprehensive Cancer Center	Baltimore21287	NCT05142189	Map
MD	Kaiser Permanente-Woodlawn Medical Center	Baltimore21244	NCT05642572	Map
MD	Research Site	Baltimore21201	NCT06417814	Map
MD	Sinai Hospital of Baltimore	Baltimore21215	NCT05624996	Map
MD	University of Maryland Greenebaum Comprehensive Cancer Center	Baltimore21201	NCT06538038	Map
MD	Research Site	Bethesda20817	NCT06350097	Map
MD	Research Site	Bethesda20817	NCT06417814	Map
MD	Walter Reed National Military Medical Center	Bethesda20889-5600	NCT04181060	Map
MD	UPMC Western Maryland	Cumberland21502	NCT05642572	Map
MD	Kaiser Permanente-Gaithersburg Medical Center	Gaithersburg20879	NCT05642572	Map
MD	Kaiser Permanente - Largo Medical Center	Largo20774	NCT05642572	Map
MD	Kaiser Permanente Lutherville - Timonium Medical Center	Lutherville21093	NCT05642572	Map
MD	TidalHealth Richard A Henson Cancer Institute	Ocean Pines21811	NCT05624996	Map
MD	Maryland Oncology Hematology	Rockville20850	NCT04486833	Map
MD	TidalHealth Peninsula Regional	Salisbury21801	NCT05624996	Map
MD	William E Kahlert Regional Cancer Center/Sinai Hospital	Westminster21157	NCT05624996	Map
MA	Dana-Farber Cancer Institute	Boston02215	NCT04665206	Map
MA	Dana-Farber Cancer Institute	Boston02215	NCT05785741	Map
MA	Massachusetts General Hospital	Boston02114	NCT04665206	Map
MA	Massachusetts General Hospital (Data Collection Only)	Boston02114	NCT04410796	Map
MA	Massachusetts General Hospital Cancer Center	Boston02114	NCT03191149	Map
MA	Research Site	Boston02215	NCT06417814	Map
MA	Tufts Medical Center	Boston02111	NCT06538038	Map
MA	Lowell General Hosptial	Lowell01854	NCT06538038	Map
MA	Baystate Medical Center	Springfield01199	NCT05642572	Map
MA	Tufts Medical Center Cancer Center Stoneham	Stoneham02180	NCT06538038	Map
MA	UMass Memorial Medical Center - University Campus	Worcester01655	NCT04181060	Map
MA	UMass Memorial Medical Center - University Campus	Worcester01655	NCT05624996	Map
MA	UMass Memorial Medical Center - University Campus	Worcester01655	NCT05642572	Map
MI	MyMichigan Medical Center Gratiot	Alma48801	NCT03191149	Map
MI	MyMichigan Medical Center Alpena	Alpena49707	NCT03191149	Map
MI	Trinity Health Saint Joseph Mercy Hospital Ann Arbor	Ann Arbor48106	NCT03191149	Map
MI	Trinity Health Saint Joseph Mercy Hospital Ann Arbor	Ann Arbor48106	NCT04181060	Map
MI	Trinity Health Saint Joseph Mercy Hospital Ann Arbor	Ann Arbor48106	NCT05624996	Map
MI	Trinity Health Saint Joseph Mercy Hospital Ann Arbor	Ann Arbor48106	NCT05642572	Map
MI	Bronson Battle Creek	Battle Creek49017	NCT03191149	Map
MI	McLaren Cancer Institute-Bay City	Bay City48706	NCT05624996	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Brighton	Brighton48114	NCT03191149	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Brighton	Brighton48114	NCT04181060	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Brighton	Brighton48114	NCT05624996	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Brighton	Brighton48114	NCT05642572	Map
MI	Trinity Health Medical Center - Brighton	Brighton48114	NCT03191149	Map
MI	Trinity Health Medical Center - Brighton	Brighton48114	NCT04181060	Map
MI	Trinity Health Medical Center - Brighton	Brighton48114	NCT05624996	Map
MI	Trinity Health Medical Center - Brighton	Brighton48114	NCT05642572	Map
MI	Henry Ford Cancer Institute-Downriver	Brownstown48183	NCT05624996	—
MI	Trinity Health IHA Medical Group Hematology Oncology - Canton	Canton48188	NCT03191149	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Canton	Canton48188	NCT04181060	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Canton	Canton48188	NCT05642572	Map
MI	Trinity Health Medical Center - Canton	Canton48188	NCT03191149	Map
MI	Trinity Health Medical Center - Canton	Canton48188	NCT04181060	Map
MI	Trinity Health Medical Center - Canton	Canton48188	NCT05642572	Map
MI	Chelsea Hospital	Chelsea48118	NCT03191149	Map
MI	Chelsea Hospital	Chelsea48118	NCT04181060	Map
MI	Chelsea Hospital	Chelsea48118	NCT05624996	Map
MI	Chelsea Hospital	Chelsea48118	NCT05642572	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital	Chelsea48118	NCT03191149	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital	Chelsea48118	NCT04181060	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital	Chelsea48118	NCT05624996	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital	Chelsea48118	NCT05642572	Map
MI	Hematology Oncology Consultants-Clarkston	Clarkston48346	NCT03191149	Map
MI	Hematology Oncology Consultants-Clarkston	Clarkston48346	NCT04181060	Map
MI	McLaren Cancer Institute-Clarkston	Clarkston48346	NCT05624996	Map
MI	Michigan Healthcare Professionals Clarkston	Clarkston48346	NCT05624996	Map
MI	Henry Ford Macomb Hospital-Clinton Township	Clinton Township48038	NCT05624996	Map
MI	Corewell Health Dearborn Hospital	Dearborn48124	NCT04181060	Map
MI	Henry Ford Medical Center-Fairlane	Dearborn48126	NCT05624996	Map
MI	Henry Ford Medical Center-Fairlane	Dearborn48126	NCT05642572	Map
MI	Henry Ford Health Saint John Hospital	Detroit48236	NCT03191149	Map
MI	Henry Ford Health Saint John Hospital	Detroit48236	NCT04181060	Map
MI	Henry Ford Health System	Detroit48202	NCT05785741	Map
MI	Henry Ford Health System	Detroit48202	NCT06507306	Map
MI	Henry Ford Hospital	Detroit48202	NCT03191149	Map
MI	Henry Ford Hospital	Detroit48202	NCT05624996	Map
MI	Henry Ford Hospital	Detroit48202	NCT05642572	Map
MI	Research Site	Detroit48201	NCT06350097	Map
MI	Research Site	Detroit48202	NCT06417814	Map
MI	Wayne State University/Karmanos Cancer Institute	Detroit48201	NCT05624996	Map
MI	Henry Ford River District Hospital	East China Township48054	NCT03191149	—
MI	Henry Ford River District Hospital	East China Township48054	NCT04181060	—
MI	Corewell Health Farmington Hills Hospital	Farmington Hills48336	NCT05624996	Map
MI	Michigan Healthcare Professionals Farmington	Farmington Hills48334	NCT05624996	Map
MI	Weisberg Cancer Treatment Center	Farmington Hills48334	NCT05624996	Map
MI	Cancer Hematology Centers - Flint	Flint48503	NCT03191149	Map
MI	Cancer Hematology Centers - Flint	Flint48503	NCT04181060	Map
MI	Cancer Hematology Centers - Flint	Flint48503	NCT05642572	Map
MI	Genesee Hematology Oncology PC	Flint48503	NCT03191149	Map
MI	Genesys Hurley Cancer Institute	Flint48503	NCT03191149	Map
MI	Genesys Hurley Cancer Institute	Flint48503	NCT04181060	Map
MI	Genesys Hurley Cancer Institute	Flint48503	NCT05642572	Map
MI	Hurley Medical Center	Flint48503	NCT03191149	Map
MI	Hurley Medical Center	Flint48503	NCT04181060	Map
MI	Hurley Medical Center	Flint48503	NCT05642572	Map
MI	McLaren Cancer Institute-Flint	Flint48532	NCT05624996	Map
MI	MyMichigan Medical Center Gladwin	Gladwin48624	NCT03191149	Map
MI	Corewell Health Grand Rapids Hospitals - Butterworth Hospital	Grand Rapids49503	NCT03191149	Map
MI	Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital	Grand Rapids49503	NCT03191149	Map
MI	Trinity Health Grand Rapids Hospital	Grand Rapids49503	NCT03191149	Map
MI	Trinity Health Grand Rapids Hospital	Grand Rapids49503	NCT05624996	Map
MI	Henry Ford Saint John Hospital - Academic	Grosse Pointe Woods48236	NCT03191149	Map
MI	Henry Ford Saint John Hospital - Academic	Grosse Pointe Woods48236	NCT04181060	Map
MI	Henry Ford Saint John Hospital - Breast	Grosse Pointe Woods48236	NCT03191149	Map
MI	Henry Ford Saint John Hospital - Van Elslander	Grosse Pointe Woods48236	NCT03191149	Map
MI	Henry Ford Saint John Hospital - Van Elslander	Grosse Pointe Woods48236	NCT04181060	Map
MI	Allegiance Health	Jackson49201	NCT05624996	Map
MI	Beacon Kalamazoo	Kalamazoo49048	NCT03191149	Map
MI	Beacon Kalamazoo	Kalamazoo49048	NCT05624996	Map
MI	Beacon Kalamazoo Cancer Center	Kalamazoo49009	NCT03191149	Map
MI	Bronson Methodist Hospital	Kalamazoo49007	NCT03191149	Map
MI	Bronson Methodist Hospital	Kalamazoo49007	NCT05624996	Map
MI	West Michigan Cancer Center	Kalamazoo49007	NCT03191149	Map
MI	West Michigan Cancer Center	Kalamazoo49007	NCT05624996	Map
MI	Karmanos Cancer Institute at McLaren Greater Lansing	Lansing48910	NCT05624996	Map
MI	University of Michigan Health - Sparrow Lansing	Lansing48912	NCT03191149	Map
MI	University of Michigan Health - Sparrow Lansing	Lansing48912	NCT04181060	Map
MI	University of Michigan Health - Sparrow Lansing	Lansing48912	NCT05624996	Map
MI	University of Michigan Health - Sparrow Lansing	Lansing48912	NCT05642572	Map
MI	McLaren Cancer Institute-Lapeer Region	Lapeer48446	NCT05624996	Map
MI	Trinity Health Saint Mary Mercy Livonia Hospital	Livonia48154	NCT03191149	Map
MI	Trinity Health Saint Mary Mercy Livonia Hospital	Livonia48154	NCT04181060	Map
MI	Trinity Health Saint Mary Mercy Livonia Hospital	Livonia48154	NCT05624996	Map
MI	Trinity Health Saint Mary Mercy Livonia Hospital	Livonia48154	NCT05642572	Map
MI	Henry Ford Saint John Hospital - Macomb Medical	Macomb48044	NCT03191149	Map
MI	Henry Ford Saint John Hospital - Macomb Medical	Macomb48044	NCT04181060	Map
MI	Henry Ford Warren Hospital - Breast Macomb	Macomb48044	NCT03191149	Map
MI	Michigan Healthcare Professionals Macomb	Macomb48044	NCT05624996	Map
MI	Michigan Healthcare Professionals Madison Heights	Madison Heights48071	NCT05624996	Map
MI	MyMichigan Medical Center Midland	Midland48670	NCT03191149	Map
MI	McLaren Cancer Institute-Macomb	Mount Clemens48043	NCT05624996	Map
MI	McLaren Cancer Institute-Central Michigan	Mount Pleasant48858	NCT05624996	Map
MI	MyMichigan Medical Center Mount Pleasant	Mount Pleasant48858	NCT03191149	Map
MI	Trinity Health Muskegon Hospital	Muskegon49444	NCT03191149	Map
MI	Corewell Health Lakeland Hospitals - Niles Hospital	Niles49120	NCT03191149	Map
MI	Cancer and Hematology Centers of Western Michigan - Norton Shores	Norton Shores49444	NCT03191149	Map
MI	Henry Ford Health Providence Novi Hospital	Novi48374	NCT03191149	Map
MI	Henry Ford Medical Center-Columbus	Novi48377	NCT05624996	Map
MI	Henry Ford Medical Center-Columbus	Novi48377	NCT05642572	Map
MI	McLaren Cancer Institute-Northern Michigan	Petoskey49770	NCT05624996	Map
MI	Hope Cancer Center	Pontiac48341	NCT03191149	Map
MI	Michigan Healthcare Professionals Pontiac	Pontiac48341	NCT03191149	Map
MI	Michigan Healthcare Professionals Pontiac	Pontiac48341	NCT04181060	Map
MI	Michigan Healthcare Professionals Pontiac	Pontiac48341	NCT05624996	Map
MI	Newland Medical Associates-Pontiac	Pontiac48341	NCT03191149	Map
MI	Newland Medical Associates-Pontiac	Pontiac48341	NCT04181060	Map
MI	Trinity Health Saint Joseph Mercy Oakland Hospital	Pontiac48341	NCT03191149	Map
MI	Trinity Health Saint Joseph Mercy Oakland Hospital	Pontiac48341	NCT04181060	Map
MI	Trinity Health Saint Joseph Mercy Oakland Hospital	Pontiac48341	NCT05624996	Map
MI	Trinity Health Saint Joseph Mercy Oakland Hospital	Pontiac48341	NCT05642572	Map
MI	McLaren-Port Huron	Port Huron48060	NCT05624996	Map
MI	Corewell Health Reed City Hospital	Reed City49677	NCT03191149	Map
MI	Corewell Health William Beaumont University Hospital	Royal Oak48073	NCT05624996	Map
MI	MyMichigan Medical Center Saginaw	Saginaw48601	NCT03191149	Map
MI	MyMichigan Medical Center Saginaw	Saginaw48601	NCT04181060	Map
MI	MyMichigan Medical Center Saginaw	Saginaw48601	NCT05642572	Map
MI	Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center	Saint Joseph49085	NCT03191149	Map
MI	Corewell Health Lakeland Hospitals - Saint Joseph Hospital	Saint Joseph49085	NCT03191149	Map
MI	Henry Ford Health Providence Southfield Hospital	Southfield48075	NCT03191149	Map
MI	MyMichigan Medical Center Tawas	Tawas City48764	NCT03191149	Map
MI	MyMichigan Medical Center Tawas	Tawas City48764	NCT04181060	Map
MI	MyMichigan Medical Center Tawas	Tawas City48764	NCT05642572	Map
MI	Munson Medical Center	Traverse City49684	NCT03191149	Map
MI	Munson Medical Center	Traverse City49684	NCT05624996	Map
MI	Corewell Health Beaumont Troy Hospital	Troy48085	NCT04181060	Map
MI	Corewell Health Beaumont Troy Hospital	Troy48085	NCT05624996	Map
MI	Michigan Healthcare Professionals Troy	Troy48098	NCT05624996	Map
MI	Henry Ford Health Warren Hospital	Warren48093	NCT03191149	Map
MI	Henry Ford Health Warren Hospital	Warren48093	NCT04181060	Map
MI	Henry Ford Health Warren Hospital	Warren48093	NCT05624996	Map
MI	Henry Ford Madison Heights Hospital - Breast	Warren48093	NCT03191149	Map
MI	Henry Ford Warren Hospital - GLCMS	Warren48093	NCT03191149	Map
MI	Henry Ford Warren Hospital - GLCMS	Warren48093	NCT04181060	Map
MI	Henry Ford West Bloomfield Hospital	West Bloomfield48322	NCT05624996	Map
MI	Henry Ford West Bloomfield Hospital	West Bloomfield48322	NCT05642572	Map
MI	Henry Ford Wyandotte Hospital	Wyandotte48192	NCT05642572	Map
MI	University of Michigan Health - West	Wyoming49519	NCT03191149	Map
MI	University of Michigan Health - West	Wyoming49519	NCT05624996	Map
MI	Huron Gastroenterology PC	Ypsilanti48106	NCT03191149	Map
MI	Huron Gastroenterology PC	Ypsilanti48106	NCT04181060	Map
MI	Huron Gastroenterology PC	Ypsilanti48106	NCT05642572	Map
MI	Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus	Ypsilanti48197	NCT03191149	Map
MI	Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus	Ypsilanti48197	NCT04181060	Map
MI	Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus	Ypsilanti48197	NCT05624996	Map
MI	Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus	Ypsilanti48197	NCT05642572	Map
MN	Sanford Joe Lueken Cancer Center	Bemidji56601	NCT05624996	Map
MN	Sanford Joe Lueken Cancer Center	Bemidji56601	NCT05642572	Map
MN	Essentia Health Saint Joseph's Medical Center	Brainerd56401	NCT05624996	Map
MN	Minnesota Oncology - Burnsville	Burnsville55337	NCT03191149	Map
MN	Minnesota Oncology - Burnsville	Burnsville55337	NCT04181060	Map
MN	Minnesota Oncology - Burnsville	Burnsville55337	NCT06538038	Map
MN	Cambridge Medical Center	Cambridge55008	NCT03191149	Map
MN	Cambridge Medical Center	Cambridge55008	NCT06538038	Map
MN	Minnesota Oncology Hematology PA-Chaska	Chaska55318	NCT03191149	Map
MN	Mercy Hospital	Coon Rapids55433	NCT03191149	Map
MN	Mercy Hospital	Coon Rapids55433	NCT04181060	Map
MN	Mercy Hospital	Coon Rapids55433	NCT05642572	Map
MN	Mercy Hospital	Coon Rapids55433	NCT06538038	Map
MN	Minnesota Oncology - Coon Rapids	Coon Rapids55433	NCT03191149	Map
MN	Essentia Health - Deer River Clinic	Deer River56636	NCT05624996	Map
MN	Essentia Health - Deer River Clinic	Deer River56636	NCT05642572	Map
MN	Essentia Health Cancer Center	Duluth55805	NCT05624996	Map
MN	Essentia Health Cancer Center	Duluth55805	NCT05642572	Map
MN	Essentia Health Saint Mary's Medical Center	Duluth55805	NCT05624996	Map
MN	Miller-Dwan Hospital	Duluth55805	NCT05624996	Map
MN	Fairview Southdale Hospital	Edina55435	NCT03191149	Map
MN	Fairview Southdale Hospital	Edina55435	NCT04181060	Map
MN	Fairview Southdale Hospital	Edina55435	NCT05642572	Map
MN	Fairview Southdale Hospital	Edina55435	NCT06538038	Map
MN	Minnesota Oncology - Edina	Edina55435	NCT03191149	Map
MN	Essentia Health Hibbing Clinic	Hibbing55746	NCT05624996	Map
MN	Essentia Health Hibbing Clinic	Hibbing55746	NCT05642572	Map
MN	Fairview Clinics and Surgery Center Maple Grove	Maple Grove55369	NCT03191149	Map
MN	Fairview Clinics and Surgery Center Maple Grove	Maple Grove55369	NCT04181060	Map
MN	Fairview Clinics and Surgery Center Maple Grove	Maple Grove55369	NCT06538038	Map
MN	Minnesota Oncology - Maple Grove	Maple Grove55369	NCT03191149	Map
MN	Minnesota Oncology Hematology PA-Maplewood	Maplewood55109	NCT03191149	Map
MN	Minnesota Oncology Hematology PA-Maplewood	Maplewood55109	NCT04181060	Map
MN	Minnesota Oncology Hematology PA-Maplewood	Maplewood55109	NCT06538038	Map
MN	Saint John's Hospital - Healtheast	Maplewood55109	NCT03191149	Map
MN	Saint John's Hospital - Healtheast	Maplewood55109	NCT04181060	Map
MN	Saint John's Hospital - Healtheast	Maplewood55109	NCT06538038	Map
MN	Abbott-Northwestern Hospital	Minneapolis55407	NCT03191149	Map
MN	Abbott-Northwestern Hospital	Minneapolis55407	NCT04181060	Map
MN	Abbott-Northwestern Hospital	Minneapolis55407	NCT05642572	Map
MN	Abbott-Northwestern Hospital	Minneapolis55407	NCT06538038	Map
MN	Health Partners Inc	Minneapolis55454	NCT03191149	Map
MN	Health Partners Inc.	Minneapolis55454	NCT06538038	Map
MN	Hennepin County Medical Center	Minneapolis55415	NCT04181060	Map
MN	Hennepin County Medical Center	Minneapolis55415	NCT06538038	Map
MN	M Health Fairview University of Minnesota Medical Center	Minneapolis55455	NCT04665206	Map
MN	Monticello Cancer Center	Monticello55362	NCT03191149	Map
MN	Monticello Cancer Center	Monticello55362	NCT06538038	Map
MN	New Ulm Medical Center	New Ulm56073	NCT03191149	Map
MN	New Ulm Medical Center	New Ulm56073	NCT06538038	Map
MN	Fairview Northland Medical Center	Princeton55371	NCT03191149	Map
MN	Fairview Northland Medical Center	Princeton55371	NCT06538038	Map
MN	North Memorial Medical Health Center	Robbinsdale55422	NCT03191149	Map
MN	North Memorial Medical Health Center	Robbinsdale55422	NCT06538038	Map
MN	Mayo Clinic in Rochester	Rochester55905	NCT05624996	Map
MN	Coborn Cancer Center at Saint Cloud Hospital	Saint Cloud56303	NCT05624996	Map
MN	Metro MN	Saint Louis Park55426	NCT06538038	Map
MN	Park Nicollet Clinic - Saint Louis Park	Saint Louis Park55416	NCT03191149	Map
MN	Park Nicollet Clinic - Saint Louis Park	Saint Louis Park55416	NCT04181060	Map
MN	Park Nicollet Clinic - Saint Louis Park	Saint Louis Park55416	NCT05642572	Map
MN	Park Nicollet Clinic - Saint Louis Park	Saint Louis Park55416	NCT06538038	Map
MN	Regions Hospital	Saint Paul55101	NCT03191149	Map
MN	Regions Hospital	Saint Paul55101	NCT04181060	Map
MN	Regions Hospital	Saint Paul55101	NCT05642572	Map
MN	Regions Hospital	Saint Paul55101	NCT06538038	Map
MN	Research Site	Saint Paul55102	NCT06350097	Map
MN	United Hospital	Saint Paul55102	NCT03191149	Map
MN	United Hospital	Saint Paul55102	NCT04181060	Map
MN	United Hospital	Saint Paul55102	NCT05642572	Map
MN	United Hospital	Saint Paul55102	NCT06538038	Map
MN	Essentia Health Sandstone	Sandstone55072	NCT05624996	Map
MN	Essentia Health Sandstone	Sandstone55072	NCT05642572	Map
MN	Saint Francis Regional Medical Center	Shakopee55379	NCT03191149	Map
MN	Saint Francis Regional Medical Center	Shakopee55379	NCT04181060	Map
MN	Saint Francis Regional Medical Center	Shakopee55379	NCT06538038	Map
MN	Lakeview Hospital	Stillwater55082	NCT03191149	Map
MN	Lakeview Hospital	Stillwater55082	NCT06538038	Map
MN	Essentia Health Virginia Clinic	Virginia55792	NCT05624996	Map
MN	Essentia Health Virginia Clinic	Virginia55792	NCT05642572	Map
MN	Ridgeview Medical Center	Waconia55387	NCT03191149	Map
MN	Ridgeview Medical Center	Waconia55387	NCT04181060	Map
MN	Ridgeview Medical Center	Waconia55387	NCT05642572	Map
MN	Ridgeview Medical Center	Waconia55387	NCT06538038	Map
MN	Rice Memorial Hospital	Willmar56201	NCT03191149	Map
MN	Rice Memorial Hospital	Willmar56201	NCT06538038	Map
MN	Minnesota Oncology Hematology PA-Woodbury	Woodbury55125	NCT03191149	Map
MN	Minnesota Oncology Hematology PA-Woodbury	Woodbury55125	NCT06538038	Map
MN	Fairview Lakes Medical Center	Wyoming55092	NCT03191149	Map
MN	Fairview Lakes Medical Center	Wyoming55092	NCT06538038	Map
MS	Baptist Memorial Hospital and Cancer Center - Golden Triangle	Columbus39705	NCT06538038	Map
MS	Baptist Memorial Hospital and Cancer Center-Golden Triangle	Columbus39705	NCT04181060	Map
MS	Baptist Memorial Hospital and Cancer Center-Golden Triangle	Columbus39705	NCT05642572	Map
MS	Baptist Cancer Center - Grenada	Grenada38901	NCT06538038	Map
MS	Baptist Cancer Center-Grenada	Grenada38901	NCT04181060	Map
MS	Baptist Cancer Center-Grenada	Grenada38901	NCT05642572	Map
MS	Jackson Oncology Associates PLLC	Jackson39202	NCT06538038	Map
MS	Mississippi Baptist Medical Center	Jackson39202	NCT06538038	Map
MS	University of Mississippi Medical Center	Jackson39216	NCT05642572	Map
MS	Baptist Memorial Hospital and Cancer Center - Union	New Albany38652	NCT06538038	Map
MS	Baptist Memorial Hospital and Cancer Center-Union County	New Albany38652	NCT04181060	Map
MS	Baptist Memorial Hospital and Cancer Center-Union County	New Albany38652	NCT05642572	Map
MS	Baptist Memorial Hospital and Cancer Center - Oxford	Oxford38655	NCT06538038	Map
MS	Baptist Memorial Hospital and Cancer Center-Oxford	Oxford38655	NCT04181060	Map
MS	Baptist Memorial Hospital and Cancer Center-Oxford	Oxford38655	NCT05642572	Map
MS	Baptist Memorial Hospital and Cancer Center - Desoto	Southhaven38671	NCT06538038	Map
MS	Baptist Memorial Hospital and Cancer Center-Desoto	Southhaven38671	NCT04181060	Map
MS	Baptist Memorial Hospital and Cancer Center-Desoto	Southhaven38671	NCT05624996	Map
MS	Baptist Memorial Hospital and Cancer Center-Desoto	Southhaven38671	NCT05642572	Map
MO	Mercy Oncology and Hematology - Clayton-Clarkson	Ballwin63011	NCT03191149	Map
MO	Central Care Cancer Center - Bolivar	Bolivar65613	NCT03191149	Map
MO	Cox Cancer Center Branson	Branson65616	NCT03191149	Map
MO	Mercy Cancer Center - Cape Girardeau	Cape Girardeau63703	NCT03191149	Map
MO	Saint Francis Medical Center	Cape Girardeau63703	NCT03191149	Map
MO	Saint Francis Medical Center	Cape Girardeau63703	NCT04181060	Map
MO	Saint Francis Medical Center	Cape Girardeau63703	NCT05624996	Map
MO	Saint Francis Medical Center	Cape Girardeau63703	NCT05642572	Map
MO	Saint Luke's Hospital	Chesterfield63017	NCT04181060	Map
MO	MU Health - University Hospital/Ellis Fischel Cancer Center	Columbia65212	NCT05624996	Map
MO	Parkland Health Center - Farmington	Farmington63640	NCT03191149	Map
MO	Parkland Health Center - Farmington	Farmington63640	NCT04181060	Map
MO	Parkland Health Center - Farmington	Farmington63640	NCT05624996	Map
MO	Parkland Health Center - Farmington	Farmington63640	NCT05642572	Map
MO	Freeman Health System	Joplin64804	NCT03191149	Map
MO	Freeman Health System	Joplin64804	NCT05624996	Map
MO	Mercy Clinic Joplin, LLC	Joplin64804	NCT06538038	Map
MO	Mercy Hospital Joplin	Joplin64804	NCT03191149	Map
MO	Research Site	Kansas City64132	NCT06417814	Map
MO	University Health Truman Medical Center	Kansas City64108	NCT05642572	Map
MO	University of Kansas Cancer Center - Briarcliff	Kansas City64116	NCT05624996	Map
MO	University of Kansas Cancer Center - Briarcliff	Kansas City64116	NCT05642572	Map
MO	University of Kansas Cancer Center - North	Kansas City64154	NCT05624996	Map
MO	University of Kansas Cancer Center - North	Kansas City64154	NCT05642572	Map
MO	University of Kansas Cancer Center - Lee's Summit	Lee's Summit64064	NCT05624996	Map
MO	University of Kansas Cancer Center - Lee's Summit	Lee's Summit64064	NCT05642572	Map
MO	Lake Regional Hospital	Osage Beach65065	NCT03191149	Map
MO	Mercy Clinic Cancer and Hematology	Rolla65401	NCT06538038	Map
MO	Mercy Clinic-Rolla-Cancer and Hematology	Rolla65401	NCT03191149	Map
MO	Phelps Health Delbert Day Cancer Institute	Rolla65401	NCT03191149	Map
MO	Heartland Regional Medical Center	Saint Joseph64506	NCT03191149	Map
MO	Sainte Genevieve County Memorial Hospital	Sainte Genevieve63670	NCT03191149	Map
MO	Sainte Genevieve County Memorial Hospital	Sainte Genevieve63670	NCT04181060	Map
MO	Sainte Genevieve County Memorial Hospital	Sainte Genevieve63670	NCT05624996	Map
MO	Sainte Genevieve County Memorial Hospital	Sainte Genevieve63670	NCT05642572	Map
MO	CoxHealth South Hospital	Springfield65807	NCT03191149	Map
MO	Mercy Clinic Springfield Communities	Springfield65804	NCT06538038	Map
MO	Mercy Hospital Springfield	Springfield65804	NCT03191149	Map
MO	Mercy Hospital Springfield	Springfield65804	NCT05624996	Map
MO	Mercy Clinic East Communities	St Louis63128	NCT06538038	Map
MO	Mercy Clinic East Communities	St Louis63141	NCT06538038	Map
MO	Mercy Hospital Saint Louis	St Louis63141	NCT03191149	Map
MO	Mercy Hospital Saint Louis	St Louis63141	NCT04181060	Map
MO	Mercy Hospital Saint Louis	St Louis63141	NCT05624996	Map
MO	Mercy Hospital Saint Louis	St Louis63141	NCT05642572	Map
MO	Mercy Hospital South	St Louis63128	NCT03191149	Map
MO	Mercy Hospital South	St Louis63128	NCT04181060	Map
MO	Mercy Hospital South	St Louis63128	NCT05624996	Map
MO	Mercy Hospital South	St Louis63128	NCT05642572	Map
MO	Mercy Infusion Center - Chippewa	St Louis63109	NCT03191149	Map
MO	Missouri Baptist Medical Center	St Louis63131	NCT03191149	Map
MO	Missouri Baptist Medical Center	St Louis63131	NCT04181060	Map
MO	Missouri Baptist Medical Center	St Louis63131	NCT05624996	Map
MO	Missouri Baptist Medical Center	St Louis63131	NCT05642572	Map
MO	Research Site	St Louis63110	NCT06350097	Map
MO	Missouri Baptist Sullivan Hospital	Sullivan63080	NCT03191149	Map
MO	Missouri Baptist Sullivan Hospital	Sullivan63080	NCT04181060	Map
MO	Missouri Baptist Sullivan Hospital	Sullivan63080	NCT05624996	Map
MO	Missouri Baptist Sullivan Hospital	Sullivan63080	NCT05642572	Map
MO	BJC Outpatient Center at Sunset Hills	Sunset Hills63127	NCT03191149	Map
MO	BJC Outpatient Center at Sunset Hills	Sunset Hills63127	NCT04181060	Map
MO	BJC Outpatient Center at Sunset Hills	Sunset Hills63127	NCT05624996	Map
MO	BJC Outpatient Center at Sunset Hills	Sunset Hills63127	NCT05642572	Map
MO	Mercy Hospital Washington	Washington63090	NCT03191149	Map
MT	Community Hospital of Anaconda	Anaconda59711	NCT03191149	Map
MT	Community Hospital of Anaconda	Anaconda59711	NCT04181060	Map
MT	Community Hospital of Anaconda	Anaconda59711	NCT05642572	Map
MT	Billings Clinic Cancer Center	Billings59101	NCT03191149	Map
MT	Billings Clinic Cancer Center	Billings59101	NCT04181060	Map
MT	Billings Clinic Cancer Center	Billings59101	NCT05624996	Map
MT	Billings Clinic Cancer Center	Billings59101	NCT05642572	Map
MT	Bozeman Health Deaconess Hospital	Bozeman59715	NCT03191149	Map
MT	Bozeman Health Deaconess Hospital	Bozeman59715	NCT04181060	Map
MT	Bozeman Health Deaconess Hospital	Bozeman59715	NCT05624996	Map
MT	Bozeman Health Deaconess Hospital	Bozeman59715	NCT05642572	Map
MT	Benefis Sletten Cancer Institute	Great Falls59405	NCT03191149	Map
MT	Benefis Sletten Cancer Institute	Great Falls59405	NCT04181060	Map
MT	Benefis Sletten Cancer Institute	Great Falls59405	NCT05624996	Map
MT	Benefis Sletten Cancer Institute	Great Falls59405	NCT05642572	Map
MT	Great Falls Clinic	Great Falls59405	NCT03191149	Map
MT	Hi-Line Sletten Cancer Center	Havre59501	NCT03191149	Map
MT	Benefis Helena Specialty Center	Helena59601	NCT03191149	Map
MT	Logan Health Medical Center	Kalispell59901	NCT03191149	Map
MT	Logan Health Medical Center	Kalispell59901	NCT04181060	Map
MT	Logan Health Medical Center	Kalispell59901	NCT05642572	Map
MT	Community Medical Center	Missoula59804	NCT03191149	Map
MT	Community Medical Center	Missoula59804	NCT04181060	Map
MT	Community Medical Center	Missoula59804	NCT05642572	Map
NE	Cancer Partners of Nebraska	Lincoln68516	NCT04181060	Map
NE	Nho - Revive Research Institute /ID# 276115	Lincoln68506	NCT07005102	Map
NE	Nebraska Cancer Specialists/Oncology Hematology West PC - MECC	Omaha68114	NCT03191149	Map
NE	Nebraska Cancer Specialists/Oncology Hematology West PC - MECC	Omaha68114	NCT05624996	Map
NE	Nebraska Methodist Hospital	Omaha68114	NCT03191149	Map
NE	Nebraska Methodist Hospital	Omaha68114	NCT05624996	Map
NE	Research Site	Omaha68124	NCT06417814	Map
NV	OptumCare Cancer Care at Charleston	Las Vegas89102	NCT05642572	Map
NV	OptumCare Cancer Care at Fort Apache	Las Vegas89183	NCT05642572	Map
NV	Research Site	Las Vegas89169	NCT06350097	Map
NV	Renown Regional Medical Center	Reno89502	NCT05624996	Map
NV	Renown Regional Medical Center /ID# 276049	Reno89502	NCT07005102	Map
NH	New Hampshire Oncology Hematology PA-Concord	Concord03301	NCT05642572	Map
NH	Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center	Lebanon03756	NCT05624996	Map
NH	Solinsky Center for Cancer Care	Manchester03103	NCT05642572	Map
NJ	Memorial Sloan Kettering Basking Ridge	Basking Ridge07920	NCT04181060	Map
NJ	Memorial Sloan Kettering Basking Ridge	Basking Ridge07920	NCT05624996	Map
NJ	Memorial Sloan Kettering Basking Ridge (All Protocol Activities)	Basking Ridge07920	NCT06741085	Map
NJ	Memorial Sloan Kettering Basking Ridge (All Protocol Activities)	Basking Ridge07920	NCT07535437	Map
NJ	Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)	Basking Ridge07920	NCT04410796	Map
NJ	Cooper Hospital University Medical Center	Camden08103	NCT05624996	Map
NJ	Jefferson Cherry Hill Hospital	Cherry Hill08002	NCT05624996	Map
NJ	Englewood Hospital and Medical Center	Englewood07631	NCT04181060	Map
NJ	Hackensack Meridian Health	Hackensack07601	NCT04410796	Map
NJ	John Theurer Cancer Center at Hackensack University Medical Center	Hackensack07601	NCT06618287	Map
NJ	The Cancer Institute of New Jersey Hamilton	Hamilton08690	NCT05624996	Map
NJ	Jersey City Medical Center	Jersey City07302	NCT04181060	Map
NJ	Jersey City Medical Center	Jersey City07302	NCT05624996	Map
NJ	Monmouth Medical Center Southern Campus	Lakewood08701	NCT04181060	Map
NJ	Monmouth Medical Center Southern Campus	Lakewood08701	NCT05624996	Map
NJ	Saint Barnabas Medical Center	Livingston07039	NCT04181060	Map
NJ	Saint Barnabas Medical Center	Livingston07039	NCT05624996	Map
NJ	Monmouth Medical Center	Long Branch07740	NCT04181060	Map
NJ	Monmouth Medical Center	Long Branch07740	NCT05624996	Map
NJ	Memorial Sloan Kettering Monmouth	Middletown07748	NCT04181060	Map
NJ	Memorial Sloan Kettering Monmouth	Middletown07748	NCT05624996	Map
NJ	Memorial Sloan Kettering Monmouth (All Protocol Activities)	Middletown07748	NCT06741085	Map
NJ	Memorial Sloan Kettering Monmouth (All Protocol Activities)	Middletown07748	NCT07535437	Map
NJ	Memorial Sloan Kettering Monmouth (Limited Protocol Activities)	Middletown07748	NCT04410796	Map
NJ	Memorial Sloan Kettering Bergen	Montvale07645	NCT04181060	Map
NJ	Memorial Sloan Kettering Bergen	Montvale07645	NCT05624996	Map
NJ	Memorial Sloan Kettering Bergen (All Protocol Activities)	Montvale07645	NCT06741085	Map
NJ	Memorial Sloan Kettering Bergen (All Protocol Activities)	Montvale07645	NCT07535437	Map
NJ	Memorial Sloan Kettering Bergen (Limited Protocol Activities)	Montvale07645	NCT04410796	Map
NJ	Virtua Samson Cancer Center	Moorestown08057	NCT05642572	Map
NJ	Virtua Samson Cancer Center	Moorestown08057	NCT06538038	Map
NJ	Atlantic Health Cancer Consortium Community Oncology Research Program	Morristown07960	NCT06538038	Map
NJ	Morristown Medical Center	Morristown07960	NCT06538038	Map
NJ	Research Site	Morristown07960	NCT06417814	Map
NJ	Rutgers Cancer Institute of New Jersey	New Brunswick08903	NCT04181060	Map
NJ	Rutgers Cancer Institute of New Jersey	New Brunswick08903	NCT05624996	Map
NJ	Rutgers Cancer Institute of New Jersey	New Brunswick08903	NCT06538038	Map
NJ	Rutgers New Jersey Medical School	Newark07101	NCT05624996	Map
NJ	Research Site	Northfield08225	NCT06417814	Map
NJ	The Valley Hospital - Luckow Pavilion	Paramus07652	NCT04486833	Map
NJ	The Valley Hospital - Luckow Pavilion	Paramus07652	NCT04181060	Map
NJ	The Valley Hospital - Luckow Pavilion	Paramus07652	NCT06538038	Map
NJ	Valley Health System Ridgewood Campus	Ridgewood07450	NCT04181060	Map
NJ	Sidney Kimmel Cancer Center Washington Township	Sewell08080	NCT05624996	Map
NJ	Sidney Kimmel Cancer Center Washington Township	Sewell08080	NCT06538038	Map
NJ	Robert Wood Johnson University Hospital Somerset	Somerville08876	NCT05624996	Map
NJ	Overlook Medical Center	Summit07901	NCT06538038	Map
NJ	Community Medical Center	Toms River08755	NCT05624996	Map
NJ	Virtua Voorhees	Voorhees Township08043	NCT05642572	Map
NJ	Virtua Voorhees	Voorhees Township08043	NCT06538038	Map
NM	Presbyterian Kaseman Hospital	Albuquerque87110	NCT05624996	Map
NM	University of New Mexico Cancer Center	Albuquerque87106	NCT04181060	Map
NM	University of New Mexico Cancer Center	Albuquerque87106	NCT05624996	Map
NM	University of New Mexico Cancer Center	Albuquerque87106	NCT05642572	Map
NM	Memorial Medical Center-Las Cruces	Las Cruces88011	NCT05624996	Map
NM	Presbyterian Rust Medical Center/Jorgensen Cancer Center	Rio Rancho87124	NCT05624996	Map
NY	Northwell Health Imbert Cancer Center	Bay Shore11706	NCT05624996	Map
NY	Roswell Park Cancer Institute	Buffalo14263	NCT04181060	Map
NY	Sands Cancer Center	Canandiaqua14424	NCT05624996	—
NY	Memorial Sloan Kettering Commack	Commack11725	NCT04181060	Map
NY	Memorial Sloan Kettering Commack	Commack11725	NCT05624996	Map
NY	Memorial Sloan Kettering Commack (Limited protocol activities)	Commack11725	NCT04410796	Map
NY	Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)	Commack11725	NCT06741085	Map
NY	Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)	Commack11725	NCT07535437	Map
NY	The Cancer Institute at Saint Francis Hospital	East Hills11548	NCT04181060	Map
NY	The Cancer Institute at St. Francis Hospital	East Hills11548	NCT06538038	Map
NY	Memorial Sloan Kettering Westchester	East White Plains10604	NCT05624996	Map
NY	Glens Falls Hospital	Glens Falls12801	NCT04181060	Map
NY	Glens Falls Hospital	Glens Falls12801	NCT05624996	Map
NY	Northwell Health Cancer Institute at Huntington	Greenlawn11740	NCT05624996	Map
NY	Memorial Sloan Kettering Westchester	Harrison10604	NCT04181060	Map
NY	Memorial Sloan Kettering Westchester (All Protocol Activities)	Harrison10604	NCT06741085	Map
NY	Memorial Sloan Kettering Westchester (All Protocol Activities)	Harrison10604	NCT07535437	Map
NY	Memorial Sloan Kettering Westchester (Limited protocol activities)	Harrison10604	NCT04410796	Map
NY	Northwell Health/Center for Advanced Medicine	Lake Success11042	NCT05624996	Map
NY	David H. Koch Center for Cancer Center at Memorial Sloan Kettering Cancer Center	Long Island City11101	NCT06507306	Map
NY	Lenox Hill Hospital	New York10075	NCT05624996	Map
NY	Manhattan Eye Ear and Throat Hospital	New York10065	NCT05624996	Map
NY	Memorial Sloan Kettering Cancer Center	New York10065	NCT04665206	Map
NY	Memorial Sloan Kettering Cancer Center	New York10065	NCT04181060	Map
NY	Memorial Sloan Kettering Cancer Center	New York10065	NCT05624996	Map
NY	Memorial Sloan Kettering Cancer Center (All protocol activities)	New York10065	NCT04410796	Map
NY	Memorial Sloan Kettering Cancer Center (All Protocol Activities)	New York10065	NCT06741085	Map
NY	Memorial Sloan Kettering Cancer Center (All Protocol Activities)	New York10065	NCT07535437	Map
NY	Montefiore	New York10467	NCT06538038	Map
NY	Mount Sinai Chelsea	New York10011	NCT04181060	Map
NY	Mount Sinai Hospital	New York10029	NCT04181060	Map
NY	New York Proton Center	New York10035	NCT05624996	Map
NY	New York University	New York10010	NCT04410796	Map
NY	Research Site	New York10065	NCT06350097	Map
NY	Research Site	New York10065	NCT06417814	Map
NY	Upstate Cancer Center at Oswego	Oswego13126	NCT04181060	Map
NY	Highland Hospital	Rochester14620	NCT05624996	Map
NY	University of Rochester	Rochester14642	NCT05624996	Map
NY	University of Rochester	Rochester14642	NCT05642572	Map
NY	Wilmot Cancer Institute Radiation Oncology at Greece	Rochester14606	NCT05624996	Map
NY	Memorial Sloan Kettering Nassau (All Protocol Activities)	Rockville Centre11553	NCT06741085	Map
NY	Staten Island University Hospital	Staten Island10305	NCT05624996	Map
NY	Stony Brook University Medical Center	Stony Brook11794	NCT05624996	Map
NY	State University of New York Upstate Medical University	Syracuse13210	NCT04181060	Map
NY	State University of New York Upstate Medical University	Syracuse13210	NCT05624996	Map
NY	SUNY Upstate Medical University	Syracuse13210	NCT06538038	Map
NY	James J Peters VA Medical Center	The Bronx10468	NCT05642572	Map
NY	Montefiore Medical Center - Moses Campus	The Bronx10467	NCT04181060	Map
NY	Montefiore Medical Center - Moses Campus	The Bronx10467	NCT05624996	Map
NY	Montefiore Medical Center - Moses Campus	The Bronx10467	NCT05642572	Map
NY	Montefiore Medical Center-Einstein Campus	The Bronx10461	NCT04181060	Map
NY	Montefiore Medical Center-Einstein Campus	The Bronx10461	NCT05624996	Map
NY	Montefiore Medical Center-Einstein Campus	The Bronx10461	NCT05642572	Map
NY	Montefiore Medical Center-Einstein Campus	The Bronx10461	NCT06538038	Map
NY	Montefiore Medical Center-Weiler Hospital	The Bronx10461	NCT05624996	Map
NY	Research Site	The Bronx10461	NCT06417814	Map
NY	Memorial Sloan Kettering Nassau	Uniondale11553	NCT04181060	Map
NY	Memorial Sloan Kettering Nassau	Uniondale11553	NCT05624996	Map
NY	Memorial Sloan Kettering Nassau (All Protocol Activities)	Uniondale11553	NCT07535437	Map
NY	Memorial Sloan Kettering Nassau (Limited Protocol Activities)	Uniondale11553	NCT04410796	Map
NY	Westchester Medical Center	Valhalla10595	NCT05624996	Map
NY	Upstate Cancer Center at Verona	Verona13478	NCT04181060	Map
NY	Wilmot Cancer Institute at Webster	Webster14580	NCT05624996	Map
NY	Good Samaritan University Hospital	West Islip11795	NCT04181060	Map
NY	Good Samaritan University Hospital	West Islip11795	NCT06538038	Map
NY	Dickstein Cancer Treatment Center	White Plains10601	NCT04181060	Map
NC	Atrium Health Stanly/LCI-Albemarle	Albemarle28002	NCT05624996	Map
NC	Duke Cancer Center Cary	Cary27518	NCT05624996	Map
NC	UNC Lineberger Comprehensive Cancer Center	Chapel Hill27599	NCT05624996	Map
NC	Atrium Health Pineville/LCI-Pineville	Charlotte28210	NCT05624996	Map
NC	Atrium Health University City/LCI-University	Charlotte28262	NCT05624996	Map
NC	Carolinas Medical Center/Levine Cancer Institute	Charlotte28203	NCT05624996	Map
NC	Levine Cancer Institute-Ballantyne	Charlotte28277	NCT05624996	Map
NC	Novant Health Presbyterian Medical Center	Charlotte28204	NCT04181060	Map
NC	Novant Health Presbyterian Medical Center	Charlotte28204	NCT05624996	Map
NC	Wake Forest University at Clemmons	Clemmons27012	NCT05624996	Map
NC	Southeastern Medical Oncology Center-Clinton	Clinton28328	NCT04181060	Map
NC	Atrium Health Cabarrus/LCI-Concord	Concord28025	NCT05624996	Map
NC	Duke University Medical Center	Durham27710	NCT05624996	Map
NC	Durham VA Medical Center	Durham27705	NCT05642572	Map
NC	Levine Cancer Institute - Rutherford	Forest City28043	NCT05624996	Map
NC	CaroMont Regional Medical Center	Gastonia28054	NCT05624996	Map
NC	Southeastern Medical Oncology Center-Goldsboro	Goldsboro27534	NCT04181060	Map
NC	Novant Health Breast Surgery - Greensboro	Greensboro27403	NCT05624996	Map
NC	UNC Pardee Cancer Center	Hendersonville28791	NCT06538038	Map
NC	Hayworth Cancer Center	High Point27262	NCT05624996	Map
NC	Novant Health Cancer Institute - Huntersville	Huntersville28078	NCT04181060	Map
NC	Novant Health Cancer Institute - Huntersville	Huntersville28078	NCT05624996	Map
NC	Novant Health Presbyterian Medical Center Huntersville	Huntersville28078	NCT05624996	Map
NC	Southeastern Medical Oncology Center-Jacksonville	Jacksonville28546	NCT04181060	Map
NC	Novant Health Cancer Institute - Kernersville	Kernersville27284	NCT04181060	Map
NC	Novant Health Cancer Institute - Kernersville	Kernersville27284	NCT05624996	Map
NC	Levine Cancer Institute - Union West	Matthews28104	NCT05624996	Map
NC	Matthews Radiation Oncology Center	Matthews28105	NCT05624996	Map
NC	Novant Health Cancer Institute - Matthews	Matthews28105	NCT04181060	Map
NC	Novant Health Cancer Institute - Matthews	Matthews28105	NCT05624996	Map
NC	Atrium Health Union/LCI-Union	Monroe28112	NCT05624996	Map
NC	Novant Health Cancer Institute - Mooresville	Mooresville28117	NCT04181060	Map
NC	Novant Health Cancer Institute - Mooresville	Mooresville28117	NCT05624996	Map
NC	Novant Health Cancer Institute - Mount Airy	Mount Airy27030	NCT04181060	Map
NC	Novant Health Cancer Institute - Mount Airy	Mount Airy27030	NCT05624996	Map
NC	Novant Health Cancer Institute - Wilkesboro	North Wilkesboro28659	NCT05624996	Map
NC	FirstHealth of the Carolinas-Moore Regional Hospital	Pinehurst28374	NCT03191149	Map
NC	FirstHealth of the Carolinas-Moore Regional Hospital	Pinehurst28374	NCT06538038	Map
NC	Duke Cancer Center Raleigh	Raleigh27609	NCT05624996	Map
NC	Novant Health Cancer Institute - Rowan	Salisbury28144	NCT05624996	Map
NC	Rowan Regional Medical Center	Salisbury28144	NCT05624996	Map
NC	Atrium Health Cleveland/LCI-Cleveland	Shelby28150	NCT05624996	Map
NC	Wake Forest Baptist Health - Hematology Oncology - Statesville	Statesville28677	NCT05624996	Map
NC	Novant Health Cancer Institute - Statesville	Stateville28625	NCT05624996	—
NC	Novant Cancer Institute Radiation Oncology - Supply	Supply28462	NCT05624996	Map
NC	Novant Health Cancer Institute - Thomasville	Thomasville27360	NCT05624996	Map
NC	Wake Forest Baptist Health - Wilkes Medical Center	Wilkesboro28659	NCT05624996	Map
NC	Novant Health Cancer Institute Radiation Oncology - Wilmington	Wilmington28401	NCT05624996	Map
NC	Novant Health New Hanover Regional Medical Center	Wilmington28401	NCT05624996	Map
NC	Novant Health Forsyth Medical Center	Winston-Salem27103	NCT04181060	Map
NC	Novant Health Forsyth Medical Center	Winston-Salem27103	NCT05624996	Map
NC	Wake Forest University Health Sciences	Winston-Salem27157	NCT05624996	Map
ND	Sanford Bismarck Medical Center	Bismarck58501	NCT05624996	Map
ND	Sanford Bismarck Medical Center	Bismarck58501	NCT05642572	Map
ND	Sanford Broadway Medical Center	Fargo58122	NCT05624996	Map
ND	Sanford Broadway Medical Center	Fargo58122	NCT05642572	Map
ND	Sanford Roger Maris Cancer Center	Fargo58122	NCT05624996	Map
ND	Sanford Roger Maris Cancer Center	Fargo58122	NCT05642572	Map
ND	Altru Cancer Center	Grand Forks58201	NCT05624996	Map
OH	Cleveland Clinic Akron General	Akron44307	NCT05624996	Map
OH	UH Seidman Cancer Center at UH Avon Health Center	Avon44011	NCT04181060	Map
OH	UH Seidman Cancer Center at UH Avon Health Center	Avon44011	NCT05624996	Map
OH	UHHS-Chagrin Highlands Medical Center	Beachwood44122	NCT04181060	Map
OH	UHHS-Chagrin Highlands Medical Center	Beachwood44122	NCT05624996	Map
OH	Strecker Cancer Center-Belpre	Belpre45714	NCT04181060	Map
OH	Strecker Cancer Center-Belpre	Belpre45714	NCT05642572	Map
OH	Aultman	Canton44710	NCT06538038	Map
OH	Aultman Health Foundation	Canton44710	NCT05624996	Map
OH	Aultman Health Foundation	Canton44710	NCT05642572	Map
OH	Cleveland Clinic Mercy Hospital	Canton44708	NCT05624996	Map
OH	Cleveland Clinic Mercy Hospital	Canton44708	NCT05642572	Map
OH	Gabrail Cancer Center Research	Canton44718	NCT04486833	Map
OH	Miami Valley Hospital South	Centerville45459	NCT04181060	Map
OH	Miami Valley Hospital South	Centerville45459	NCT05624996	Map
OH	Miami Valley Hospital South	Centerville45459	NCT05642572	Map
OH	Miami Valley Hospital South	Centerville45459	NCT06538038	Map
OH	Adena Regional Medical Center	Chillicothe45601	NCT04181060	Map
OH	Adena Regional Medical Center	Chillicothe45601	NCT05642572	Map
OH	Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center	Cincinnati45219	NCT05785741	Map
OH	The Lindner Center for Research and Education at The Christ Hospital	Cincinnati45219	NCT06507306	Map
OH	University of Cincinnati Cancer Center-UC Medical Center	Cincinnati45219	NCT04181060	Map
OH	Case Western Reserve University	Cleveland44106	NCT04181060	Map
OH	Case Western Reserve University	Cleveland44106	NCT05624996	Map
OH	Cleveland Clinic	Cleveland44195	NCT06618287	Map
OH	Cleveland Clinic Foundation	Cleveland44195	NCT04181060	Map
OH	Columbus Oncology and Hematology Associates Inc	Columbus43214	NCT04181060	Map
OH	Doctors Hospital	Columbus43228	NCT04181060	Map
OH	Doctors Hospital	Columbus43228	NCT05624996	Map
OH	Grant Medical Center	Columbus43215	NCT04181060	Map
OH	Grant Medical Center	Columbus43215	NCT05624996	Map
OH	Mount Carmel East Hospital	Columbus43213	NCT05642572	Map
OH	Ohio State University Comprehensive Cancer Center	Columbus43210	NCT04780568	Map
OH	Ohio State University Comprehensive Cancer Center	Columbus43210	NCT03191149	Map
OH	Riverside Methodist Hospital	Columbus43214	NCT05624996	Map
OH	The Mark H Zangmeister Center	Columbus43219	NCT04181060	Map
OH	The Mark H Zangmeister Center	Columbus43219	NCT05642572	Map
OH	Miami Valley Hospital	Dayton45409	NCT04181060	Map
OH	Miami Valley Hospital	Dayton45409	NCT05624996	Map
OH	Miami Valley Hospital	Dayton45409	NCT05642572	Map
OH	Miami Valley Hospital North	Dayton45415	NCT04181060	Map
OH	Miami Valley Hospital North	Dayton45415	NCT05624996	Map
OH	Miami Valley Hospital North	Dayton45415	NCT05642572	Map
OH	Premier Blood and Cancer Center	Dayton45409	NCT04181060	Map
OH	Premier Blood and Cancer Center	Dayton45409	NCT05624996	Map
OH	Premier Blood and Cancer Center	Dayton45409	NCT05642572	Map
OH	Delaware Health Center-Grady Cancer Center	Delaware43015	NCT04181060	Map
OH	Delaware Health Center-Grady Cancer Center	Delaware43015	NCT05624996	Map
OH	Grady Memorial Hospital	Delaware43015	NCT05624996	Map
OH	Dublin Methodist Hospital	Dublin43016	NCT05624996	Map
OH	Miami Valley Hospital North	Englewood45415	NCT06538038	Map
OH	Atrium Medical Center-Middletown Regional Hospital	Franklin45005-1066	NCT04181060	Map
OH	Atrium Medical Center-Middletown Regional Hospital	Franklin45005-1066	NCT05624996	Map
OH	Atrium Medical Center-Middletown Regional Hospital	Franklin45005-1066	NCT05642572	Map
OH	Atrium Medical Center-Middletown Regional Hospital	Franklin45005	NCT06538038	Map
OH	Dayton Physicians LLC-Atrium	Franklin45005	NCT04181060	Map
OH	Miami Valley Cancer Care and Infusion	Greenville45331	NCT04181060	Map
OH	Miami Valley Cancer Care and Infusion	Greenville45331	NCT05624996	Map
OH	Miami Valley Cancer Care and Infusion	Greenville45331	NCT05642572	Map
OH	Miami Valley Cancer Care and Infusion	Greenville45331	NCT06538038	Map
OH	Mount Carmel Grove City Hospital	Grove City43123	NCT05642572	Map
OH	OhioHealth Mansfield Hospital	Mansfield44903	NCT05624996	Map
OH	Marietta Memorial Hospital	Marietta45750	NCT04181060	Map
OH	OhioHealth Marion General Hospital	Marion43302	NCT04181060	Map
OH	OhioHealth Marion General Hospital	Marion43302	NCT05624996	Map
OH	Memorial Hospital	Marysville43040	NCT04181060	Map
OH	Memorial Hospital	Marysville43040	NCT05642572	Map
OH	Research Site	Maumee43537	NCT06417814	Map
OH	Hillcrest Hospital Cancer Center	Mayfield Heights44124	NCT04181060	Map
OH	UH Seidman Cancer Center at Lake Health Mentor Campus	Mentor44060	NCT04181060	Map
OH	UH Seidman Cancer Center at Lake Health Mentor Campus	Mentor44060	NCT05624996	Map
OH	UH Seidman Cancer Center at Southwest General Hospital	Middleburg Heights44130	NCT04181060	Map
OH	Knox Community Hospital	Mount Vernon43050	NCT04181060	Map
OH	Knox Community Hospital	Mount Vernon43050	NCT05642572	Map
OH	Licking Memorial Hospital	Newark43055	NCT04181060	Map
OH	Licking Memorial Hospital	Newark43055	NCT05642572	Map
OH	Mercy Health - Perrysburg Hospital	Perrysburg43551	NCT05624996	Map
OH	Mercy Health - Perrysburg Hospital	Perrysburg43551	NCT05642572	Map
OH	Southern Ohio Medical Center	Portsmouth45662	NCT04181060	Map
OH	Southern Ohio Medical Center	Portsmouth45662	NCT05642572	Map
OH	Springfield Regional Cancer Center	Springfield45504	NCT04181060	Map
OH	Springfield Regional Cancer Center	Springfield45504	NCT05642572	Map
OH	Trinity's Tony Teramana Cancer Center	Steubenville43952	NCT05642572	Map
OH	ProMedica Flower Hospital	Sylvania43560	NCT05642572	Map
OH	Mercy Health - Saint Anne Hospital	Toledo43623	NCT05642572	Map
OH	Upper Valley Medical Center	Troy45373	NCT04181060	Map
OH	Upper Valley Medical Center	Troy45373	NCT05624996	Map
OH	Upper Valley Medical Center	Troy45373	NCT05642572	Map
OH	Upper Valley Medical Center	Troy45373	NCT06538038	Map
OH	University of Cincinnati Cancer Center-West Chester	West Chester45069	NCT04181060	Map
OH	Saint Ann's Hospital	Westerville43081	NCT05642572	Map
OH	Genesis Healthcare System Cancer Care Center	Zanesville43701	NCT04181060	Map
OH	Genesis Healthcare System Cancer Care Center	Zanesville43701	NCT05642572	Map
OK	Cancer Centers of Southwest Oklahoma Research	Lawton73505	NCT05642572	Map
OK	Integris Cancer Institute of Oklahoma	Oklahoma City73142	NCT04181060	Map
OK	Integris Southwest Medical Center	Oklahoma City73109	NCT04181060	Map
OK	Mercy Clinic Oklahoma Communities, Inc.	Oklahoma City73120	NCT06538038	Map
OK	Mercy Hospital Oklahoma City	Oklahoma City73120	NCT03191149	Map
OK	University of Oklahoma Health Sciences Center	Oklahoma City73104	NCT03191149	Map
OK	University of Oklahoma Health Sciences Center	Oklahoma City73104	NCT04181060	Map
OK	University of Oklahoma Health Sciences Center	Oklahoma City73104	NCT05624996	Map
OK	University of Oklahoma Health Sciences Center	Oklahoma City73104	NCT05642572	Map
OR	Saint Alphonsus Cancer Care Center-Baker City	Baker City97814	NCT03191149	Map
OR	Saint Charles Health System	Bend97701	NCT04181060	Map
OR	Good Samaritan Hospital	Corvallis97330	NCT03191149	Map
OR	Legacy Mount Hood Medical Center	Gresham97030	NCT05624996	Map
OR	Providence Newberg Medical Center	Newberg97132	NCT04181060	Map
OR	Providence Newberg Medical Center	Newberg97132	NCT05642572	Map
OR	Saint Alphonsus Cancer Care Center-Ontario	Ontario97914	NCT03191149	Map
OR	Saint Alphonsus Cancer Care Center-Ontario	Ontario97914	NCT04181060	Map
OR	Saint Alphonsus Cancer Care Center-Ontario	Ontario97914	NCT05642572	Map
OR	Providence Willamette Falls Medical Center	Oregon City97045	NCT04181060	Map
OR	Providence Willamette Falls Medical Center	Oregon City97045	NCT05642572	Map
OR	Kaiser Permanente Northwest	Portland97227	NCT05642572	Map
OR	Legacy Good Samaritan Hospital and Medical Center	Portland97210	NCT05624996	Map
OR	Oregon Health and Science University	Portland97239	NCT05642572	Map
OR	Providence Portland Medical Center	Portland97213	NCT04181060	Map
OR	Providence Portland Medical Center	Portland97213	NCT05642572	Map
OR	Providence Saint Vincent Medical Center	Portland97225	NCT04181060	Map
OR	Providence Saint Vincent Medical Center	Portland97225	NCT05642572	Map
OR	Legacy Meridian Park Hospital	Tualatin97062	NCT05624996	Map
PA	Lehigh Valley Hospital-Cedar Crest	Allentown18103	NCT03191149	Map
PA	Lehigh Valley Hospital-Cedar Crest	Allentown18103	NCT04181060	Map
PA	UPMC Altoona	Altoona16601	NCT05642572	Map
PA	UPMC-Heritage Valley Health System Beaver	Beaver15009	NCT05642572	Map
PA	Lehigh Valley Hospital - Muhlenberg	Bethlehem18017	NCT03191149	Map
PA	Lehigh Valley Hospital - Muhlenberg	Bethlehem18017	NCT04181060	Map
PA	Bryn Mawr Hospital	Bryn Mawr19010	NCT03191149	Map
PA	Bryn Mawr Hospital	Bryn Mawr19010	NCT04181060	Map
PA	UPMC Hillman Cancer Center at Butler Health System	Butler16001	NCT05642572	Map
PA	Carlisle Regional Cancer Center	Carlisle17015	NCT05642572	Map
PA	Christiana Care Health System-Concord Health Center	Chadds Ford19317	NCT05624996	Map
PA	Chambersburg Hospital	Chambersburg17201	NCT05624996	Map
PA	WellSpan Medical Oncology and Hematology	Chambersburg17201	NCT04181060	Map
PA	WellSpan Medical Oncology and Hematology	Chambersburg17201	NCT05642572	Map
PA	UPMC Hillman Cancer Center - Passavant - Cranberry	Cranberry Township16066	NCT05642572	Map
PA	Geisinger Medical Center	Danville17822	NCT05624996	Map
PA	Geisinger Medical Center	Danville17822	NCT05642572	Map
PA	Geisinger Medical Center	Danville17822	NCT06538038	Map
PA	Geisinger Cancer Center Dickson City	Dickson City18519	NCT05642572	Map
PA	Pocono Medical Center	East Stroudsburg18301	NCT03191149	Map
PA	Ephrata Cancer Center	Ephrata17522	NCT04181060	Map
PA	Ephrata Cancer Center	Ephrata17522	NCT05624996	Map
PA	Ephrata Cancer Center	Ephrata17522	NCT05642572	Map
PA	UPMC Hillman Cancer Center Erie	Erie16505	NCT05642572	Map
PA	UPMC Cancer Center at UPMC Horizon	Farrell16121	NCT05642572	Map
PA	Adams Cancer Center	Gettysburg17325	NCT04181060	Map
PA	Adams Cancer Center	Gettysburg17325	NCT05624996	Map
PA	Adams Cancer Center	Gettysburg17325	NCT05642572	Map
PA	UPMC Cancer Centers - Arnold Palmer Pavilion	Greensburg15601	NCT05642572	Map
PA	WellSpan Medical Oncology and Hematology	Hanover17331	NCT04181060	Map
PA	UPMC Pinnacle Cancer Center/Community Osteopathic Campus	Harrisburg17109	NCT05642572	Map
PA	Geisinger Medical Center-Cancer Center Hazleton	Hazleton18201	NCT06538038	Map
PA	Lehigh Valley Hospital-Hazleton	Hazleton18201	NCT03191149	Map
PA	Penn State Milton S Hershey Medical Center	Hershey17033-0850	NCT05624996	Map
PA	IRMC Cancer Center	Indiana15701	NCT05642572	Map
PA	UPMC-Johnstown/John P. Murtha Regional Cancer Center	Johnstown15901	NCT05642572	Map
PA	Lancaster General Ann B Barshinger Cancer Institute	Lancaster17601	NCT05624996	Map
PA	Sechler Family Cancer Center	Lebanon17042	NCT04181060	Map
PA	Sechler Family Cancer Center	Lebanon17042	NCT05624996	Map
PA	Sechler Family Cancer Center	Lebanon17042	NCT05642572	Map
PA	Geisinger Medical Oncology-Lewisburg	Lewisburg17837	NCT05624996	Map
PA	Geisinger Medical Oncology-Lewisburg	Lewisburg17837	NCT05642572	Map
PA	Geisinger Medical Oncology-Lewisburg	Lewisburg17837	NCT06538038	Map
PA	Lewistown Hospital	Lewistown17044	NCT06538038	Map
PA	UPMC Cancer Center at UPMC McKeesport	McKeesport15132	NCT05642572	Map
PA	UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion	Mechanicsburg17050	NCT05642572	Map
PA	Riddle Memorial Hospital	Media19063	NCT03191149	Map
PA	Riddle Memorial Hospital	Media19063	NCT04181060	Map
PA	UPMC Hillman Cancer Center - Monroeville	Monroeville15146	NCT05642572	Map
PA	UPMC Hillman Cancer Center in Coraopolis	Moon Township15108	NCT05642572	Map
PA	UPMC Hillman Cancer Center - Part of Frick Hospital	Mount Pleasant15666	NCT05642572	Map
PA	UPMC Cancer Center-Natrona Heights	Natrona Heights15065	NCT05642572	Map
PA	UPMC Hillman Cancer Center - New Castle	New Castle16105	NCT05642572	Map
PA	Arnold Palmer Cancer Center Medical Oncology Norwin	North Huntingdon15642	NCT05642572	—
PA	Lankenau Medical Center	Paoli19301	NCT06538038	Map
PA	Paoli Memorial Hospital	Paoli19301	NCT03191149	Map
PA	Paoli Memorial Hospital	Paoli19301	NCT04181060	Map
PA	Einstein Medical Center	Philadelphia19141	NCT06538038	Map
PA	Fox Chase Cancer Center	Philadelphia19111	NCT04181060	Map
PA	Fox Chase Cancer Center	Philadelphia19111	NCT05624996	Map
PA	Jefferson Torresdale Hospital	Philadelphia19114	NCT06538038	Map
PA	Temple University Hospital	Philadelphia19140	NCT05624996	Map
PA	Thomas Jefferson University Hospital	Philadelphia19107	NCT05624996	Map
PA	Thomas Jefferson University Hospital	Philadelphia19107	NCT06538038	Map
PA	University of Pennsylvania	Philadelphia19104	NCT06538038	Map
PA	University of Pennsylvania/Abramson Cancer Center	Philadelphia19104	NCT05624996	Map
PA	Allegheny General Hospital	Pittsburgh15212	NCT06538038	Map
PA	Research Site	Pittsburgh15232	NCT06417814	Map
PA	University of Pittsburgh Cancer Institute (UPCI)	Pittsburgh15232	NCT05642572	Map
PA	UPMC-Mercy Hospital	Pittsburgh15219	NCT05642572	Map
PA	UPMC-Passavant Hospital	Pittsburgh15237	NCT05642572	Map
PA	UPMC-Saint Clair Hospital Cancer Center	Pittsburgh15243	NCT05642572	Map
PA	UPMC-Saint Margaret	Pittsburgh15215	NCT05642572	Map
PA	Geisinger Cancer Services-Pottsville	Pottsville17901	NCT06538038	Map
PA	Guthrie Medical Group PC-Robert Packer Hospital	Sayre18840	NCT04181060	Map
PA	Community Medical Center	Scranton18510	NCT05642572	Map
PA	Community Medical Center	Scranton18510	NCT06538038	Map
PA	UPMC Cancer Center at UPMC Northwest	Seneca16346	NCT05642572	Map
PA	Geisinger Medical Group	State College16801	NCT06538038	Map
PA	UPMC Cancer Center-Uniontown	Uniontown15401	NCT05642572	Map
PA	UPMC Cancer Center-Washington	Washington15301	NCT05642572	Map
PA	UPMC West Mifflin-Cancer Center Jefferson	West Mifflin15122	NCT05642572	Map
PA	Reading Hospital	West Reading19611	NCT05624996	Map
PA	Geisinger Wyoming Valley/Henry Cancer Center	Wilkes-Barre18711	NCT05624996	Map
PA	Geisinger Wyoming Valley/Henry Cancer Center	Wilkes-Barre18711	NCT05642572	Map
PA	Geisinger Wyoming Valley/Henry Cancer Center	Wilkes-Barre18711	NCT06538038	Map
PA	Divine Providence Hospital	Williamsport17754	NCT05642572	Map
PA	Asplundh Cancer Pavilion	Willow Grove19090	NCT05624996	Map
PA	Asplundh Cancer Pavilion	Willow Grove19090	NCT06538038	Map
PA	Lankenau Medical Center	Wynnewood19096	NCT03191149	Map
PA	Lankenau Medical Center	Wynnewood19096	NCT04181060	Map
PA	Lankenau Medical Center	Wynnewood19096	NCT05624996	Map
PA	UPMC Memorial	York17408	NCT05642572	Map
PA	WellSpan Health-York Cancer Center	York17403	NCT04181060	Map
PA	WellSpan Health-York Cancer Center	York17403	NCT05624996	Map
PA	WellSpan Health-York Cancer Center	York17403	NCT05642572	Map
PA	WellSpan Health-York Hospital	York17403	NCT04181060	Map
PA	WellSpan Health-York Hospital	York17403	NCT05624996	Map
RI	Smilow Cancer Hospital Care Center - Westerly	Westerly02891	NCT05642572	Map
SC	AnMed Health Cancer Center	Anderson29621	NCT05642572	Map
SC	Lewis Cancer and Research Pavilion at Saint Joseph's/Candler: SJC Bluffton Campus	Bluffton29910	NCT06538038	Map
SC	Saint Joseph's/Candler - Bluffton Campus	Bluffton29910	NCT05624996	Map
SC	Saint Joseph's/Candler - Bluffton Campus	Bluffton29910	NCT05642572	Map
SC	Prisma Health Cancer Institute - Spartanburg	Boiling Springs29316	NCT05642572	Map
SC	Medical University of South Carolina	Charleston29425	NCT05642572	Map
SC	Ralph H Johnson VA Medical Center	Charleston29401	NCT05642572	Map
SC	Prisma Health Cancer Institute - Easley	Easley29640	NCT05642572	Map
SC	Gibbs Cancer Center-Gaffney	Gaffney29341	NCT05624996	Map
SC	Prisma Health Cancer Institute - Butternut	Greenville29605	NCT05642572	Map
SC	Prisma Health Cancer Institute - Eastside	Greenville29615	NCT05642572	Map
SC	Prisma Health Cancer Institute - Faris	Greenville29605	NCT05642572	Map
SC	Prisma Health Greenville Memorial Hospital	Greenville29605	NCT05642572	Map
SC	Saint Francis Cancer Center	Greenville29607	NCT05624996	Map
SC	Saint Francis Hospital	Greenville29601	NCT05624996	Map
SC	Gibbs Cancer Center-Pelham	Greer29651	NCT05624996	Map
SC	Prisma Health Cancer Institute - Greer	Greer29650	NCT05642572	Map
SC	Lewis Cancer and Research Pavilion at Saint Joseph's/Candler: South Carolina Cancer Specialists	Hilton Head Island29926	NCT06538038	Map
SC	Lancaster Radiation Therapy Center	Lancaster29720	NCT05624996	Map
SC	Levine Cancer Institute-Rock Hill	Rock Hill29732	NCT05624996	Map
SC	Rock Hill Radiation Therapy Center	Rock Hill29730	NCT05624996	Map
SC	Prisma Health Cancer Institute - Seneca	Seneca29672	NCT05642572	Map
SC	Spartanburg Medical Center	Spartanburg29303	NCT05624996	Map
SC	SMC Center for Hematology Oncology Union	Union29379	NCT05624996	Map
SC	Lexington Medical Center	West Columbia29169	NCT05624996	Map
SD	Sanford Cancer Center Oncology Clinic	Sioux Falls57104	NCT04181060	Map
SD	Sanford Cancer Center Oncology Clinic	Sioux Falls57104	NCT05624996	Map
SD	Sanford Cancer Center Oncology Clinic	Sioux Falls57104	NCT05642572	Map
SD	Sanford USD Medical Center - Sioux Falls	Sioux Falls57117-5134	NCT04181060	Map
SD	Sanford USD Medical Center - Sioux Falls	Sioux Falls57117-5134	NCT05624996	Map
SD	Sanford USD Medical Center - Sioux Falls	Sioux Falls57117-5134	NCT05642572	Map
TN	Research Site	Chattanooga37404	NCT06417814	Map
TN	Baptist Memorial Hospital and Cancer Center - Collierville	Collierville38017	NCT06538038	Map
TN	Baptist Memorial Hospital and Cancer Center-Collierville	Collierville38017	NCT04181060	Map
TN	Baptist Memorial Hospital and Cancer Center-Collierville	Collierville38017	NCT05624996	Map
TN	Baptist Memorial Hospital and Cancer Center-Collierville	Collierville38017	NCT05642572	Map
TN	University of Tennessee - Knoxville	Knoxville37920	NCT05624996	Map
TN	Baptist Memorial Hospital and Cancer Center - Memphis	Memphis38120	NCT06538038	Map
TN	Baptist Memorial Hospital and Cancer Center-Memphis	Memphis38120	NCT04181060	Map
TN	Baptist Memorial Hospital and Cancer Center-Memphis	Memphis38120	NCT05624996	Map
TN	Baptist Memorial Hospital and Cancer Center-Memphis	Memphis38120	NCT05642572	Map
TN	Baptist Memorial Hospital for Women	Memphis38120	NCT06538038	Map
TN	Research Site	Nashville37203	NCT06417814	Map
TN	Sarah Cannon and HCA Research Institute	Nashville37203	NCT06507306	Map
TN	Sarah Cannon Research Institute	Nashville37203	NCT04410796	Map
TN	Tennessee Oncology, PLLC	Nashville37203	NCT05785741	Map
TN	Vanderbilt University	Nashville37232	NCT06538038	Map
TX	The Don and Sybil Harrington Cancer Center	Amarillo79106	NCT05642572	Map
TX	Texas Oncology - South Austin /ID# 276033	Austin78745	NCT07005102	Map
TX	Houston Methodist San Jacinto Hospital	Baytown77521	NCT04181060	Map
TX	MD Anderson in The Woodlands	Conroe77384	NCT05624996	Map
TX	Houston Methodist Cypress Hospital	Cypress77429	NCT04181060	Map
TX	Parkland Memorial Hospital	Dallas75235	NCT04181060	Map
TX	UT Southwest	Dallas75235	NCT06538038	Map
TX	UT Southwestern Simmons Cancer Center - RedBird	Dallas75237	NCT04181060	Map
TX	UT Southwestern/Simmons Cancer Center-Dallas	Dallas75390	NCT04181060	Map
TX	JPS Oncology & Infusion Center	Fort Worth76104	NCT06538038	Map
TX	UT Southwestern/Simmons Cancer Center-Fort Worth	Fort Worth76104	NCT04181060	Map
TX	Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center	Houston77030	NCT05624996	Map
TX	Ben Taub General Hospital	Houston77030	NCT05624996	Map
TX	Houston Methodist Hospital	Houston77030	NCT04181060	Map
TX	Houston Methodist West Hospital	Houston77094	NCT04181060	Map
TX	M D Anderson Cancer Center	Houston77030	NCT05624996	Map
TX	MD Anderson Cancer Center	Houston77030	NCT04665206	Map
TX	MD Anderson Cancer Center	Houston77030	NCT05142189	Map
TX	MD ANDERSON CANCER CENTER (Data Collection Only)	Houston77030	NCT04410796	Map
TX	MD Anderson West Houston	Houston77079	NCT05624996	Map
TX	Methodist Willowbrook Hospital	Houston77070	NCT04181060	Map
TX	NEXT Houston	Houston77054	NCT07315113	Map
TX	Research Site	Houston77030	NCT06350097	Map
TX	The University of Texas MD Anderson Cancer Center /ID# 275107	Houston77030	NCT07005102	Map
TX	NEXT Oncology - Irving	Irving75039	NCT06618287	Map
TX	MD Anderson League City	League City77573	NCT05624996	Map
TX	Houston Methodist Saint John Hospital	Nassau Bay77058	NCT04181060	Map
TX	Texas Oncology - Palestine Cancer Center /ID# 276034	Palestine75801	NCT07005102	Map
TX	UT Southwestern Clinical Center at Richardson/Plano	Richardson75080	NCT04181060	Map
TX	New Experimental Therapeutics of San Antonio - NEXT Oncology	San Antonio78229	NCT06507306	Map
TX	NEXT Oncology	San Antonio78229	NCT04665206	Map
TX	Houston Methodist Sugar Land Hospital	Sugar Land77479	NCT04181060	Map
TX	MD Anderson in Sugar Land	Sugar Land77478	NCT05624996	Map
TX	Houston Methodist The Woodlands Hospital	The Woodlands77385	NCT04181060	Map
TX	Research Site	Webster77598	NCT06350097	Map
TX	Research Site	Woodway76712	NCT06350097	Map
UT	Huntsman Cancer Institute/University of Utah	Salt Lake City84112	NCT05642572	Map
VT	Central Vermont Medical Center/National Life Cancer Treatment	Berlin Corners05602	NCT05624996	Map
VT	Central Vermont Medical Center/National Life Cancer Treatment	Berlin Corners05602	NCT05642572	Map
VT	University of Vermont and State Agricultural College	Burlington05405	NCT05624996	Map
VT	University of Vermont and State Agricultural College	Burlington05405	NCT05642572	Map
VT	University of Vermont Medical Center	Burlington05401	NCT05624996	Map
VT	University of Vermont Medical Center	Burlington05401	NCT05642572	Map
VT	Dartmouth Cancer Center - North	Saint Johnsbury05819	NCT05624996	Map
VA	Virginia Cancer Specialists, PC	Arlington22201	NCT04665206	Map
VA	University of Virginia Cancer Center	Charlottesville22908	NCT03191149	Map
VA	University of Virginia Cancer Center	Charlottesville22908	NCT04181060	Map
VA	University of Virginia Cancer Center	Charlottesville22908	NCT05642572	Map
VA	New Experimental Therapeutics of Virginia - NEXT Oncology	Fairfax22031	NCT06507306	Map
VA	NEXT Virginia	Fairfax22031	NCT05142189	Map
VA	NEXT Virginia	Fairfax22031	NCT05785741	Map
VA	NEXT Virginia	Fairfax22031	NCT07315113	Map
VA	Research Site	Fairfax22031	NCT06350097	Map
VA	Research Site	Fairfax22031	NCT06417814	Map
VA	Virginia Cancer Specialists	Fairfax22031	NCT04486833	Map
VA	Virginia Cancer Specialists - Fairfax /ID# 275071	Fairfax22031	NCT07005102	Map
VA	Research Site	Fort Belvoir22060	NCT06350097	Map
VA	Kaiser Permanente Tysons Corner Medical Center	McLean22102	NCT05642572	Map
VA	Research Site	Midlothian23114	NCT06350097	Map
VA	Virginia Oncology Associates	Norfolk23502	NCT04486833	Map
VA	Kaiser Permanente-Caton Hill Medical Center	Woodbridge22192	NCT05642572	Map
WA	FHCC Overlake	Bellevue98004	NCT05642572	Map
WA	Kadlec Clinic Hematology and Oncology	Kennewick99336	NCT04181060	Map
WA	FHCC at EvergreenHealth	Kirkland98034	NCT05642572	Map
WA	Valley Medical Center	Renton98055	NCT05642572	Map
WA	FHCC at Northwest Hospital	Seattle98133	NCT05642572	Map
WA	Fred Hutchinson Cancer Center	Seattle98109	NCT03191149	Map
WA	Fred Hutchinson Cancer Center	Seattle98109	NCT05642572	Map
WA	Swedish Medical Center	Seattle98104	NCT06618287	Map
WA	Swedish Medical Center-First Hill	Seattle98122	NCT05642572	Map
WA	University of Washington (Data Collection Only)	Seattle98109	NCT04410796	Map
WA	University of Washington Medical Center - Montlake	Seattle98195	NCT03191149	Map
WA	University of Washington Medical Center - Montlake	Seattle98195	NCT05642572	Map
WA	University of Washington Medical Center /ID# 275866	Seattle98195	NCT07005102	Map
WA	Virginia Mason Medical Center	Seattle98101	NCT05624996	Map
WA	Legacy Cancer Institute Medical Oncology and Day Treatment	Vancouver98684	NCT05624996	Map
WA	Legacy Salmon Creek Hospital	Vancouver98686	NCT05624996	Map
WV	West Virginia University Charleston Division	Charleston25304	NCT04181060	Map
WV	Edwards Comprehensive Cancer Center	Huntington25701	NCT05624996	Map
WV	Edwards Comprehensive Cancer Center	Huntington25701	NCT05642572	Map
WV	West Virginia University Healthcare	Morgantown26506	NCT05624996	Map
WI	Langlade Hospital and Cancer Center	Antigo54409	NCT05624996	Map
WI	Langlade Hospital and Cancer Center	Antigo54409	NCT05642572	Map
WI	ThedaCare Regional Cancer Center	Appleton54911	NCT04181060	Map
WI	ThedaCare Regional Cancer Center	Appleton54911	NCT06538038	Map
WI	ThedaCare Regional Medical Center - Appleton	Appleton54911	NCT06538038	Map
WI	Duluth Clinic Ashland	Ashland54806	NCT05624996	Map
WI	Duluth Clinic Ashland	Ashland54806	NCT05642572	Map
WI	Northwest Wisconsin Cancer Center	Ashland54806	NCT05624996	Map
WI	ThedaCare Cancer Care - Berlin	Berlin54923	NCT04181060	Map
WI	ThedaCare Cancer Care - Berlin	Berlin54923	NCT06538038	Map
WI	Aurora Cancer Care-Southern Lakes VLCC	Burlington53105	NCT03191149	Map
WI	Aurora Cancer Care-Southern Lakes VLCC	Burlington53105	NCT05624996	Map
WI	Aurora Cancer Care-Southern Lakes VLCC	Burlington53105	NCT05642572	Map
WI	Aurora Cancer Care-Southern Lakes VLCC	Burlington53105	NCT06538038	Map
WI	Marshfield Clinic-Chippewa Center	Chippewa Falls54729	NCT03191149	Map
WI	Aurora Saint Luke's South Shore	Cudahy53110	NCT03191149	Map
WI	Aurora Saint Luke's South Shore	Cudahy53110	NCT06538038	Map
WI	Marshfield Medical Center-EC Cancer Center	Eau Claire54701	NCT03191149	Map
WI	Marshfield Medical Center-EC Cancer Center	Eau Claire54701	NCT04181060	Map
WI	Marshfield Medical Center-EC Cancer Center	Eau Claire54701	NCT05624996	Map
WI	Marshfield Medical Center-EC Cancer Center	Eau Claire54701	NCT05642572	Map
WI	Aurora Health Center-Fond du Lac	Fond du Lac54937	NCT03191149	Map
WI	AHC Germantown Health Center	Germantown53022	NCT06538038	Map
WI	Aurora Health Care Germantown Health Center	Germantown53022	NCT03191149	Map
WI	Aurora Health Care Germantown Health Center	Germantown53022	NCT05624996	Map
WI	Aurora Health Care Germantown Health Center	Germantown53022	NCT05642572	Map
WI	Aurora Cancer Care-Grafton	Grafton53024	NCT03191149	Map
WI	Aurora Cancer Care-Grafton	Grafton53024	NCT05624996	Map
WI	Aurora Cancer Care-Grafton	Grafton53024	NCT05642572	Map
WI	Aurora Cancer Care-Grafton	Grafton53024	NCT06538038	Map
WI	Aurora BayCare Medical Center	Green Bay54311	NCT03191149	Map
WI	Aurora BayCare Medical Center	Green Bay54311	NCT05624996	Map
WI	Aurora BayCare Medical Center	Green Bay54311	NCT05642572	Map
WI	Aurora BayCare Medical Center	Green Bay54311	NCT06538038	Map
WI	Saint Vincent Hospital Cancer Center Green Bay	Green Bay54301	NCT05624996	Map
WI	Essentia Health-Hayward Clinic	Hayward54843	NCT05624996	Map
WI	Mercyhealth Hospital and Cancer Center - Janesville	Janesville53548	NCT04181060	Map
WI	Mercyhealth Hospital and Cancer Center - Janesville	Janesville53548	NCT06538038	Map
WI	University of Wisconsin Carbone Cancer Center - Johnson Creek	Johnson Creek53038	NCT05624996	Map
WI	Aurora Cancer Care-Kenosha South	Kenosha53142	NCT03191149	Map
WI	Aurora Cancer Care-Kenosha South	Kenosha53142	NCT05624996	Map
WI	Aurora Cancer Care-Kenosha South	Kenosha53142	NCT05642572	Map
WI	Aurora Cancer Care-Kenosha South	Kenosha53142	NCT06538038	Map
WI	Gundersen Lutheran Medical Center	La Crosse54601	NCT03191149	Map
WI	Gundersen Lutheran Medical Center	La Crosse54601	NCT04181060	Map
WI	Gundersen Lutheran Medical Center	La Crosse54601	NCT05642572	Map
WI	Gundersen Lutheran Medical Foundation	La Crosse54601	NCT06538038	Map
WI	Marshfield Medical Center - Ladysmith	Ladysmith54848	NCT03191149	Map
WI	University of Wisconsin Carbone Cancer Center	Madison53715	NCT06538038	Map
WI	University of Wisconsin Carbone Cancer Center - Eastpark Medical Center	Madison53718	NCT05624996	Map
WI	University of Wisconsin Carbone Cancer Center - University Hospital	Madison53792	NCT05624996	Map
WI	William S Middleton VA Medical Center	Madison53705	NCT05624996	Map
WI	Aurora Bay Area Medical Group-Marinette	Marinette54143	NCT03191149	Map
WI	Aurora Bay Area Medical Group-Marinette	Marinette54143	NCT05624996	Map
WI	Aurora Bay Area Medical Group-Marinette	Marinette54143	NCT05642572	Map
WI	Marshfield Medical Center	Marshfield54449	NCT06538038	Map
WI	Marshfield Medical Center-Marshfield	Marshfield54449	NCT03191149	Map
WI	Marshfield Medical Center-Marshfield	Marshfield54449	NCT04181060	Map
WI	Marshfield Medical Center-Marshfield	Marshfield54449	NCT05624996	Map
WI	Marshfield Medical Center-Marshfield	Marshfield54449	NCT05642572	Map
WI	Aspirus Medford Hospital	Medford54451	NCT05642572	Map
WI	Froedtert Menomonee Falls Hospital	Menomonee Falls53051	NCT05624996	Map
WI	Aurora Cancer Care-Milwaukee	Milwaukee53209	NCT03191149	Map
WI	Aurora Cancer Care-Milwaukee	Milwaukee53209	NCT05624996	Map
WI	Aurora Cancer Care-Milwaukee	Milwaukee53209	NCT05642572	Map
WI	Aurora Cancer Care-Milwaukee	Milwaukee53209	NCT06538038	Map
WI	Aurora NCORP	Milwaukee53215	NCT06538038	Map
WI	Aurora Saint Luke's Medical Center	Milwaukee53215	NCT03191149	Map
WI	Aurora Saint Luke's Medical Center	Milwaukee53215	NCT05624996	Map
WI	Aurora Saint Luke's Medical Center	Milwaukee53215	NCT05642572	Map
WI	Aurora Saint Luke's Medical Center	Milwaukee53215	NCT06538038	Map
WI	Aurora Sinai Medical Center	Milwaukee53233	NCT03191149	Map
WI	Aurora Sinai Medical Center	Milwaukee53233	NCT05624996	Map
WI	Aurora Sinai Medical Center	Milwaukee53233	NCT05642572	Map
WI	Aurora Sinai Medical Center	Milwaukee53233	NCT06538038	Map
WI	Aurora West Allis Medical Center	Milwaukee53227	NCT06538038	Map
WI	Medical College of Wisconsin	Milwaukee53226	NCT04181060	Map
WI	Medical College of Wisconsin	Milwaukee53226	NCT05624996	Map
WI	Research Site	Milwaukee53226	NCT06350097	Map
WI	Zablocki Veterans Administration Medical Center	Milwaukee53295	NCT05624996	Map
WI	Marshfield Medical Center - Minocqua	Minocqua54548	NCT03191149	Map
WI	Marshfield Medical Center - Minocqua	Minocqua54548	NCT04181060	Map
WI	Marshfield Medical Center - Minocqua	Minocqua54548	NCT05624996	Map
WI	Marshfield Medical Center - Minocqua	Minocqua54548	NCT05642572	Map
WI	ProHealth D N Greenwald Center	Mukwonago53149	NCT04181060	Map
WI	ProHealth D N Greenwald Center	Mukwonago53149	NCT05624996	Map
WI	ThedaCare Regional Medical Center - Neenah	Neenah54956	NCT04181060	Map
WI	ThedaCare Regional Medical Center - Neenah	Neenah54956	NCT06538038	Map
WI	ThedaCare Cancer Care - New London	New London54961	NCT04181060	Map
WI	ThedaCare Cancer Care - New London	New London54961	NCT06538038	Map
WI	Cancer Center of Western Wisconsin	New Richmond54017	NCT03191149	Map
WI	Drexel Town Square Health Center	Oak Creek53154	NCT05624996	Map
WI	ProHealth Oconomowoc Memorial Hospital	Oconomowoc53066	NCT04181060	Map
WI	ProHealth Oconomowoc Memorial Hospital	Oconomowoc53066	NCT05624996	Map
WI	ThedaCare Cancer Care - Oshkosh	Oshkosh54904	NCT04181060	Map
WI	ThedaCare Cancer Care - Oshkosh	Oshkosh54904	NCT06538038	Map
WI	Vince Lombardi Cancer Clinic - Oshkosh	Oshkosh54904	NCT03191149	Map
WI	Vince Lombardi Cancer Clinic - Oshkosh	Oshkosh54904	NCT05624996	Map
WI	Vince Lombardi Cancer Clinic - Oshkosh	Oshkosh54904	NCT05642572	Map
WI	Vince Lombardi Cancer Clinic-Oshkosh	Oshkosh54904	NCT06538038	Map
WI	Aurora Cancer Care-Racine	Racine53406	NCT03191149	Map
WI	Aurora Cancer Care-Racine	Racine53406	NCT05624996	Map
WI	Aurora Cancer Care-Racine	Racine53406	NCT05642572	Map
WI	Aurora Cancer Care-Racine	Racine53406	NCT06538038	Map
WI	Aspirus Cancer Care - James Beck Cancer Center	Rhinelander54501	NCT05624996	Map
WI	Aspirus Cancer Care - James Beck Cancer Center	Rhinelander54501	NCT05642572	Map
WI	Marshfield Medical Center-Rice Lake	Rice Lake54868	NCT03191149	Map
WI	Marshfield Medical Center-Rice Lake	Rice Lake54868	NCT05624996	Map
WI	Marshfield Medical Center-Rice Lake	Rice Lake54868	NCT05642572	Map
WI	ThedaCare Cancer Care - Shawano	Shawano54166	NCT04181060	Map
WI	ThedaCare Cancer Care - Shawano	Shawano54166	NCT06538038	Map
WI	Saint Vincent Hospital Cancer Center at Sheboygan	Sheboygan53081	NCT05624996	Map
WI	Vince Lombardi Cancer Clinic-Sheboygan	Sheboygan53081	NCT03191149	Map
WI	Vince Lombardi Cancer Clinic-Sheboygan	Sheboygan53081	NCT05624996	Map
WI	Vince Lombardi Cancer Clinic-Sheboygan	Sheboygan53081	NCT05642572	Map
WI	Vince Lombardi Cancer Clinic-Sheboygan	Sheboygan53081	NCT06538038	Map
WI	Essentia Health-Spooner Clinic	Spooner54801	NCT05624996	Map
WI	Aspirus Cancer Care - Stevens Point	Stevens Point54481	NCT05624996	Map
WI	Aspirus Cancer Care - Stevens Point	Stevens Point54481	NCT05642572	Map
WI	Marshfield Medical Center-River Region at Stevens Point	Stevens Point54482	NCT03191149	Map
WI	Marshfield Medical Center-River Region at Stevens Point	Stevens Point54482	NCT04181060	Map
WI	Marshfield Medical Center-River Region at Stevens Point	Stevens Point54482	NCT05624996	Map
WI	Marshfield Medical Center-River Region at Stevens Point	Stevens Point54482	NCT05642572	Map
WI	Saint Vincent Hospital Cancer Center at Sturgeon Bay	Sturgeon Bay54235-1495	NCT05624996	Map
WI	Aurora Medical Center in Summit	Summit53066	NCT03191149	—
WI	Aurora Medical Center in Summit	Summit53066	NCT05624996	—
WI	Aurora Medical Center in Summit	Summit53066	NCT05642572	—
WI	Aurora Medical Center in Summit	Summit53066	NCT06538038	—
WI	Essentia Health Saint Mary's Hospital - Superior	Superior54880	NCT05624996	Map
WI	Vince Lombardi Cancer Clinic-Two Rivers	Two Rivers54241	NCT03191149	Map
WI	Vince Lombardi Cancer Clinic-Two Rivers	Two Rivers54241	NCT05642572	Map
WI	Vince Lombardi Cancer Clinic-Two Rivers	Two Rivers54241	NCT06538038	Map
WI	ProHealth	Waukesha53022	NCT06538038	Map
WI	ProHealth Waukesha Memorial Hospital	Waukesha53188	NCT04181060	Map
WI	UW Cancer Center at ProHealth Care	Waukesha53188	NCT04181060	Map
WI	UW Cancer Center at ProHealth Care	Waukesha53188	NCT05624996	Map
WI	ThedaCare Cancer Care - Waupaca	Waupaca54981	NCT04181060	Map
WI	ThedaCare Cancer Care - Waupaca	Waupaca54981	NCT06538038	Map
WI	Aspirus Regional Cancer Center	Wausau54401	NCT05624996	Map
WI	Aspirus Regional Cancer Center	Wausau54401	NCT05642572	Map
WI	Marshfield Clinic-Wausau Center	Wausau54401	NCT03191149	Map
WI	Aurora Cancer Care-Milwaukee West	Wauwatosa53226	NCT03191149	Map
WI	Aurora Cancer Care-Milwaukee West	Wauwatosa53226	NCT05624996	Map
WI	Aurora Cancer Care-Milwaukee West	Wauwatosa53226	NCT05642572	Map
WI	Aurora Cancer Care-Milwaukee West	Wauwatosa53226	NCT06538038	Map
WI	Aurora West Allis Medical Center	West Allis53227	NCT03191149	Map
WI	Aurora West Allis Medical Center	West Allis53227	NCT05624996	Map
WI	Aurora West Allis Medical Center	West Allis53227	NCT05642572	Map
WI	Froedtert West Bend Hospital/Kraemer Cancer Center	West Bend53095	NCT05624996	Map
WI	Marshfield Medical Center - Weston	Weston54476	NCT03191149	Map
WI	Marshfield Medical Center - Weston	Weston54476	NCT04181060	Map
WI	Marshfield Medical Center - Weston	Weston54476	NCT05624996	Map
WI	Marshfield Medical Center - Weston	Weston54476	NCT05642572	Map
WI	Aspirus Cancer Care - Wisconsin Rapids	Wisconsin Rapids54494	NCT05624996	Map
WI	Aspirus Cancer Care - Wisconsin Rapids	Wisconsin Rapids54494	NCT05642572	Map
WI	Marshfield Clinic - Wisconsin Rapids Center	Wisconsin Rapids54494	NCT03191149	Map
WY	Memorial Hospital of Laramie County	Cheyenne82001	NCT03191149	Map
WY	Billings Clinic-Cody	Cody82414	NCT03191149	Map

Osimertinib clinical trials at a glance: phase × recruitment status

Phase	recruiting	active not recruiting	completed	terminated	withdrawn	suspended	not yet recruiting	unknown	Total
Early P1			1				1		2
P1	9	10	13	6	2		2	3	45
P1/P2	8	7	6	1			3	2	27
P2	29	28	18	5			13	14	107
P2/P3	1	1	1				1		4
P3	11	11	2	2	1		3	2	32
P4	1	1	1				1	1	5
N/A	5	2	9			1	1	6	24

Recruiting Osimertinib clinical trials (89)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT ID	Title	Phase	Indication	Enrollment	Started
NCT07005102	A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer	P2/P3	Non-Squamous Non-Small Cell Lung Cancer	854	Aug 2025
NCT07329322	EGFRPhase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib or Sacituzumab Tirumotecan for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer	P2	Non-Small Cell Lung Cancer	60	Mar 2026
NCT07256509	A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung Cancer	P2	Non-Small Cell Lung Cancer	120	Nov 2025
NCT06709274	MOTION-NSCLCMinimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC	N/A	Non-Small Cell Lung Cancer	342	Nov 2024
NCT05142189	LuCa-MERIT-1Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer	P1	Non-Small Cell Lung Cancer	320	Jun 2022
NCT05624996	Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer	P3	Locally Advanced Lung Non-Small Cell Carcinoma	474	Jul 2023
NCT06350097	TROPION-Lung14Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer	P3	Non-small Cell Lung Cancer	582	Apr 2024
NCT06618287	A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors	P1/P2	Lung Cancer	416	Feb 2025
NCT07177092	SURGAN-TKIPrimary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer	P2	Non-Small Cell Lung Cancer	118	Sep 2025
NCT07279935	REVIVEOsimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.	P4	Non-small Cell Lung Cancer	100	May 2026
NCT07379476	Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer	P2	Lung Cancer (NSCLC)	64	Feb 2026
NCT04665206	Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors	P1/P2	Solid Tumor, Adult	434	Mar 2021
NCT06824792	SINGULARITYOptimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System	P4	Advanced Solid Tumors	3,000	Mar 2025
NCT06908772	Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer Patients	P2/P3	Recurrent or Metastatic NSCLC Patients With Classical EGFR Mutations Accompanied by MET Amplification or Overexpression	390	Apr 2025
NCT06206850	Neo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib	P2	Non-squamous NSCLC	20	Feb 2024
NCT07285148	A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer	P1/P2	Non-Small Cell Lung Cancer	253	Jun 2026
NCT07038460	NEO-LISIA Multicenter Phase II Randomized Trial of Limertinib Followed by Sintilimab and Chemotherapy vs. Limertinib Followed by Limertinib and Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB EGFR-Mutant NSCLC	P2	Resectable Non-small Cell Lung Cancer	134	Jul 2025
NCT06692491	SPRINGStudy of Precision Treatment for Rare Tumours in China Guided by PDO and NGS	P2	Rare Tumour	200	Jan 2025
NCT06436144	Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC	P2	Non Small Cell Lung Cancer	93	Jun 2024
NCT07153055	LOTSLurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer	P1/P2	Small Cell Lung Cancer ( SCLC )	16	May 2026
NCT07229729	A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer	P2	Non-small Cell Lung Cancer	300	Nov 2025
NCT07206498	WAYWIN103A Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC	P1/P2	Non Small Cell Lung Cancer (NSCLC)	48	Oct 2025
NCT05686434	OSTAROsimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)	P2	NSCLC, Stage I	65	Oct 2022
NCT06970639	EGFRA Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases	P3	NSCLC Patients With Brain Metastasis	380	Sep 2024
NCT06538038	Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients	—	Non Small Cell Lung Cancer	538	Sep 2024
NCT04780568	Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer	P1	Metastatic Lung Non-Small Cell Carcinoma	24	Jan 2022
NCT07376382	SYNSTAR-02A Phase Ⅲ Clinical Study of SYS6010 in Combination With Osimertinib in Patients With Locally Advanced or Metastatic NSCLC	P3	NSCLC	680	Jun 2026
NCT07295821	NSCLCOsimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study	P2	Lung Cancer	60	Apr 2026
NCT06735391	NSCLCA Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive Mutations	P3	Locally Advanced or Metastatic Non-squamous NSCLC	516	Oct 2024
NCT06383728	GALAXY-02Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma	P2	Lung Cancer	51	Apr 2024
NCT06323148	ECTOP-1022Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)	P3	Lung Cancer	226	Apr 2024
NCT04486833	Acclaim-1Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib	P1/P2	Carcinoma, Non-Small Cell Lung	158	Sep 2021
NCT06829459	A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs	P3	Non-Small Cell Lung Cancer	350	Apr 2025
NCT05401110	Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer	P1	Non Small Cell Lung Cancer	60	Sep 2023
NCT07058519	A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC	P2	Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)	250	Sep 2025
NCT07505173	HOPE-WBRTHippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer	P2	Naive Advanced Non-small Cell Lung Cancer With EGFR-sensitive Mutations (EGFR Exon 19 Deletion and Exon 21 L858R Mutation) and Symptomatic Brain Metastases	74	Jan 2026
NCT07486648	PrecisionOsimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib	P1/P2	Lung Cancer (NSCLC)	53	May 2026
NCT07363252	REMAINInvestigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC Patients	—	EGFR-mutated NSCLC	100	Apr 2026
NCT07079475	TIAN-SHAN8Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)	P1/P2	Non-Small Cell Lung Cancer	160	Jul 2025
NCT06895928	A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors	P2	Advanced Solid Tumors	400	Mar 2025
NCT06838273	A Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment in Patients With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(PANKU-Lung04)	P3	Non-small Cell Lung Cancer	720	Feb 2025
NCT07375316	A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positive ctDNA After lead-in Osimertinib Monotherapy	P2	Non Small Cell Lung Cancer	120	Dec 2025
NCT06486142	ERISEGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study	P3	Non-Small Cell Lung Cancer	200	Sep 2022
NCT05011487	NOCE01Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC	P2	Non-Small Cell Lung Cancer	30	Aug 2021
NCT06417814	TROPION-Lung15A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer	P3	Metastatic Non-small Cell Lung Cancer	744	Oct 2024
NCT07361705	Zorifertinib With Osimertinib for NSCLC With Meningeal Progression	P1	Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment	42	Jan 2026
NCT06557096	CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC	Early P1	Non Small Cell Lung Cancer	100	Aug 2024
NCT07485452	OSIBBBOOSTBoosting Osimertinib Blood Brain Barrier Penetration	P2	Non-Small Cell Lung Cancer	7	Jun 2026
NCT06142617	A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.	P2	Non Small Cell Lung Cancer	37	Dec 2023
NCT05642572	Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)	P2	Recurrent Lung Non-Small Cell Carcinoma	66	May 2023
NCT06530719	A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical Surgery	P2	Lung Neoplasms	54	Jul 2024
NCT07535437	A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer	P1/P2	Non-Small Cell Lung Cancer	66	Apr 2026
NCT05785741	A Study of DB-1310 in Advanced/Metastatic Solid Tumors	P1/P2	Advanced Solid Tumor	1,000	Aug 2023
NCT06380348	NSCLCJMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations	P3	Local Advanced or Metastatic NSCLC	398	Apr 2024
NCT06452433	Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.	P2	Non-small Cell Lung Cancer	91	Jun 2024
NCT07323641	Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer	P2	Lung Non-Small Cell Carcinoma	60	Feb 2026
NCT06752408	ANOTHERAumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer	P2	Non Small Cell Lung Cancer	316	Dec 2024
NCT06918782	Real-world Experience With Combination Chemotherapy and Osimertinib in Poor Prognostic Group of Metastatic EGFR-mutated Lung Adenocarcinoma	P2	Lung Cancer (NSCLC)	47	May 2025
NCT06741085	SRSA Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain	P2	Non Small Cell Lung Cancer Metastatic	56	Dec 2024
NCT05382728	FLETEOPhase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)	P3	NSCLC	680	Jun 2022
NCT05948813	TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases	P2	NSCLC	420	Aug 2023
NCT04322890	PIKACHUTreatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation	P2	Non Small Cell Lung Cancer	6,000	Apr 2020
NCT05528458	Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma	P2	Lung Adenocarcinoma	59	Sep 2022
NCT04591002	Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)	P2	Lung Cancer	43	Sep 2022
NCT06670196	EGFRA Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer	P3	Non-Small Cell Lung Cancer	420	Nov 2024
NCT06574347	KYLIN-2Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.	P2	Non-Small-Cell Lung Cancer	120	Aug 2024
NCT07315113	Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer	P1	EGFR Mutation Positive Non-small Cell Lung Cancer	18	Dec 2025
NCT03191149	Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change	P2	Advanced Lung Non-Small Cell Carcinoma	46	Apr 2018
NCT04335292	OCELOTOsimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge	P2	Non-Small Cell Lung Cancer	200	Jan 2021
NCT04410796	Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers	P2	Metastatic Non-small Cell Lung Cancer	571	May 2020
NCT06507306	A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies	P1	Solid Tumor, Adult	100	Jun 2024
NCT07322783	Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification	P2	EGFR Positive Non-small Cell Lung Cancer	60	Jan 2025
NCT06363734	Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial	P2	Non-small Cell Lung Cancer	32	Apr 2024
NCT04181060	Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer	P3	Advanced Lung Non-Squamous Non-Small Cell Carcinoma	300	Dec 2020
NCT04085315	Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer	P1	Lung Cancer Metastatic	38	Nov 2019
NCT06319950	High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases	P2	Lung Cancer, Nonsmall Cell	255	Apr 2024
NCT04762199	MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer	P1	Advanced Lung Non-Small Cell Carcinoma	69	Feb 2021
NCT06185400	RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations	P2	Non Small Cell Lung Cancer	108	Feb 2024
NCT05281406	PACE-LUNGAdditional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)	P2	NSCLC Stage IIIB	50	Nov 2021
NCT06067776	Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer	P1	Metastatic Lung Non-Small Cell Carcinoma	36	Jan 2024
NCT06532149	EROSERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer	—	NSCLC Stage IV	80	Aug 2024
NCT06304441	Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer	N/A	Leptomeningeal Metastasis	100	Apr 2024
NCT06018688	Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.	P2	Non Small Cell Lung Cancer	44	Sep 2023
NCT06498986	A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer	P2	Non-small Cell Lung Cancer	40	Jul 2024
NCT06071013	Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients	P1/P2	Non-small Cell Lung Cancer	20	Feb 2024
NCT06014827	SBRTBiologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma	P2	Lung Non-Small Cell Carcinoma	32	Oct 2024
NCT04772235	TOTEMPhase I Study of Repotrectinib and Osimertinib in NSCLC Patients	P1	Nsclc	32	Feb 2022
NCT06362980	EGFRA Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations	P1	NSCLC	20	May 2024
NCT06604689	AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases	—	NSCLC (Advanced Non-small Cell Lung Cancer)	800	Sep 2024

Osimertinib clinical trials by indication

Non-Small Cell Lung Cancer (25)

NCT	Acronym	Phase	Status	Title
NCT05120349	ADAURA2	P3	active not recruiting	A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection
NCT07329322	EGFR	P2	recruiting	Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib or Sacituzumab Tirumotecan for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
NCT07256509	—	P2	not yet recruiting	A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung Cancer
NCT06709274	MOTION-NSCLC	N/A	not yet recruiting	Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC
NCT05142189	LuCa-MERIT-1	P1	recruiting	Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
NCT07177092	SURGAN-TKI	P2	not yet recruiting	Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer
NCT07285148	—	P1/P2	not yet recruiting	A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer
NCT04351555	NeoADAURA	P3	active not recruiting	A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
+ 17 more, see All trials below.

Non-small Cell Lung Cancer (23)

NCT	Acronym	Phase	Status	Title
NCT06350097	TROPION-Lung14	P3	recruiting	Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
NCT07279935	REVIVE	P4	recruiting	Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.
NCT07229729	—	P2	recruiting	A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
NCT05546866	—	P2	active not recruiting	Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRm
NCT06838273	—	P3	recruiting	A Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment in Patients With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(PANKU-Lung04)
NCT06452433	—	P2	not yet recruiting	Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.
NCT05880706	—	P2	active not recruiting	A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
NCT04765059	COMPEL	P3	active not recruiting	A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)
+ 15 more, see All trials below.

Non Small Cell Lung Cancer (23)

NCT	Acronym	Phase	Status	Title
NCT06436144	—	P2	not yet recruiting	Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC
NCT06538038	—	N/A	recruiting	Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
NCT05401110	—	P1	recruiting	Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
NCT07375316	—	P2	recruiting	A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positive ctDNA After lead-in Osimertinib Monotherapy
NCT06557096	—	Early P1	not yet recruiting	CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC
NCT06142617	—	P2	not yet recruiting	A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.
NCT06752408	ANOTHER	P2	not yet recruiting	Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer
NCT04322890	PIKACHU	P2	recruiting	Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation
+ 15 more, see All trials below.

NSCLC (16)

NCT	Acronym	Phase	Status	Title
NCT07376382	SYNSTAR-02	P3	not yet recruiting	A Phase Ⅲ Clinical Study of SYS6010 in Combination With Osimertinib in Patients With Locally Advanced or Metastatic NSCLC
NCT05773092	—	P2	active not recruiting	A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC
NCT05382728	FLETEO	P3	recruiting	Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)
NCT05948813	—	P2	recruiting	TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
NCT05693090	—	P1	withdrawn	Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer
NCT05089916	ROSE	P2	active not recruiting	Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study
NCT06362980	EGFR	P1	recruiting	A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations
NCT02856893	APPLE	P2	completed	Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)
+ 8 more, see All trials below.

Lung Cancer (13)

NCT	Acronym	Phase	Status	Title
NCT06618287	—	P1/P2	recruiting	A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT07295821	NSCLC	P2	recruiting	Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study
NCT06383728	GALAXY-02	P2	recruiting	Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma
NCT06323148	ECTOP-1022	P3	not yet recruiting	Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)
NCT04591002	—	P2	recruiting	Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)
NCT06194448	NEOLA	P2	active not recruiting	To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations
NCT04545710	—	P2	active not recruiting	Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
NCT03567642	—	P1	active not recruiting	A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
+ 5 more, see All trials below.

Carcinoma, Non-Small-Cell Lung (13)

NCT	Acronym	Phase	Status	Title
NCT03833154	PACIFIC-4	P3	active not recruiting	Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation
NCT03586453	—	P2	active not recruiting	Osimertinib In EGFR Mutant Lung Cancer
NCT04487080	MARIPOSA	P3	active not recruiting	A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT05163249	FLOWERS	P2	active not recruiting	Osimertinib With or Without Savolitinib as 1L in de Novo MET+, EGFR+ NSCLC
NCT03381274	MEDI9447	P1/P2	active not recruiting	Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study
NCT04974879	EGFR	P2	unknown	Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer
NCT05104281	EGFR	P3	unknown	Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer
NCT04391283	—	N/A	unknown	First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting
+ 5 more, see All trials below.

Metastatic Lung Non-Small Cell Carcinoma (7)

NCT	Acronym	Phase	Status	Title
NCT04780568	—	P1	recruiting	Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer
NCT04285671	EGFR	P1/P2	active not recruiting	Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer
NCT02496663	—	P1	active not recruiting	Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor
NCT02503722	TAK-228	P1	active not recruiting	Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer
NCT06067776	—	P1	not yet recruiting	Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer
NCT02971501	—	P2	active not recruiting	Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
NCT05498389	—	P1/P2	unknown	EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer

Advanced Lung Non-Small Cell Carcinoma (4)

NCT	Acronym	Phase	Status	Title
NCT05166616	—	P1	active not recruiting	Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer
NCT03191149	—	P2	recruiting	Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
NCT03831932	—	P1/P2	active not recruiting	Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer
NCT04762199	—	P1	recruiting	MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

Lung Cancer (NSCLC) (3)

NCT	Acronym	Phase	Status	Title
NCT07379476	—	P2	recruiting	Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer
NCT07486648	Precision	P1/P2	not yet recruiting	Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib
NCT06918782	—	P2	not yet recruiting	Real-world Experience With Combination Chemotherapy and Osimertinib in Poor Prognostic Group of Metastatic EGFR-mutated Lung Adenocarcinoma

Lung Non-Small Cell Carcinoma (3)

NCT	Acronym	Phase	Status	Title
NCT07323641	—	P2	recruiting	Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
NCT03410043	—	P2	active not recruiting	Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study
NCT06014827	SBRT	P2	recruiting	Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma

Non Small Cell Lung Cancer Metastatic (3)

NCT	Acronym	Phase	Status	Title
NCT06741085	SRS	P2	recruiting	A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
NCT04233021	ORBITAL	P2	completed	Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation
NCT03133546	BOOSTER	P2	completed	Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M

Metastatic Non-small Cell Lung Cancer (3)

NCT	Acronym	Phase	Status	Title
NCT06417814	TROPION-Lung15	P3	recruiting	A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT04410796	—	P2	recruiting	Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
NCT03810807	—	P1	completed	Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer

Lung Neoplasms (3)

NCT	Acronym	Phase	Status	Title
NCT06530719	—	P2	not yet recruiting	A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical Surgery
NCT04862780	SYMPHONY	P1	terminated	(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
NCT02769286	LiquidLung-O	P2	completed	Osimertinib in First and Second Line Treatment of NSCLC Harboring EGFR Mutations From Circulating Tumor DNA

Leptomeningeal Metastasis (3)

NCT	Acronym	Phase	Status	Title
NCT06304441	—	N/A	recruiting	Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer
NCT04148898	OWONBNSCLCLM	P2	unknown	Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
NCT04425681	OWBLM	P2	unknown	Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer

Advanced Lung Non-Squamous Non-Small Cell Carcinoma (3)

NCT	Acronym	Phase	Status	Title
NCT04181060	—	P3	recruiting	Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
NCT05017025	—	P1/P2	active not recruiting	Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer
NCT02520778	—	P1	completed	Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer (NSCLC) (3)

NCT	Acronym	Phase	Status	Title
NCT03667820	SABR	P2	active not recruiting	Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC
NCT04563871	BLOSSOM	P2	completed	Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC)
NCT03255083	EGFR	P1	terminated	DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer (NSCLC) (2)

NCT	Acronym	Phase	Status	Title
NCT07206498	WAYWIN103	P1/P2	recruiting	A Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC
NCT03853551	—	P4	completed	Osimertinib Study in Indian Patients

Advanced Solid Tumors (2)

NCT	Acronym	Phase	Status	Title
NCT06824792	SINGULARITY	P4	not yet recruiting	Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System
NCT06895928	—	P2	recruiting	A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors

EGFR Positive Non-small Cell Lung Cancer (2)

NCT	Acronym	Phase	Status	Title
NCT07322783	—	P2	recruiting	Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification
NCT04001777	AZD9291	P1	active not recruiting	A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC Patients

Non-Small-Cell Lung Cancer (2)

NCT	Acronym	Phase	Status	Title
NCT06827145	—	P2	active not recruiting	Combination of Vebreltinib and Osimertinib in Patients with EGFR 21 L858R Mutation Advanced NSCLC
NCT06574347	KYLIN-2	P2	recruiting	Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.

NSCLC (Advanced Non-small Cell Lung Cancer) (2)

NCT	Acronym	Phase	Status	Title
NCT07491211	—	N/A	active not recruiting	Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases
NCT06604689	—	N/A	recruiting	AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases

NSCLC Stage IV (2)

NCT	Acronym	Phase	Status	Title
NCT06532149	EROS	N/A	recruiting	ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
NCT04908956	STEREO	P2	terminated	Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO)

Solid Tumor, Adult (2)

NCT	Acronym	Phase	Status	Title
NCT04665206	—	P1/P2	recruiting	Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
NCT06507306	—	P1	recruiting	A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Local Advanced or Metastatic NSCLC (2)

NCT	Acronym	Phase	Status	Title
NCT06380348	NSCLC	P3	not yet recruiting	JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations
NCT06391944	NSCLC	P2	active not recruiting	JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations

Non-squamous NSCLC (2)

NCT	Acronym	Phase	Status	Title
NCT06206850	—	P2	recruiting	Neo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib
NCT04413201	AFAMOSI	P4	active not recruiting	AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients with EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC

Non-Small Cell Lung Cancer (NSCLC) (2)

NCT	Acronym	Phase	Status	Title
NCT05801029	OSTARA	P2	active not recruiting	A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations
NCT04676477	—	P1	active not recruiting	HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer

Recurrent Lung Non-Small Cell Carcinoma (2)

NCT	Acronym	Phase	Status	Title
NCT05642572	—	P2	recruiting	Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
NCT04479306	—	P1	completed	Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer

Locally Advanced or Metastatic Non-Small Cell Lung Cancer (2)

NCT	Acronym	Phase	Status	Title
NCT05132777	—	P2	unknown	Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer
NCT05513664	—	N/A	unknown	Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer

Lung Adenocarcinoma (2)

NCT	Acronym	Phase	Status	Title
NCT05528458	—	P2	recruiting	Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma
NCT02759835	—	P2	completed	Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib

Carcinoma (2)

NCT	Acronym	Phase	Status	Title
NCT03778229	SAVANNAH	P2	active not recruiting	Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib
NCT05261399	SAFFRON	P3	active not recruiting	Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment

Metastatic Non Small Cell Lung Cancer (2)

NCT	Acronym	Phase	Status	Title
NCT04743505	NSCLC	P1/P2	active not recruiting	Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
NCT03497767	OUTRUN	P2	completed	A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases

Solid Tumor (2)

NCT	Acronym	Phase	Status	Title
NCT04720976	—	P1/P2	completed	JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors
NCT03989115	—	P1/P2	completed	Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC

Advanced Solid Tumors Cancer (2)

NCT	Acronym	Phase	Status	Title
NCT02099058	PK	P1	active not recruiting	A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors
NCT04721015	IV	P1	active not recruiting	Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors

Non-Small Cell Lung Cancer Stage IIIB (2)

NCT	Acronym	Phase	Status	Title
NCT03543683	—	P2	completed	Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC
NCT03532698	—	N/A	unknown	Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)

Lung Cancer Non-small Cell Stage IV (2)

NCT	Acronym	Phase	Status	Title
NCT03769103	—	P2	active not recruiting	Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC
NCT04184921	—	P2	completed	Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients

EGFR Gene Mutation (2)

NCT	Acronym	Phase	Status	Title
NCT03755102	—	Early P1	completed	A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.
NCT02954523	AZD9291	P1/P2	terminated	Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Advanced Lymphoma (2)

NCT	Acronym	Phase	Status	Title
NCT06303167	—	P2	active not recruiting	Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)
NCT02465060	—	P2	active not recruiting	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Small Cell Lung Cancer ( SCLC ) (1)

NCT	Acronym	Phase	Status	Title
NCT07153055	LOTS	P1/P2	not yet recruiting	Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer

EGFR-mutated NSCLC (1)

NCT	Acronym	Phase	Status	Title
NCT07363252	REMAIN	N/A	recruiting	Investigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC Patients

Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment (1)

NCT	Acronym	Phase	Status	Title
NCT07361705	—	P1	not yet recruiting	Zorifertinib With Osimertinib for NSCLC With Meningeal Progression

Naive Advanced Non-small Cell Lung Cancer With EGFR-sensitive Mutations (EGFR Exon 19 Deletion and Exon 21 L858R Mutation) and Symptomatic Brain Metastases (1)

NCT	Acronym	Phase	Status	Title
NCT07505173	HOPE-WBRT	P2	recruiting	Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer

EGFR Mutation Positive Non-small Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT07315113	—	P1	recruiting	Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC) (1)

NCT	Acronym	Phase	Status	Title
NCT07058519	—	P2	recruiting	A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC

Non-Squamous Non-Small Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT07005102	—	P2/P3	recruiting	A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Resectable Non-small Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT07038460	NEO-LISI	P2	not yet recruiting	A Multicenter Phase II Randomized Trial of Limertinib Followed by Sintilimab and Chemotherapy vs. Limertinib Followed by Limertinib and Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB EGFR-Mutant NSCLC

Advanced Breast Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT06630325	SMMART-ACT	P2	terminated	A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Recurrent or Metastatic NSCLC Patients With Classical EGFR Mutations Accompanied by MET Amplification or Overexpression (1)

NCT	Acronym	Phase	Status	Title
NCT06908772	—	P2/P3	not yet recruiting	Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer Patients

Rare Tumour (1)

NCT	Acronym	Phase	Status	Title
NCT06692491	SPRING	P2	not yet recruiting	Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS

Locally Advanced or Metastatic Non-squamous NSCLC (1)

NCT	Acronym	Phase	Status	Title
NCT06735391	NSCLC	P3	recruiting	A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive Mutations

NSCLC Patients With Brain Metastasis (1)

NCT	Acronym	Phase	Status	Title
NCT06970639	EGFR	P3	recruiting	A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases

Lung Cancer, Nonsmall Cell (1)

NCT	Acronym	Phase	Status	Title
NCT06319950	—	P2	not yet recruiting	High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases

Colorectal Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT05954871	—	P1	completed	Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer

Advanced Solid Tumor (1)

NCT	Acronym	Phase	Status	Title
NCT05785741	—	P1/P2	recruiting	A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Locally Advanced Lung Non-Small Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT05624996	—	P3	recruiting	Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT05629234	ROSY-T	P3	active not recruiting	Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Osimertinib (TAGRISSO) (ROSY-T)

Stage II-IIIB Non-small Cell Lung Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT05526755	TARGET	P2	active not recruiting	A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)

Brain Tumor (1)

NCT	Acronym	Phase	Status	Title
NCT05120960	—	P1	withdrawn	A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors

Stage IV Non-small Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT05583409	—	N/A	unknown	SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC

Advanced Solid Tumours (1)

NCT	Acronym	Phase	Status	Title
NCT05647122	EGRET	P1	active not recruiting	First in Human Study of AZD9592 in Solid Tumors

NSCLC, Stage I (1)

NCT	Acronym	Phase	Status	Title
NCT05686434	OSTAR	P2	recruiting	Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)

Advanced Non-small Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT05489731	VIC-1911	P1	unknown	VIC-1911 Combined With Osimertinib for EGFR -Mutant Non-small Cell Lung Cancer

Nonsmall-cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT05284994	—	P1/P2	unknown	TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer

Nsclc (1)

NCT	Acronym	Phase	Status	Title
NCT04772235	TOTEM	P1	recruiting	Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients

Lung Neoplasm (1)

NCT	Acronym	Phase	Status	Title
NCT05153408	HARMONY	P1	terminated	(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC

Solid Tumors, Adult (1)

NCT	Acronym	Phase	Status	Title
NCT05228015	—	P1	terminated	Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

NSCLC Stage IIIB (1)

NCT	Acronym	Phase	Status	Title
NCT05281406	PACE-LUNG	P2	recruiting	Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)

Carcinoma, Non-Small Cell Lung (1)

NCT	Acronym	Phase	Status	Title
NCT04486833	Acclaim-1	P1/P2	recruiting	Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

Advanced Non-squamous Non-small-cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT04959981	HERKULES-2	P1	completed	A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC

Stage IIIB Non-small Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT06525246	—	P1	completed	Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer

Healthy Volunteers (1)

NCT	Acronym	Phase	Status	Title
NCT04798638	—	P1	completed	A Study to Assess the Effect of Food on the Pharmacokinetics of TY-9591 in Healthy Volunteers

Non-Small Cell Lung Cancer Metastatic (1)

NCT	Acronym	Phase	Status	Title
NCT04868877	—	P1/P2	active not recruiting	Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

Neurocognitive (1)

NCT	Acronym	Phase	Status	Title
NCT04829019	—	P2	unknown	Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI

Non-small Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT04695925	TOP	P3	active not recruiting	Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations

Non-Small Cell Lung Cancer With EGFR Mutation (1)

NCT	Acronym	Phase	Status	Title
NCT04770688	AUTOMAN	P1/P2	completed	Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib

EGFR T790M (1)

NCT	Acronym	Phase	Status	Title
NCT05458726	—	P2	unknown	Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC

Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder) (1)

NCT	Acronym	Phase	Status	Title
NCT04141644	Osi+Ipi	P1	active not recruiting	Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC

Non-squamous, Non-Small Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT04179890	UpSwinG	N/A	completed	The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib

Lung Cancer Metastatic (1)

NCT	Acronym	Phase	Status	Title
NCT04085315	—	P1	recruiting	Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

EGFR Gene Amplification (1)

NCT	Acronym	Phase	Status	Title
NCT03732352	—	P2	completed	18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma

Third-generation TKI (1)

NCT	Acronym	Phase	Status	Title
NCT06613633	—	N/A	completed	Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC

Stage I Non-Small Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT03433469	—	P2	active not recruiting	Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery

Non Small Cell Lung Cancer (Stage III) (1)

NCT	Acronym	Phase	Status	Title
NCT03521154	LAURA	P3	active not recruiting	A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)

EGF-R Positive Non-Small Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT04965701	FLOWER	N/A	completed	First Line Osimertinib in the Real World: an Inter-regional Prospective Study

EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT03239340	ELIOS	P2	completed	A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib

EGFR-mutated NSCLC (Disorder) (1)

NCT	Acronym	Phase	Status	Title
NCT03418532	—	P1	terminated	MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC

Locally Advanced or Metastatic NSCLC (1)

NCT	Acronym	Phase	Status	Title
NCT03414814	—	P2	completed	Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation

Advanced Solid Tumors Which Are cMET-dependent (1)

NCT	Acronym	Phase	Status	Title
NCT03040973	—	P2	active not recruiting	Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

T790M Positive NSCLC Patients (1)

NCT	Acronym	Phase	Status	Title
NCT03133234	—	N/A	completed	Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLC

Solid Tumours (1)

NCT	Acronym	Phase	Status	Title
NCT02923947	—	P1	completed	Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney Impairment

Nonsmall Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT03050411	—	P1	unknown	Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

Progression Free Survival (1)

NCT	Acronym	Phase	Status	Title
NCT02959749	—	P2/P3	completed	Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer

Metastatic Non-Small Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT02411448	RELAY	P3	active not recruiting	A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)

Anticancer Treatment (1)

NCT	Acronym	Phase	Status	Title
NCT02151981	AURA3	P3	completed	AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Osimertinib pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Acronym	NCT	Phase	Status	Indication	Enrollment	PubMed
REVIVE	NCT07279935	P4	recruiting	Non-small Cell Lung Cancer	100	—
SINGULARITY	NCT06824792	P4	not yet recruiting	Advanced Solid Tumors	3,000	—
AFAMOSI	NCT04413201	P4	active not recruiting	Non-squamous NSCLC	34	—
TEMPLE-2	NCT05785208	P4	unknown	Non Small Cell Lung Cancer	122	—
ADAURA2	NCT05120349	P3	active not recruiting	Non-Small Cell Lung Cancer	390	—
TROPION-Lung14	NCT06350097	P3	recruiting	Non-small Cell Lung Cancer	582	—
EGFR	NCT06970639	P3	recruiting	NSCLC Patients With Brain Metastasis	380	—
NeoADAURA	NCT04351555	P3	active not recruiting	Non-Small Cell Lung Cancer	358	PMID 34278827
SYNSTAR-02	NCT07376382	P3	not yet recruiting	NSCLC	680	—
NSCLC	NCT06735391	P3	recruiting	Locally Advanced or Metastatic Non-squamous NSCLC	516	—
ECTOP-1022	NCT06323148	P3	not yet recruiting	Lung Cancer	226	—
PACIFIC-4	NCT03833154	P3	active not recruiting	Carcinoma, Non-Small-Cell Lung	724	—
ERIS	NCT06486142	P3	recruiting	Non-Small Cell Lung Cancer	200	—
TROPION-Lung15	NCT06417814	P3	recruiting	Metastatic Non-small Cell Lung Cancer	744	PMID 41466843
NSCLC	NCT06380348	P3	not yet recruiting	Local Advanced or Metastatic NSCLC	398	—
FLETEO	NCT05382728	P3	recruiting	NSCLC	680	—
TOP	NCT04695925	P3	active not recruiting	Non-small Cell Carcinoma	294	—
MARIPOSA	NCT04487080	P3	active not recruiting	Carcinoma, Non-Small-Cell Lung	1,074	PMID 40923797
LAURA	NCT03521154	P3	active not recruiting	Non Small Cell Lung Cancer (Stage III)	216	PMID 38476120
EGFR	NCT06670196	P3	recruiting	Non-Small Cell Lung Cancer	420	—
COMPEL	NCT04765059	P3	active not recruiting	Non-small Cell Lung Cancer	98	—
ROSY-T	NCT05629234	P3	active not recruiting	Cancer	37	—
RELAY	NCT02411448	P3	active not recruiting	Metastatic Non-Small Cell Lung Cancer	545	PMID 29317191
FLAURA2	NCT04035486	P3	active not recruiting	Non-Small Cell Lung Cancer	587	PMID 33610453
SAFFRON	NCT05261399	P3	active not recruiting	Carcinoma	345	—
SACHI	NCT05015608	P3	completed	Non-small Cell Lung Cancer	216	PMID 41544643
EGFR	NCT05104281	P3	unknown	Carcinoma, Non-Small-Cell Lung	60	PMID 37016906
ATTACK	NCT04870190	P3	unknown	NSCLC	232	—
AURA3	NCT02151981	P3	completed	Anticancer Treatment	421	PMID 26159065
GEOMETRY-E	NCT04816214	P3	terminated	Carcinoma, Non-Small-Cell Lung	6	—
EGFR	NCT07329322	P2	recruiting	Non-Small Cell Lung Cancer	60	—
SURGAN-TKI	NCT07177092	P2	not yet recruiting	Non-Small Cell Lung Cancer	118	—
NEO-LISI	NCT07038460	P2	not yet recruiting	Resectable Non-small Cell Lung Cancer	134	—
SPRING	NCT06692491	P2	not yet recruiting	Rare Tumour	200	—
TARGET	NCT05526755	P2	active not recruiting	Stage II-IIIB Non-small Cell Lung Carcinoma	188	PMID 37914594
OSTAR	NCT05686434	P2	recruiting	NSCLC, Stage I	65	—
NSCLC	NCT07295821	P2	recruiting	Lung Cancer	60	—
GALAXY-02	NCT06383728	P2	recruiting	Lung Cancer	51	—
HOPE-WBRT	NCT07505173	P2	recruiting	Naive Advanced Non-small Cell Lung Cancer With EGFR-sensitive Mutations (EGFR Exon 19 Deletion and Exon 21 L858R Mutation) and Symptomatic Brain Metastases	74	—
NOCE01	NCT05011487	P2	recruiting	Non-Small Cell Lung Cancer	30	—
OSIBBBOOST	NCT07485452	P2	recruiting	Non-Small Cell Lung Cancer	7	PMID 37125403
ANOTHER	NCT06752408	P2	not yet recruiting	Non Small Cell Lung Cancer	316	—
SRS	NCT06741085	P2	recruiting	Non Small Cell Lung Cancer Metastatic	56	—
PIKACHU	NCT04322890	P2	recruiting	Non Small Cell Lung Cancer	6,000	—
OSTARA	NCT05801029	P2	active not recruiting	Non-Small Cell Lung Cancer (NSCLC)	60	—
SABR	NCT03667820	P2	active not recruiting	Non-small Cell Lung Cancer (NSCLC)	41	PMID 41054436
KYLIN-2	NCT06574347	P2	recruiting	Non-Small-Cell Lung Cancer	120	—
NEOLA	NCT06194448	P2	active not recruiting	Lung Cancer	76	PMID 41236484
OCELOT	NCT04335292	P2	recruiting	Non-Small Cell Lung Cancer	200	—
ROSE	NCT05089916	P2	active not recruiting	NSCLC	42	—
NSCLC	NCT03909334	P2	active not recruiting	Non Small Cell Lung Cancer	160	PMID 39378386
FLAME	NCT04769388	P2	active not recruiting	Non Small Cell Lung Cancer	80	—
SAVANNAH	NCT03778229	P2	active not recruiting	Carcinoma	367	PMID 41308232
SKB264-II-04	NCT05816252	P2	active not recruiting	Non-small Cell Lung Cancer	356	—
PACE-LUNG	NCT05281406	P2	recruiting	NSCLC Stage IIIB	50	—
NSCLC	NCT06391944	P2	active not recruiting	Local Advanced or Metastatic NSCLC	161	—
FLOWERS	NCT05163249	P2	active not recruiting	Carcinoma, Non-Small-Cell Lung	44	PMID 41530133
SBRT	NCT06014827	P2	recruiting	Lung Non-Small Cell Carcinoma	32	—
INSIGHT 2	NCT03940703	P2	active not recruiting	Non-small Cell Lung Cancer	140	PMID 39089305
CoC	NCT04606771	P2	active not recruiting	Non-Small Cell Lung Cancer	30	—
SMMART-ACT	NCT06630325	P2	terminated	Advanced Breast Carcinoma	6	—
FIOL	NCT03804580	P2	unknown	Lung Cancer	100	—
APPLE	NCT02856893	P2	completed	NSCLC	156	PMID 38324744
ORCHARD	NCT03944772	P2	active not recruiting	Non-Small Cell Lung Cancer	247	PMID 34389237
MELROSE	NCT03865511	P2	unknown	Non-small Cell Lung Cancer	150	PMID 31648999
EGFR	NCT04974879	P2	unknown	Carcinoma, Non-Small-Cell Lung	20	—
ORBITAL	NCT04233021	P2	completed	Non Small Cell Lung Cancer Metastatic	57	—
SDANT	NCT05085054	P2	unknown	Non Small Cell Lung Cancer	30	—
OUTRUN	NCT03497767	P2	completed	Metastatic Non Small Cell Lung Cancer	40	—
COMBINATION	NCT05298176	P2	completed	Non-Small Cell Lung Cancer	5	—
STEREO	NCT04908956	P2	terminated	NSCLC Stage IV	6	PMID 23154552
BOOSTER	NCT03133546	P2	completed	Non Small Cell Lung Cancer Metastatic	155	PMID 22285168
CAPLAND	NCT04811001	P2	unknown	NSCLC	170	—
BLOSSOM	NCT04563871	P2	completed	Non-small Cell Lung Cancer (NSCLC)	73	PMID 38828959
ELIOS	NCT03239340	P2	completed	EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer	154	—
MINOVA	NCT05215951	P2	terminated	Lung Cancer	4	—
THEROS	NCT03810066	P2	completed	NSCLC	16	PMID 38575188
ALTN-03	NCT04029350	P2	unknown	Non Small Cell Lung Cancer	53	PMID 30975627
OWONBNSCLCLM	NCT04148898	P2	unknown	Leptomeningeal Metastasis	80	PMID 30642536
OWBLM	NCT04425681	P2	unknown	Leptomeningeal Metastasis	20	PMID 30059262
TRAEMOS	NCT03784599	P2	terminated	Carcinoma, Non-Small-Cell Lung	28	—
LiquidLung-O	NCT02769286	P2	completed	Lung Neoplasms	38	PMID 23816960
AZENT	NCT02841579	P2	completed	Non-Small Cell Lung Cancer	22	PMID 34763195

Terminated and withdrawn Osimertinib trials (18)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

NCT06093503withdrawnStudy of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met Protein
NCT05693090withdrawnTipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer
NCT06630325terminatedA Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer
NCT04862780terminated(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
NCT05421936suspendedOsimertinib for NSCLC With Uncommon EGFR Mutations
NCT05228015terminatedOral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors
NCT05120960withdrawnA Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors
NCT06032936terminatedBBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations
NCT04908956terminatedOsimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO)
NCT05493501terminatedAumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer
NCT05215951terminatedOsimertinib Plus Chemotherapy in Uncommon EGFRm NSCLC
NCT02954523terminatedDasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
NCT04438902terminatedOsimertinib Combined With Anlotinib in EGFR T790M Mutated NSCLC Patients With Progression on Osimertinib Treatment
NCT04816214terminatedStudy Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy
NCT05153408terminated(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
NCT03784599terminatedT-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC
NCT03255083terminatedDS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
NCT03418532terminatedMP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC

All Osimertinib trials (246)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT ID	Acronym	Title	Phase	Status	Enrollment	Sponsor	Started
NCT07005102		A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer	P2/P3	recruiting	854	AbbVie	Aug 2025
NCT05120349	ADAURA2	A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection	P3	active not recruiting	390	AstraZeneca	Feb 2022
NCT07329322	EGFR	Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib or Sacituzumab Tirumotecan for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer	P2	recruiting	60	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	Mar 2026
NCT07256509		A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung Cancer	P2	not yet recruiting	120	CSPC Megalith Biopharmaceutical Co.,Ltd.	Nov 2025
NCT06709274	MOTION-NSCLC	Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC	N/A	not yet recruiting	342	Guangdong Association of Clinical Trials	Nov 2024
NCT05142189	LuCa-MERIT-1	Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer	P1	recruiting	320	BioNTech SE	Jun 2022
NCT05624996		Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer	P3	recruiting	474	NRG Oncology	Jul 2023
NCT06350097	TROPION-Lung14	Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer	P3	recruiting	582	AstraZeneca	Apr 2024
NCT06618287		A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors	P1/P2	recruiting	416	Bristol-Myers Squibb	Feb 2025
NCT07177092	SURGAN-TKI	Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer	P2	not yet recruiting	118	Jianxing He	Sep 2025
NCT07279935	REVIVE	Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.	P4	recruiting	100	AstraZeneca	May 2026
NCT07379476		Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer	P2	recruiting	64	Chinese University of Hong Kong	Feb 2026
NCT04665206		Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors	P1/P2	recruiting	434	Vivace Therapeutics, Inc	Mar 2021
NCT06824792	SINGULARITY	Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System	P4	not yet recruiting	3,000	NING LI	Mar 2025
NCT06908772		Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer Patients	P2/P3	not yet recruiting	390	Shanghai JMT-Bio Inc.	Apr 2025
NCT06206850		Neo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib	P2	recruiting	20	Jair Bar, M.D., Ph.D.	Feb 2024
NCT07285148		A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer	P1/P2	not yet recruiting	253	Beijing Pearl Biotechnology Limited Liability Company	Jun 2026
NCT07038460	NEO-LISI	A Multicenter Phase II Randomized Trial of Limertinib Followed by Sintilimab and Chemotherapy vs. Limertinib Followed by Limertinib and Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB EGFR-Mutant NSCLC	P2	not yet recruiting	134	Wen-zhao ZHONG	Jul 2025
NCT06692491	SPRING	Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS	P2	not yet recruiting	200	Peking University Shenzhen Hospital	Jan 2025
NCT06436144		Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC	P2	not yet recruiting	93	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	Jun 2024
NCT04743505	NSCLC	Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)	P1/P2	active not recruiting	27	Washington University School of Medicine	Jan 2022
NCT05526755	TARGET	A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)	P2	active not recruiting	188	AstraZeneca	Mar 2023
NCT07153055	LOTS	Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer	P1/P2	not yet recruiting	16	Misty Shields	May 2026
NCT07229729		A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer	P2	recruiting	300	Shanghai Hengrui Pharmaceutical Co., Ltd.	Nov 2025
NCT07206498	WAYWIN103	A Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC	P1/P2	recruiting	48	Wayshine Biopharm, Inc.	Oct 2025
NCT05686434	OSTAR	Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)	P2	recruiting	65	Tianjin Medical University Cancer Institute and Hospital	Oct 2022
NCT06970639	EGFR	A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases	P3	recruiting	380	Allist Pharmaceuticals, Inc.	Sep 2024
NCT06538038		Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients	—	recruiting	538	PrECOG, LLC.	Sep 2024
NCT04780568		Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer	P1	recruiting	24	Ohio State University Comprehensive Cancer Center	Jan 2022
NCT05546866		Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRm	P2	active not recruiting	51	AstraZeneca	Feb 2023
NCT04351555	NeoADAURA	A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer	P3	active not recruiting	358	AstraZeneca	Dec 2020
NCT07376382	SYNSTAR-02	A Phase Ⅲ Clinical Study of SYS6010 in Combination With Osimertinib in Patients With Locally Advanced or Metastatic NSCLC	P3	not yet recruiting	680	CSPC Megalith Biopharmaceutical Co.,Ltd.	Jun 2026
NCT07295821	NSCLC	Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study	P2	recruiting	60	AstraZeneca	Apr 2026
NCT06735391	NSCLC	A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive Mutations	P3	recruiting	516	Shanghai JMT-Bio Inc.	Oct 2024
NCT06383728	GALAXY-02	Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma	P2	recruiting	51	The First Affiliated Hospital of Guangzhou Medical University	Apr 2024
NCT06323148	ECTOP-1022	Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)	P3	not yet recruiting	226	Fudan University	Apr 2024
NCT04486833	Acclaim-1	Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib	P1/P2	recruiting	158	Genprex, Inc.	Sep 2021
NCT06829459		A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs	P3	recruiting	350	Shanghai JMT-Bio Inc.	Apr 2025
NCT05401110		Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer	P1	recruiting	60	Karen Reckamp, MD, MS	Sep 2023
NCT07058519		A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC	P2	recruiting	250	Shanghai Chest Hospital	Sep 2025
NCT07505173	HOPE-WBRT	Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer	P2	recruiting	74	Tianjin Medical University Cancer Institute and Hospital	Jan 2026
NCT07486648	Precision	Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib	P1/P2	not yet recruiting	53	Shanxi Province Cancer Hospital	May 2026
NCT07363252	REMAIN	Investigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC Patients	—	recruiting	100	Gruppo Oncologico Italiano di Ricerca Clinica	Apr 2026
NCT07079475	TIAN-SHAN8	Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)	P1/P2	recruiting	160	Dizal (Jiangsu) Pharmaceutical Co., Ltd.	Jul 2025
NCT06895928		A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors	P2	recruiting	400	Shanghai Hengrui Pharmaceutical Co., Ltd.	Mar 2025
NCT06838273		A Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment in Patients With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(PANKU-Lung04)	P3	recruiting	720	Sichuan Baili Pharmaceutical Co., Ltd.	Feb 2025
NCT07375316		A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positive ctDNA After lead-in Osimertinib Monotherapy	P2	recruiting	120	Guangdong Association of Clinical Trials	Dec 2025
NCT03833154	PACIFIC-4	Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation	P3	active not recruiting	724	AstraZeneca	Mar 2019
NCT06827145		Combination of Vebreltinib and Osimertinib in Patients with EGFR 21 L858R Mutation Advanced NSCLC	P2	active not recruiting	30	National Cancer Center, China	Oct 2024
NCT06486142	ERIS	EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study	P3	recruiting	200	Region Skane	Sep 2022
NCT05011487	NOCE01	Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC	P2	recruiting	30	Sun Yat-sen University	Aug 2021
NCT06417814	TROPION-Lung15	A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer	P3	recruiting	744	AstraZeneca	Oct 2024
NCT07361705		Zorifertinib With Osimertinib for NSCLC With Meningeal Progression	P1	not yet recruiting	42	Alpha Biopharma (Jiangsu) Co., Ltd.	Jan 2026
NCT03586453		Osimertinib In EGFR Mutant Lung Cancer	P2	active not recruiting	30	Dana-Farber Cancer Institute	Aug 2018
NCT05647122	EGRET	First in Human Study of AZD9592 in Solid Tumors	P1	active not recruiting	167	AstraZeneca	Dec 2022
NCT06557096		CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC	Early P1	not yet recruiting	100	Second Affiliated Hospital of Nanchang University	Aug 2024
NCT07485452	OSIBBBOOST	Boosting Osimertinib Blood Brain Barrier Penetration	P2	recruiting	7	Maastricht University Medical Center	Jun 2026
NCT06142617		A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.	P2	not yet recruiting	37	Peking Union Medical College Hospital	Dec 2023
NCT05642572		Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)	P2	recruiting	66	SWOG Cancer Research Network	May 2023
NCT06530719		A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical Surgery	P2	not yet recruiting	54	Jin Ying	Jul 2024
NCT07535437		A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer	P1/P2	recruiting	66	Memorial Sloan Kettering Cancer Center	Apr 2026
NCT05785741		A Study of DB-1310 in Advanced/Metastatic Solid Tumors	P1/P2	recruiting	1,000	DualityBio Inc.	Aug 2023
NCT04141644	Osi+Ipi	Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC	P1	active not recruiting	24	University of Utah	Aug 2020
NCT06093503		Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met Protein	P3	withdrawn	0	AbbVie	May 2024
NCT05773092		A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC	P2	active not recruiting	30	National Cancer Centre, Singapore	Aug 2023
NCT06380348	NSCLC	JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations	P3	not yet recruiting	398	Shanghai JMT-Bio Inc.	Apr 2024
NCT06452433		Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.	P2	not yet recruiting	91	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Jun 2024
NCT07323641		Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer	P2	recruiting	60	Jonsson Comprehensive Cancer Center	Feb 2026
NCT06752408	ANOTHER	Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer	P2	not yet recruiting	316	Peking Union Medical College Hospital	Dec 2024
NCT06918782		Real-world Experience With Combination Chemotherapy and Osimertinib in Poor Prognostic Group of Metastatic EGFR-mutated Lung Adenocarcinoma	P2	not yet recruiting	47	The University of Hong Kong	May 2025
NCT06741085	SRS	A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain	P2	recruiting	56	Memorial Sloan Kettering Cancer Center	Dec 2024
NCT05382728	FLETEO	Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)	P3	recruiting	680	TYK Medicines, Inc	Jun 2022
NCT05948813		TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases	P2	recruiting	420	TYK Medicines, Inc	Aug 2023
NCT04695925	TOP	Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations	P3	active not recruiting	294	Li Zhang, MD	Mar 2021
NCT04322890	PIKACHU	Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation	P2	recruiting	6,000	Hunan Province Tumor Hospital	Apr 2020
NCT04285671	EGFR	Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer	P1/P2	active not recruiting	30	Jonsson Comprehensive Cancer Center	Jan 2021
NCT05528458		Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma	P2	recruiting	59	Samsung Medical Center	Sep 2022
NCT04591002		Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)	P2	recruiting	43	Samsung Medical Center	Sep 2022
NCT04487080	MARIPOSA	A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer	P3	active not recruiting	1,074	Janssen Research & Development, LLC	Sep 2020
NCT03122717		Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer	P1/P2	active not recruiting	48	Dana-Farber Cancer Institute	May 2017
NCT03521154	LAURA	A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)	P3	active not recruiting	216	AstraZeneca	Jul 2018
NCT05166616		Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer	P1	active not recruiting	8	City of Hope Medical Center	Mar 2022
NCT05801029	OSTARA	A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations	P2	active not recruiting	60	AstraZeneca	Jul 2023
NCT03667820	SABR	Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC	P2	active not recruiting	41	University of Texas Southwestern Medical Center	Sep 2018
NCT03433469		Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery	P2	active not recruiting	27	University of California, San Francisco	Jul 2018
NCT06670196	EGFR	A Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer	P3	recruiting	420	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	Nov 2024
NCT06574347	KYLIN-2	Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.	P2	recruiting	120	Avistone Biotechnology Co., Ltd.	Aug 2024
NCT05880706		A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer	P2	active not recruiting	198	Sichuan Baili Pharmaceutical Co., Ltd.	Jul 2023
NCT03040973		Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone	P2	active not recruiting	29	Novartis Pharmaceuticals	Aug 2017
NCT05693090		Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer	P1	withdrawn	0	Kura Oncology, Inc.	Feb 2023
NCT06194448	NEOLA	To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations	P2	active not recruiting	76	AstraZeneca	Apr 2024
NCT07315113		Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer	P1	recruiting	18	Nuvectis Pharma, Inc.	Dec 2025
NCT03191149		Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change	P2	recruiting	46	National Cancer Institute (NCI)	Apr 2018
NCT02496663		Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor	P1	active not recruiting	138	National Cancer Institute (NCI)	May 2016
NCT04765059	COMPEL	A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)	P3	active not recruiting	98	AstraZeneca	Sep 2021
NCT04335292	OCELOT	Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge	P2	recruiting	200	Mark Vincent	Jan 2021
NCT04410796		Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers	P2	recruiting	571	Memorial Sloan Kettering Cancer Center	May 2020
NCT04676477		HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer	P1	active not recruiting	246	Daiichi Sankyo	Jun 2021
NCT03410043		Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study	P2	active not recruiting	173	M.D. Anderson Cancer Center	Jan 2018
NCT05089916	ROSE	Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study	P2	active not recruiting	42	AIO-Studien-gGmbH	Jan 2022
NCT04868877		Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination	P1/P2	active not recruiting	194	Merus B.V.	Apr 2021
NCT03831932		Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer	P1/P2	active not recruiting	22	National Cancer Institute (NCI)	Mar 2020
NCT02503722	TAK-228	Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer	P1	active not recruiting	36	National Cancer Institute (NCI)	Mar 2017
NCT05629234	ROSY-T	Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Osimertinib (TAGRISSO) (ROSY-T)	P3	active not recruiting	37	AstraZeneca	May 2023
NCT06507306		A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies	P1	recruiting	100	Kumquat Biosciences Inc.	Jun 2024
NCT03909334	NSCLC	Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)	P2	active not recruiting	160	Xiuning Le	Jul 2019
NCT06303167		Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)	P2	active not recruiting	19	National Cancer Institute (NCI)	Jan 2016
NCT07322783		Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification	P2	recruiting	60	Qingdao Central Hospital	Jan 2025
NCT06363734		Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial	P2	recruiting	32	Tianjin Medical University Cancer Institute and Hospital	Apr 2024
NCT04769388	FLAME	Osimertinib Plus Chemotherapy vs Osimertinib in EGFRm NSCLC With Persistence Week-3 ctDNA EGFRm After 1L Osimertinib	P2	active not recruiting	80	Beijing Cancer Prevention & Treatment Society	Dec 2021
NCT04181060		Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer	P3	recruiting	300	National Cancer Institute (NCI)	Dec 2020
NCT04413201	AFAMOSI	AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients with EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC	P4	active not recruiting	34	Michael Hopp	Sep 2020
NCT04085315		Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer	P1	recruiting	38	Collin Blakely	Nov 2019
NCT03778229	SAVANNAH	Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib	P2	active not recruiting	367	AstraZeneca	Jan 2019
NCT02465060		Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	P2	active not recruiting	6,452	National Cancer Institute (NCI)	Aug 2015
NCT02411448	RELAY	A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)	P3	active not recruiting	545	Eli Lilly and Company	May 2015
NCT06319950		High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases	P2	not yet recruiting	255	Taizhou Hospital	Apr 2024
NCT05816252	SKB264-II-04	A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003)	P2	active not recruiting	356	Klus Pharma Inc.	Apr 2023
NCT03392246		A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer	P2	active not recruiting	25	Dana-Farber Cancer Institute	Jan 2018
NCT04762199		MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer	P1	recruiting	69	Emory University	Feb 2021
NCT04035486	FLAURA2	A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)	P3	active not recruiting	587	AstraZeneca	Jul 2019
NCT06185400		RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations	P2	not yet recruiting	108	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Feb 2024
NCT04545710		Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance	P2	active not recruiting	18	University of California, San Diego	Nov 2020
NCT05281406	PACE-LUNG	Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)	P2	recruiting	50	Goethe University	Nov 2021
NCT05261399	SAFFRON	Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment	P3	active not recruiting	345	AstraZeneca	Aug 2022
NCT06391944	NSCLC	JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations	P2	active not recruiting	161	Shanghai JMT-Bio Inc.	Nov 2021
NCT06067776		Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer	P1	not yet recruiting	36	Jonathan Riess	Jan 2024
NCT06532149	EROS	ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer	—	recruiting	80	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Aug 2024
NCT06304441		Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer	N/A	recruiting	100	Guangzhou Medical University	Apr 2024
NCT06018688		Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.	P2	not yet recruiting	44	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	Sep 2023
NCT06498986		A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer	P2	recruiting	40	Sichuan Baili Pharmaceutical Co., Ltd.	Jul 2024
NCT05163249	FLOWERS	Osimertinib With or Without Savolitinib as 1L in de Novo MET+, EGFR+ NSCLC	P2	active not recruiting	44	Guangdong Association of Clinical Trials	May 2022
NCT02099058	PK	A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors	P1	active not recruiting	237	AbbVie	Jan 2014
NCT06071013		Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients	P1/P2	recruiting	20	China Medical University Hospital	Feb 2024
NCT06014827	SBRT	Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma	P2	recruiting	32	City of Hope Medical Center	Oct 2024
NCT02971501		Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases	P2	active not recruiting	5	National Cancer Institute (NCI)	Jun 2018
NCT05017025		Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer	P1/P2	active not recruiting	32	M.D. Anderson Cancer Center	Feb 2022
NCT04772235	TOTEM	Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients	P1	recruiting	32	Instituto Oncológico Dr Rosell	Feb 2022
NCT04001777	AZD9291	A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC Patients	P1	active not recruiting	80	Ascentage Pharma Group Inc.	Jul 2019
NCT03567642		A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers	P1	active not recruiting	11	Memorial Sloan Kettering Cancer Center	Jun 2018
NCT03940703	INSIGHT 2	A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)	P2	active not recruiting	140	EMD Serono Research & Development Institute, Inc.	Sep 2019
NCT03381274	MEDI9447	Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study	P1/P2	active not recruiting	43	MedImmune LLC	May 2018
NCT06362980	EGFR	A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations	P1	recruiting	20	National Cancer Center, China	May 2024
NCT07491211		Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases	—	active not recruiting	300	Fudan University	Jul 2019
NCT04606771	CoC	A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC	P2	active not recruiting	30	AstraZeneca	Sep 2020
NCT06630325	SMMART-ACT	A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer	P2	terminated	6	OHSU Knight Cancer Institute	Jun 2025
NCT04721015	IV	Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors	P1	active not recruiting	81	AbbVie	Feb 2021
NCT06613633		Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC	—	completed	4,000	Fudan University	Sep 2018
NCT05103605	POSITHES	Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations	—	active not recruiting	274	AstraZeneca	May 2021
NCT05020769		SI-B001 Combined With Osimertinib Mesylate Tablets in the Treatment of Recurrent Metastatic Non-small Cell Lung Cancer.	P2/P3	active not recruiting	14	Sichuan Baili Pharmaceutical Co., Ltd.	Jan 2022
NCT03804580	FIOL	First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer	P2	unknown	100	Vestre Viken Hospital Trust	Dec 2018
NCT05583409		SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC	N/A	unknown	72	Li Zhang	Jan 2023
NCT02917993		An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer	P1/P2	completed	59	Incyte Corporation	Dec 2016
NCT03810807		Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer	P1	completed	22	Memorial Sloan Kettering Cancer Center	Jan 2019
NCT06675695	NCT02296125	Emulation of the FLAURA (NCT02296125) Trial Using Specialty Oncology Electronic Health Records Databases	—	completed	4,864	Brigham and Women's Hospital	Oct 2024
NCT05785208	TEMPLE-2	Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status.	P4	unknown	122	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Jun 2022
NCT04816838	DTP	A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harbouring EGFR Mutations	N/A	unknown	25	Yonsei University	May 2021
NCT04829019		Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI	P2	unknown	88	Sun Yat-sen University	Apr 2021
NCT06604689		AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases	—	recruiting	800	Fudan University	Sep 2024
NCT05954871		Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer	P1	completed	10	Genentech, Inc.	Jan 2024
NCT05015608	SACHI	Study on Savolitinib Combined With Osimertinib in Treatment of Advanced NSCLC With MET Amplification	P3	completed	216	Hutchison Medipharma Limited	Nov 2021
NCT02856893	APPLE	Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)	P2	completed	156	European Organisation for Research and Treatment of Cancer - EORTC	Oct 2017
NCT06525246		Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer	P1	completed	78	Ono Pharmaceutical Co., Ltd.	Aug 2021
NCT04988607		Osimertinib Plus Bevacizumab in Untreated EGFR Exon21 L858R Mutated NSCLC	P2	unknown	90	Guangdong Association of Clinical Trials	Aug 2021
NCT03944772	ORCHARD	Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)	P2	active not recruiting	247	AstraZeneca	Jun 2019
NCT03769103		Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC	P2	active not recruiting	40	British Columbia Cancer Agency	Mar 2019
NCT03865511	MELROSE	MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib	P2	unknown	150	Nantes University Hospital	Apr 2019
NCT05498389		EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer	P1/P2	unknown	115	Shanghai EpimAb Biotherapeutics Co., Ltd.	Jun 2023
NCT04974879	EGFR	Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer	P2	unknown	20	Qingdao Central Hospital	Jul 2021
NCT05104281	EGFR	Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer	P3	unknown	60	Qingdao Central Hospital	Jan 2021
NCT04391283		First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting	—	unknown	500	First Affiliated Hospital of Zhejiang University	Jul 2020
NCT04233021	ORBITAL	Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation	P2	completed	57	Intergroupe Francophone de Cancerologie Thoracique	Jul 2020
NCT04862780	SYMPHONY	(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC	P1	terminated	177	Blueprint Medicines Corporation	Jun 2021
NCT05132777		Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer	P2	unknown	155	Shanghai JMT-Bio Inc.	Nov 2021
NCT05421936	UNICORN	Osimertinib for NSCLC With Uncommon EGFR Mutations	—	suspended	100	Sheba Medical Center	Sep 2020
NCT05228015		Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors	P1	terminated	67	Ikena Oncology	Jan 2022
NCT05085054	SDANT	Salvage Surgery Following Downstaging of Advanced Non-small Cell Lung Cancer by Targeted Therapy (SDANT)	P2	unknown	30	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Jun 2022
NCT05507606		Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations	P2	unknown	50	Tianjin Medical University Cancer Institute and Hospital	Aug 2021
NCT05284994		TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer	P1/P2	unknown	160	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Mar 2022
NCT04770688	AUTOMAN	Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib	P1/P2	completed	25	Shanghai Chest Hospital	Nov 2020
NCT04870190	ATTACK	Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases	P3	unknown	232	Shanghai Chest Hospital	Jun 2021
NCT04184921		Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients	P2	completed	216	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	Jan 2019
NCT03543683		Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC	P2	completed	115	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	Jan 2018
NCT03497767	OUTRUN	A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases	P2	completed	40	Trans Tasman Radiation Oncology Group	Aug 2019
NCT03891615		Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer	P1	unknown	30	Massachusetts General Hospital	Jun 2019
NCT05489731	VIC-1911	VIC-1911 Combined With Osimertinib for EGFR -Mutant Non-small Cell Lung Cancer	P1	unknown	72	Jiesi Yingda Pharmaceutical Technology (Suzhou) Co., Ltd.	Sep 2022
NCT05120960		A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors	P1	withdrawn	0	M.D. Anderson Cancer Center	Feb 2023
NCT05298176	COMBINATION	Combining Afatinib and Concurrent Chemotherapy, Followed by Osimertinib and Concurrent Chemotherapy, in Untreated EGFR Positive NSCLC Tumors	P2	completed	5	Amsterdam UMC, location VUmc	Jan 2022
NCT06032936		BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations	P1	terminated	4	LianBio LLC	Jul 2023
NCT04908956	STEREO	Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO)	P2	terminated	6	ETOP IBCSG Partners Foundation	Aug 2022
NCT03133546	BOOSTER	Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M	P2	completed	155	ETOP IBCSG Partners Foundation	May 2017
NCT03732352		18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma	P2	completed	12	Jonsson Comprehensive Cancer Center	Nov 2018
NCT05834348	DELINOR	A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.	—	completed	5,279	Pfizer	Jun 2023
NCT04575415	BELLA	Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study	—	unknown	272	Guangdong Association of Clinical Trials	Oct 2020
NCT04811001	CAPLAND	Best EGFR-TKI Sequence in NSCLC Harboring EGFR Mutations	P2	unknown	170	Fondazione Ricerca Traslazionale	Jun 2020
NCT04720976		JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors	P1/P2	completed	58	Allist Pharmaceuticals, Inc.	Mar 2021
NCT02151981	AURA3	AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer	P3	completed	421	AstraZeneca	Aug 2014
NCT02520778		Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer	P1	completed	27	National Cancer Institute (NCI)	Aug 2016
NCT07271446	PB101	An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung Cancer	P1	completed	8	Precision Biotech Taiwan Corp.	Sep 2018
NCT02664935		National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer	P2	completed	423	University of Birmingham	May 2015
NCT04563871	BLOSSOM	Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC)	P2	completed	73	Samsung Medical Center	Nov 2020
NCT03239340	ELIOS	A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib	P2	completed	154	AstraZeneca	May 2018
NCT05493501		Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer	P3	terminated	8	EQRx International, Inc.	Dec 2022
NCT05513664		Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer	—	unknown	80	Shanghai JMT-Bio Inc.	Sep 2022
NCT04479306		Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer	P1	completed	37	M.D. Anderson Cancer Center	Jun 2020
NCT03755102		A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.	Early P1	completed	17	Memorial Sloan Kettering Cancer Center	Nov 2018
NCT04965701	FLOWER	First Line Osimertinib in the Real World: an Inter-regional Prospective Study	—	completed	200	Istituto Oncologico Veneto IRCCS	Jun 2018
NCT04959981	HERKULES-2	A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC	P1	completed	24	Erasca, Inc.	Sep 2021
NCT05215951	MINOVA	Osimertinib Plus Chemotherapy in Uncommon EGFRm NSCLC	P2	terminated	4	AstraZeneca	Jan 2022
NCT02954523	AZD9291	Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations	P1/P2	terminated	10	Chul Kim	Oct 2016
NCT04438902		Osimertinib Combined With Anlotinib in EGFR T790M Mutated NSCLC Patients With Progression on Osimertinib Treatment	P2	terminated	3	First Affiliated Hospital of Zhejiang University	Dec 2020
NCT03532698		Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)	—	unknown	100	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	Aug 2020
NCT04816214	GEOMETRY-E	Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy	P3	terminated	6	Novartis Pharmaceuticals	Sep 2021
NCT05153408	HARMONY	(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC	P1	terminated	20	Blueprint Medicines Corporation	Jan 2022
NCT05458726		Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC	P2	unknown	80	Peking Union Medical College	Sep 2020
NCT02923947		Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney Impairment	P1	completed	16	AstraZeneca	May 2017
NCT03434418		A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations	P2	completed	17	Duke University	Jun 2018
NCT03810066	THEROS	Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS)	P2	completed	16	University Hospital, Essen	Jun 2019
NCT02759835		Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib	P2	completed	37	National Cancer Institute (NCI)	Apr 2016
NCT04541407		Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease	P1	completed	1	University of Colorado, Denver	Oct 2020
NCT02789345	LY3009806	A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer	P1	completed	29	Eli Lilly and Company	Oct 2016
NCT03535363	SRS	Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC	P1	completed	6	Case Comprehensive Cancer Center	Oct 2018
NCT02803203		Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers	P1/P2	completed	49	Memorial Sloan Kettering Cancer Center	Jun 2016
NCT03455829	G1T38	G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer	P1/P2	completed	30	G1 Therapeutics, Inc.	Mar 2018
NCT03989115		Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC	P1/P2	completed	113	Revolution Medicines, Inc.	Jul 2019
NCT04029350	ALTN-03	Study of Anlotinib Combined With Osimertinib as Second-line Treatment in Stage IIIb-IV NSCLC With Confirmed EGFRm and T790M	P2	unknown	53	Tianjin Medical University Cancer Institute and Hospital	Jul 2019
NCT04798638		A Study to Assess the Effect of Food on the Pharmacokinetics of TY-9591 in Healthy Volunteers	P1	completed	16	TYK Medicines, Inc	Apr 2021
NCT03414814		Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation	P2	completed	15	Seoul National University Hospital	Jan 2018
NCT04179890	UpSwinG	The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib	—	completed	462	Boehringer Ingelheim	Dec 2019
NCT04148898	OWONBNSCLCLM	Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis	P2	unknown	80	Second Affiliated Hospital of Nanchang University	Nov 2019
NCT04425681	OWBLM	Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer	P2	unknown	20	Second Affiliated Hospital of Nanchang University	Oct 2017
NCT03784599	TRAEMOS	T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC	P2	terminated	28	The Netherlands Cancer Institute	Dec 2018
NCT03394118		TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid Biopsy	P2	completed	63	Asan Medical Center	Aug 2017
NCT03460275		Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer	P2	unknown	100	Sun Yat-sen University	Feb 2018
NCT03219970		Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting.	—	completed	156	AstraZeneca	Sep 2017
NCT03463525	ODIN-BM	Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases	P1	completed	4	AstraZeneca	Oct 2018
NCT03255083	EGFR	DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer	P1	terminated	13	Daiichi Sankyo	Apr 2019
NCT02769286	LiquidLung-O	Osimertinib in First and Second Line Treatment of NSCLC Harboring EGFR Mutations From Circulating Tumor DNA	P2	completed	38	Chonnam National University Hospital	Aug 2016
NCT03418532		MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC	P1	terminated	8	Molecular Partners AG	Mar 2018
NCT03853551		Osimertinib Study in Indian Patients	P4	completed	60	AstraZeneca	Apr 2019
NCT03790397	OSIREX	Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive	—	completed	169	Fundación GECP	Feb 2019
NCT02841579	AZENT	Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M	P2	completed	22	MedSIR	Sep 2016
NCT03370770		Afatinib Osimertinib Sequencing NIS	—	completed	204	Boehringer Ingelheim	Dec 2017
NCT03050411		Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer	P1	unknown	30	Peking University Third Hospital	May 2016
NCT02959749		Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer	P2/P3	completed	147	Qingdao Central Hospital	Aug 2015
NCT03133234		Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLC	—	completed	47	AstraZeneca	May 2017

Osimertinib clinical trials: frequently asked questions

How many Osimertinib clinical trials are there?: 246 Osimertinib clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 64 are actively recruiting participants. 51 are marked completed.
Are Osimertinib clinical trials recruiting in 2026?: Yes — 64 Osimertinib trials are actively recruiting in 2026, with 1678 U.S. sites across 51 states. See the recruiting trials and the per-state site list further down this page.
What conditions is Osimertinib being studied for?: Osimertinib is being studied for Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer, NSCLC, Lung Cancer and 269 more. The trials are grouped by indication on this page.
What phase is Osimertinib in?: Osimertinib clinical trials span 5 Phase 4, 32 Phase 3, 107 Phase 2, 45 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Osimertinib clinical trials?: The lead sponsor across the most Osimertinib trials is AstraZeneca, with 139 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Osimertinibas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 18, 2026.

Related pages on Hipa.ai:

Osimertinib overview Osimertinib evidence & publications